| S.No. | Test Code | Investigations | Price(MRP) | Sample | TEMP | Method | Schedule | Reporting | General Instructions | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | #001 | 11q 23 or LSI MLL Gene Rearrangement (ALL, AML) Blood | 5550 | 5 ml Whole Blood Sodium Heparin OR 4 ml Bone Marrow | A | FISH | Daily | Eighth Day | ||
| 2 | #002 | 17-Alpha Hydroxy Progesterone (17- OHP) | 1250 | Serum (1 ml) | R/F | CLIA / ELISA | Daily 3 PM | Next day | Clinical history required. | |
| 3 | #003 | 17-Ketosteroids | 3650 | 24 Hrs Urine (20 ml) 6 M HCL | A | Column Chroma- tography | 6 | Fourth Day | Add appropriate volume of 6M HCL to maintain pH below 5 | |
| 4 | #004 | 5- Alpha Dihydrotestosterone (5α- DHT) | 2000 | Serum (2 ml) | A/R | ELISA | Daily | Third Day | ||
| 5 | #005 | 5-HIAA (Hydroxy Indole Acetic Acid) | 2900 | 24 hrs Urine (20 ml) 6 M HCL | A/R | HPLC / Column Chromatography | 3, 6 | Fourth Day | Add appropriate volume of 6M HCL to maintain pH below 5 | |
| 6 | A001 | A4 (Androstenedione) | 1350 | Serum (2 ml) | A/R | CLIA | Daily | Third Day | Clinical history required | |
| 7 | A002 | ABO Group & RH Type (Blood Group) | 120 | WB-EDTA (3ml) | A | Agglutination | Daily | Same Day | ||
| 8 | A147 | Absolute Basophils Count (ABC) | 150 | WB-EDTA (3.0 ml) | A | Cell Counter & Microscopy | Daily | Same Day | ||
| 9 | A003 | Absolute Eosinophil Count (AEC) | 150 | WB-EDTA (3.0 ml) | A | Cell Counter & Microscopy | Daily | Same Day | ||
| 10 | A004 | Absolute lymphocyte Count (ALC) | 150 | WB-EDTA (3.0 ml) | A | Cell Counter & Microscopy | Daily | Same Day | ||
| 11 | A005 | Absolute Neutrophil Count | 150 | WB-EDTA (3.0 ml) | A | Cell Counter & Microscopy | Daily | Same Day | ||
| 12 | A006 | ACE (Angiotensin Converting Enzyme) | 900 | Serum (2 ml) | A/R | Spectrophotometry | Daily 3 PM | Same day | Overnight fasting is preffered | |
| 13 | A007 | Acetone/Ketone | 120 | Urine 10 ml | R | Chemical Analysis | Daily | Same Day | ||
| 14 | A008 | Acetyl Choline Receptor Antibody (AChR Ab) | 3300 | Serum (3 ml) | A/R | RIA / ELISA | Daily | Third Day | ||
| 15 | A009 | Acid Fast Bacilli Stain (Biopsy) | 450 | Tissue in formalin | A | Histopathology | Daily | Seventh Day | Clinical history required | |
| 16 | A010 | Acid Fast Bacilli Stain (Z. N. Stain) | 180 | Pulmonary/Extra Pulmonary (Sputum/ BAL/Urine/Pus/CSF/ Body Fliuds/Blood/ Tissue) | A | Microscopy | Daily | Same Day | ||
| 17 | A153 | Acid Fast Bacilli Stain (Z. N. Stain) 2 Samples | 300 | Pulmonary/Extra Pulmonary (Sputum/ BAL/Urine/Pus/CSF/ Body Fliuds/Blood/ Tissue) | A | Microscopy | Daily | Same Day | ||
| 18 | A154 | Acid Fast Bacilli Stain (Z. N. Stain) Second Sample | 180 | Pulmonary/Extra Pulmonary (Sputum/ BAL/Urine/Pus/CSF/ Body Fliuds/Blood/ Tissue) | A | Microscopy | Daily | Same Day | ||
| 19 | A011 | Acid Fast Bacilli Susceptibility – 10 Drug | 9000 | Positive Culture | A | Bactec MGIT Method | Daily | 15 days | ||
| 20 | A013 | Acid Fast Bacilli Susceptibility – 13 Drugs | 10000 | Positive Culture | A | Bactec MGIT Method | Daily | 15 Day | ||
| 21 | A014 | Acid Fast Bacilli Susceptibility – 3 Drugs | 3350 | Positive Culture | A | Bactec MGIT Method | Daily | 15 Day | Please specify the name of drugs. | |
| 22 | A015 | Acid Fast Bacilli Susceptibility – 5 Drug | 4600 | Positive Culture | A | Bactec MGIT Method | Daily | 15 days | ||
| 23 | A017 | Acid Fast Bacilli Susceptibility (Amikacin) | 1250 | Positive Culture | A | Bactec MGIT Method | Daily | 15 Day | ||
| 24 | A019 | Acid Fast Bacilli Susceptibility (Capreomycin) | 1250 | Positive Culture | A | Bactec MGIT Method | Daily | 15 Day | ||
| 25 | A021 | Acid Fast Bacilli Susceptibility (Ciprofloxacin) | 1250 | Positive Culture | A | Bactec MGIT Method | Daily | 15 Day | ||
| 26 | A024 | Acid Fast Bacilli Susceptibility (Clofazimine) | 1250 | Positive Culture | A | Bactec MGIT Method | Daily | 15 days | ||
| 27 | A026 | Acid Fast Bacilli Susceptibility (Cycloserine) | 1250 | Positive Culture | A | Bactec MGIT Method | Daily | 15 Day | ||
| 28 | A028 | Acid Fast Bacilli Susceptibility (Erythromycin) | 1250 | Positive Culture | A | Bactec MGIT Method | Daily | 15 days | ||
| 29 | A029 | Acid Fast Bacilli Susceptibility (Ethambutol) | 1250 | Positive Culture | A | Bactec MGIT Method | Daily | 15 Day | ||
| 30 | A031 | Acid Fast Bacilli Susceptibility (Ethionamide) | 1250 | Positive Culture | A | Bactec MGIT Method | Daily | 15 Day | ||
| 31 | A033 | Acid Fast Bacilli Susceptibility (Isoniazid) | 1250 | Positive Culture | A | Bactec MGIT Method | Daily | 15 Day | ||
| 32 | A036 | Acid Fast Bacilli Susceptibility (Kanamycin) | 1250 | Positive Culture | A | Bactec MGIT Method | Daily | 15 Day | ||
| 33 | A038 | Acid Fast Bacilli Susceptibility (Ofloxacin) | 1250 | Positive Culture | A | Bactec MGIT Method | Daily | 15 Day | ||
| 34 | A039 | Acid Fast Bacilli Susceptibility (PAS) | 1250 | Positive Culture | A | Bactec MGIT Method | Daily | 15 days | ||
| 35 | A042 | Acid Fast Bacilli Susceptibility (Prothionamide) | 1250 | Positive Culture | A | Bactec MGIT Method | Daily | 15 days | ||
| 36 | A043 | Acid Fast Bacilli Susceptibility (Pyrazinamide) | 1250 | Positive Culture | A | Bactec MGIT Method | Daily | 15 Day | ||
| 37 | A046 | Acid Fast Bacilli Susceptibility (Rifampicin) | 1250 | Positive Culture | A | Bactec MGIT Method | Daily | 18 Day | ||
| 38 | A049 | Acid Fast Bacilli Susceptibility (Roxithromycin) | 1250 | Positive Culture | A | Bactec MGIT Method | Daily | 15 days | ||
| 39 | A051 | Acid Fast Bacilli Susceptibility (Sparfloxacin) | 1250 | Positive Culture | A | Bactec MGIT Method | Daily | 15 days | ||
| 40 | A052 | Acid Fast Bacilli Susceptibility (Streptomycin) | 1250 | Positive Culture | A | Bactec MGIT Method | Daily | 15 Day | ||
| 41 | A055 | Acid Fast Bacilli Susceptibility (Vancomycin) | 1250 | Positive Culture | A | Bactec MGIT Method | Daily | 15 Day | ||
| 42 | A056 | Acid Phosphatase- Total | 250 | Serum (1 ml) add 1 drop (30ul) of 5% acetic acid to serum | R/F | Spectrophotometry | Daily 3 PM | Next Day | Add 1 drop (30ul) 5% Acetic Acid to Serum | |
| 43 | A057 | ACTH (Adreno Cortico Trophic Hormone) | 1100 | EDTA Plasma (5 ml) | R/F | CLIA | Daily 3 PM | Next Day | Separate Plasma Immediately | |
| 44 | A058 | Activated Partial Thromboplastin Time (APTT / PTTK) | 350 | Plasma Citrated (1ml) | R/F | Clotting (Coagu- lometry) | Daily | Same Day | Ensure Platelet Poor Plasma | |
| 45 | A012 | Active Vitamin B-12 (Holotranscoblamin) | 1400 | Serum (2 ml) | A | CLIA | Daily | Third Day | ||
| 46 | A059 | Adenosine Deaminase (ADA) (Ascitic Fluid) | 500 | Ascitic fluid (5 ml) | R/F | Spectrophotometry | Daily | Same Day | ||
| 47 | A060 | Adenosine Deaminase (ADA) (Body Fluid) | 500 | Any Other Body Fluid | R/F | Spectrophotometry | Daily | Same Day | ||
| 48 | A061 | Adenosine Deaminase (ADA) (Pericardial Fluid) | 500 | Pericardial Fluid (1 ml) | R/F | Spectrophotometry | Daily | Same Day | ||
| 49 | A062 | Adenosine Deaminase (ADA) (Pleural Fluid) | 500 | Pleural Fluid (1 ml) | R/F | Spectrophotometry | Daily | Same Day | ||
| 50 | A063 | Adenosine Deaminase (ADA) (Pus) | 500 | Pus (1 ml) | R/F | Spectrophotometry | Daily | Same Day | ||
| 51 | A064 | Adenosine Deaminase (ADA) (CSF) | 500 | CSF (1.0 ml) | R/F | Spectrophotometry | Daily | Same Day | ||
| 52 | A065 | Adenosine Deaminase (ADA) (Serum) | 500 | Serum (1 ml) | R/F | Spectrophotometry | Daily | Same Day | ||
| 53 | A066 | Adenovirus IgG | 2150 | Serum (3 ml) | A | Elisa | 2 | Third Day | ||
| 54 | A067 | Adenovirus IgM | 2150 | Serum (3 ml) | A | Elisa | 2 | Third Day | ||
| 55 | A068 | Adenovirus PCR | 5800 | Swabs: (Oral, Eye, Nasal)/ Respiratory Fluids (1ml) | A | PCR | Daily | 13th Day | ||
| 56 | A157 | Adrenaline Epinephrine Plasma | 3150 | EDTA 3 ml | R | EIA | 1 | 4th day | ||
| 57 | A158 | Albumin (Fluid) | 130 | Serum (1 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 58 | A159 | Alakaline phosphastase with bone fraction | 2500 | Serum (1 ml) | R | CLIA | 2, 6 | 4th day | Lebile Analyte, Sepearte at the earliest | |
| 59 | A160 | Allergy panel-III (Vegeterian+ Inhalants+ Drugs) | 5200 | Serum (1 ml) | A | ELISA | Daily | 4th day | ||
| 60 | A161 | Acid Fast Bacilli Drug Susceptility 15 drug with identification (MOTT/NTM) | 13000 | Positive Culture | A | Bactec MGIT Method | Daily | 15 Day | ||
| 61 | A162 | Anti B Titer IgG | Serum | A | Agglutination/EMT | Daily | Next day | |||
| 62 | A069 | AFP (Alpha Feto Protein) | 650 | Serum (1 ml) | A/R | CLIA | Daily | Same Day | Clinical history required | |
| 63 | A070 | Albert’s Stain | 350 | Throat Swab In Sterile Container /Amies Transport Medium | A | Microscopy/ Staining | Daily | Same Day | ||
| 64 | A071 | Albumin | 130 | Serum (1 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 65 | A072 | Albumin Globulin Ratio | 250 | Serum (1 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 66 | A073 | Alcohol | 1200 | Serum (1 ml)/ Urine Random (25 ml) (Walk in Patients) | R/F | IC | Daily | Next | Labile Analyte | |
| 67 | A143 | Aldehyde Chopra Test (For Kala Azar) | 600 | Serum (3 ml) | R/F | Biochemical Tube Cotting | Daily | 3rd Day | ||
| 68 | A074 | Aldolase | 1000 | Serum (1 ml) | R/F | Spectrophotometry | 2, 6 | Next Day | ||
| 69 | A075 | Aldosterone | 2100 | Serum (1 ml) | F | ELISA | 3, 6 | Same Day | Labile Analyte. Draw upright specimen after the patient is made sit up for 30 minutes. Mention Position Of Collecion | |
| 70 | A016 | Aldosterone to Renin Activity | 6500 | 2 ml EDTA & 2 ml Serum | A | EIA/RIA | Daily | 4th day | ||
| 71 | A076 | Alkaline Phosphatase (ALP) | 130 | Serum (1 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 72 | A077 | Allergen- Gluten | 1300 | Serum (2 ml) | A | Immunocap | 3, 6 | Third Day | ||
| 73 | A078 | Allergy- Drugs | 2300 | Serum (2 ml) | A | ELISA | 3, 6 | Third Day | ||
| 74 | A079 | Allergy- Food (Non Vegeterian Only) | 3000 | Serum (2 ml) | A | ELISA | Daily | 4th day | ||
| 75 | A080 | Allergy- Food (Vegetarian Only) | 3000 | Serum (2 ml) | A | ELISA | Daily | 4th day | ||
| 76 | A081 | Allergy- Inhalants | 3000 | Serum (2 ml) | A | ELISA | Daily | 4th day | ||
| 77 | A082 | Allergy- Phadia Top Test for Adult, For > 5 years | 1500 | Serum (3 ml) | A | Immunocap | 3, 6 | Third Day | ||
| 78 | A083 | Allergy- Phadia Top Test for Infant, For < 5 years | 1500 | Serum (3 ml) | A | Immunocap | 3, 6 | Third Day | ||
| 79 | A155 | Allergy Any Allergen | 1300 | Serum (2 ml) | A | ELISA | Daily | 4th day | ||
| 80 | A149 | Allergy 3 Panel (VPC) | 3000 | Serum (2 ml) | A | ELISA | Daily | Third Day | ||
| 81 | A150 | Allergy Panel 5 (Without Drugs) | 4500 | Serum (2 ml) | A | ELISA | Daily | Third Day | ||
| 82 | A084 | Alpha Thalassemia by PCR 5 Common deletions) | 6000 | WB EDTA (5 ml) | R/F | Multiplex DNA- PCR | 6 | 12th Day | Clinical history required | |
| 83 | A085 | Alpha-1 Antitrypsin (AAT) | 1700 | Serum (1 ml) | R/F | Nephelometry | Daily | 3rd Day | ||
| 84 | A086 | Aluminium | 3550 | Serum/ Urine (2 ml) | A | AAS | 6 | 10th Day | ||
| 85 | A087 | AMA (Anti Mitochondrial Antibodies-M2) IFA | 1780 | Serum (1 ml) | A | IFA | Daily | Fourth Day | ||
| 86 | A088 | AMA (Anti Mitochondrial Antibodies-M2) ELISA | 1300 | Serum (1 ml) | A | ELISA | Daily | Fourth Day | ||
| 87 | A090 | Amino Acid Analysis, Quantitative Plasma | 8600 | Plasma-EDTA (3.0 ml) | F | HPLC | Daily | 20th Day | Clinical history required | |
| 88 | A091 | Amino Acid Analysis, Quantitative Urine Random | 8600 | Urine in Sterile Container (10 ml) | F | HPLC | Daily | 20th Day | Without preservative | |
| 89 | A092 | Amino Acid Screen- Qualitative, CSF | 3450 | 2 ml of CSF | RT | Thin Layer Chromatography | Daily | 7th Day | ||
| 90 | A093 | Amino Acid Screen- Qualitative, Serum | 3450 | 2 ml of serum | RT | Thin Layer Chromatography | Daily | 7th Day | ||
| 91 | A094 | Amino Acid Screen- Qualitative, Urine | 3450 | 2 ml of Urine | RT | Thin Layer Chromatography | Daily | 7th Day | ||
| 92 | A095 | Amino Levulinic Acid (ALA) | 4500 | Urine (24 Hrs) (25 ml) | A | Column Chroma- tography | 2 | 5th Day | Collect 2nd morning sample. Aliquot into a dark coloured vial/ container wrapped completely with black paper or aluminium foil containing 0.1 ml Glacial Acetic acid | |
| 93 | A096 | AML1 / ETO t(8:21) (Quantitative) By FISH | 5600 | Whole blood (5.0 ml)/ Bone Marrow from 2 Green Top (Sodium Heparin) tubes. | A | FISH | Daily | 8th Day | ||
| 94 | A018 | AMLI / ETO t(8:21) By PCR | 5700 | Whole blood EDTA / Bone Marrow | A | PCR | 3, 6 | Third Day | ||
| 95 | A098 | Amphetamine | 900 | Urine (5 ml) | A | IC | Daily | Next Day | ||
| 96 | A099 | Amylase, 24 Hr. Urine | 400 | 24hrs Urine (5 ml) | A | Spectrophotometry | Daily | Same Day | 24 hours Urine volume required | |
| 97 | A100 | Amylase Serum | 400 | Serum (2 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 98 | A144 | Amylase Fluid | 450 | Fluid | A | Spectrophotometry | Daily | Same Day | ||
| 99 | A101 | ANA (Anti Nuclear Antibodies) by IFA | 890 | Serum (3 ml) | A | IFA | Daily | Third Day | ||
| 100 | A102 | ANA (Anti Nuclear Antibodies) by ELISA | 550 | Serum (2 ml) | A | ELISA | 2, 5, 7 | Next Day | ||
| 101 | A103 | ANA (Anti Nuclear Antibodies) with Titers | 1450 | Serum (3 ml) | A | IFA | 2, 5, 7 | Next Day | ||
| 102 | A104 | ANCA (Anti Neutrophil Cytoplasmic Antibodies) (P-ANCA, C- ANCA) | 2000 | Serum (3 ml) | A | ELISA | Daily | Same Day | ||
| 103 | A105 | ANCA (Anti Neutrophil Cytoplasmic Antibodies) Titer IFA | 2700 | Serum (3 ml) | A | IFA | 2, 5 | 3rd Day | ||
| 104 | A106 | Anti Islet Cell Antibodies | 2400 | Serum (3 ml) | R/F | IFA | 1 | Fourth Day | ||
| 105 | A108 | Anti Centromere Antibodies | 1750 | Serum (2 ml) | A | ELISA | 2, 5 | Next Day | ||
| 106 | A110 | ADH-Anti Diuretic Hormone (Vasopressin) | 4500 | EDTA (3 ml) | R | RIA / ELISA | 6 | Fourth Day | ||
| 107 | A111 | Anti DNAse B | 1700 | Serum (3 ml) | R | Nephelometry | 3, 6 | Same Day | ||
| 108 | A114 | Anti Endomysial Antibody (IgG), IFA | 2500 | Serum (2 ml) | A | IFA | 2, 6 | Next Day | ||
| 109 | A115 | Anti Gliadin IgA Antibodies De-amidated (DGP) | 2100 | Serum (2 ml) | A | ELISA | Daily | Second Day | ||
| 110 | A116 | Anti Gliadin IgG Antibodies De-amidated (DGP) | 2100 | Serum (2 ml) | A | ELISA | Daily | Second Day | ||
| 111 | A118 | Anti Histones Antibodies | 1900 | Serum (2 ml) | A | Immuno Blot | 2 | Third Day | ||
| 112 | A119 | Anti Microsomal Antibodies (Anti Thyroperoxidase) (TPO) | 900 | Serum (2 ml) | R/F | CLIA | Daily | Same Day | ||
| 113 | A120 | Anti Mullarian Hormone (AMH) | 1800 | Serum (2 ml) | R/F | CLIA | Daily | Same Day | ||
| 114 | A121 | Anti Ovarian Antibody (Anti Ovary Antibodies) | 3500 | Serum (3 ml) | R/F | IFA | 1st & 3rd Sat | Fourth Day | ||
| 115 | A123 | Anti Saccharomyces Cerevisiae (ASCA), IgA Antibodies (Crohn’s Disease) | 2300 | Serum (3 ml) | A | ELISA | Daily | Third Day | ||
| 116 | A124 | Anti Saccharomyces Cerevisiae (ASCA), IgG Antibodies (Crohn’s Disease) | 2300 | Serum (3 ml) | A | ELISA | Daily | Third Day | ||
| 117 | A125 | Anti Soluble Liver Antigen, (SLA) | 1900 | Serum (3 ml) | R/F | ELISA | 5 | Next Day | ||
| 118 | A126 | Anti Sperm Antibodies (ASAB) | 850 | Serum (3 ml) | R/F | ELISA | Daily | Next Day | ||
| 119 | A127 | Anti Thrombin III (AT-III) (Antigenic) | 3000 | Plasma Citrated (2 ml) | R/F | Turbidometry | Daily | Next Day | Separate Plasma Immeditely, ensure Platelet poor plasma | |
| 120 | A145 | APCR Activated Protein C Resistance | 6000 | Platelet Poor Citrated Plasma (2 ml) | A | Coagulation | 6 | Sixth Day | ||
| 121 | A128 | APO E Genotyping | 35000 | EDTA Whole Blood (5.0 ml) | R/F | PCR Reserve Probe Hybridisation | 5 | 12th Day | ||
| 122 | A129 | Apolipoprotein A1 (APO-A1) | 480 | Serum (2 ml) | A | Nephelometry | Daily | Same Day | Minimum 12 hours fasting is required | |
| 123 | A130 | Apolipoprotein B (APO-B) | 480 | Serum (2 ml) | A | Nephelometry | Daily | Same Day | Minimum 12 hours fasting is required | |
| 124 | A151 | APO A1 / APO B Ratio | 900 | Serum (2 ml) | A | Nephelometry | Daily | Same Day | Minimum 12 hours fasting is required | |
| 125 | A146 | Arogyam Profile (CBC EXT., LFT, KFT New, Lipd Profile, Blood Sugar Fasting, Iron Panel, Vitamin B 12, Urine R/M, Testosterone Total, HbA1c, Thyroid Profile-I, Vitamin D-25) | 3400 | Serum (2 ml), Fluride (1 ml), EDTA (3 ml), Urine (30ml) | A | Spectrophotom- etry, CC, Micro scopic | Daily | Same Day | ||
| 126 | A131 | Arsenic (Blood) | 3600 | WB EDTA | A | AAS | Daily | 5th Day | ||
| 127 | A132 | Arsenic (Urine) | 3600 | 24 hrs Urine (25 ml) | A | AAS – | Daily | 5th Day | 24 hour urine volume required | |
| 128 | A133 | ASMA (Anti Smooth Muscle Antibodies) IFA | 2000 | Serum (2 ml) | A | IFA | 3, 6 | Next Day | ||
| 129 | A134 | ASMA (Anti Smooth Muscle Antibodies) Elisa | 1500 | Serum (2 ml) | A | ELISA | 3, 6 | Next Day | ||
| 130 | A135 | ASO- Titer (Anti Streptolysin O Titres) Quantitative | 500 | Serum (2 ml) | A | Nephelometry | Daily | Same Day | ||
| 131 | A136 | ASO- Titer (Anti Streptolysin O Titres) Quantative | 375 | Serum (2 ml) | A | Agglutination | Daily | Same Day | ||
| 132 | A137 | Aspergillus Fumigates DNA Detector | 8000 | WB- EDTA(3ml) / Sputum / CSF(2ml) / Fluids(3ml) / Tissues (1gm) | A | PCR | 4 | Same Day | ||
| 133 | A152 | Aspergillus Fumigates | 1500 | Serum (2 ml) | A | ELISA | Daily | Fourth Day | ||
| 134 | A138 | Aspergillus IgE | 1950 | Serum (2 ml) | R/F | ELISA | Daily | Third Day | ||
| 135 | A139 | Aspergillus IgG | 1950 | Serum (2 ml) | R/F | ELISA | Daily | Third Day | ||
| 136 | A140 | Aspergillus IgM | 1950 | Serum (3 ml) | R/F | ELISA | Daily | Third Day | ||
| 137 | A141 | ATG (Antithyroglobulin Antibodies) | 1100 | Serum (2 ml) | A | CLIA | Daily | Same Day | ||
| 138 | B001 | Barbiturate | 800 | Urine (5 ml) | A | Flow Chromatographic Immunoassay | Daily | Next Day | ||
| 139 | B002 | Barr Bodies | 800 | Buccal Smear/ | A | Microscopy/ Staining | Daily | Third Day | ||
| 140 | B003 | BCR-abl Screening (Philadelphia Chromosome) (Karyotyping) | 3500 | WB-Na-Heparin (3 ml) | A | Karyotyping | Daily | 10th Day | Clinical history required | |
| 141 | B004 | BCR-abl translocation (Philadelphia Chromosome) (FISH) | 5200 | Whole blood (5.0 ml) / Bone Marrow from 2 Green Top (Sodium Heparin) tubes. | R/F | FISH | Daily | 10th Day | ||
| 142 | B005 | BCR-abl translocation (Philadelphia Chromosome) (Quantitative) (Real Time PCR) | 6800 | WB- EDTA (3mL) | R/F | Real Time PCR | Daily | Fifth Day | ||
| 143 | B006 | BCR-abl translocation (Philadelphia Chromosome) Qualitative | 4200 | 2-4ml Bone Marrow /6-8 ml Whole Blood in 2 EDTA Vacutainers. | A | RT-PCR | Daily | Fifth Day | Clinical History | |
| 144 | B007 | Bence Jones Protein (BJ Protein) | 750 | Urine Random (25 ml) | A | Biochemical | Daily | Next Day | ||
| 145 | B008 | Benzodiazepine | 900 | Urine (5 ml) | A | Flow Chromatographic Immunoassay | Daily | Next Day | ||
| 146 | B009 | Beta 2 Microglobulin, Serum | 1200 | Serum (1 ml) | A | CLIA | Daily | Third Day | Clinical history required | |
| 147 | B010 | Beta 2 Microglobulin, Urine | 1200 | Urine Spot | A | CLIA | Daily | Third Day | Clinical history required | |
| 148 | B011 | Beta HCG (Beta Human Chorionic Gonadotropin) | 550 | Serum (1 ml) | A | CLIA | Daily | Same Day | Clinical history required | |
| 149 | B012 | Beta HCG (Beta Human Chorionic Gonadotropin) (Urine) | 550 | Urine (5 ml) | A | CLIA | Daily | Same Day | Clinical history required | |
| 150 | B014 | Beta Thalassemia Mutation Detection (Multiplex PCR) | 7500 | WB-EDTA (5 ml) | A | Multiplex DNA- PCR | 2 | 15th Day | Clinical history HPLC required | |
| 151 | B015 | Beta-2 Glycoprotein-1 IgG | 1000 | Serum (2 ml) | R/F | ELISA | Daily | Third Day | ||
| 152 | B016 | Beta-2 Glycoprotein-1 IgM | 1000 | Serum (2 ml) | R/F | ELISA | Daily | Third Day | ||
| 153 | B017 | Beta-2 Glycoprotein-1 IgA | 1000 | Serum (2 ml) | R/F | ELISA | Daily | Third Day | ||
| 154 | B018 | Bicarbonate (HCO3) | 600 | Serum (2 ml) | A | Spectrophotometry | Daily 3 PM | Next Day | Labile Analyte | |
| 155 | B019 | Bile Acids | 2100 | Serum (2 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 156 | B020 | Bilirubin- Direct | 120 | Serum (1 ml) | A | Spectrophotometry | Daily | Same Day | Protect the tube from direct light | |
| 157 | B021 | Bilirubin- Indirect | 120 | Serum (1 ml) 2022 | A | Calculated | Daily | Same Day | Protect the tube from direct light | |
| 158 | B022 | Bilirubin- Total | 120 | Serum (1 ml) | A | Spectrophotometry | Daily | Same Day | Protect the tube from direct light | |
| 159 | B023 | Bilirubin Total + Direct + Indirect | 250 | Serum (2 ml) | A | Spectrophotometry | Daily | Same Day | Protect the tube from direct light | |
| 160 | B024 | Bilirubin Urine | 120 | Urine (5 ml) | A | Spectrophotometry | Daily | Same Day | Protect the tube from direct light | |
| 161 | B025 | Biopsy Mastectomy Specimen | 2000 | Tissue in formalin | A | Histopathology | Daily | 7th Day | Clinical history required | |
| 162 | B027 | Biopsy Material (Kidney) | 2000 | Tissue in 10% buffered formalin | A | Microscopy | Daily | 7th Day | clinical History | |
| 163 | B026 | Biopsy Material (Large Size) | 1500 | Tissue in 10% buffered formalin | A | Microscopy | Daily | 7th Day | Clinical history especially site, x-ray is required. Doctors contact number if available. |
|
| 164 | B026 | Biopsy Material (Extra Large Size) | 2200 | Tissue in 10% buffered formalin | A | Microscopy | Daily | 7th Day | Clinical history especially site, x-ray is required. Doctors contact number if available. |
|
| 165 | B028 | Biopsy Material (Medium Size) | 1000 | Tissue in 10% buffered formalin | A | Microscopy | Daily | 7th Day | Clinical history especially site, x-ray is required. Doctors contact number if available. |
|
| 166 | B029 | Biopsy Material (Small Size) | 700 | Tissue in 10% buffered formalin | A | Microscopy | Daily | 7th Day | Clinical history especially site, x-ray is required. Doctors contact number if available. |
|
| 167 | B056 | Biopsy Material 2 Samples (Small Size) | 1400 | Tissue in 10% buffered formalin | A | Microscopy | Daily | 7th Day | Clinical history especially site, x-ray is required. Doctors contact number if available. |
|
| 168 | B030 | Biopsy Second Opinion (upto five slide) | 1300 | Slide/ Block | A | Microscopy | Daily | 7th Day | Clinical history especially site, x-ray is required. Doctors contact number if available. |
|
| 169 | B031 | Biopsy second opinion (upto ten slide) | 1900 | Slide/ Block 171 | A | Microscopy | Daily | 7th Day | Clinical history especially site, x-ray is required. Doctors contact number if available. |
|
| 170 | B032 | Biopsy second opinion (upto two slide) | 770 | Slide/ Block | A | Microscopy | Daily | 7th Day | Clinical history especially site, x-ray is required. Doctors contact number if available. |
|
| 171 | B033 | Biopsy Slide And Block Preparation 1 | 200 | Tissue in 10% buffered formalin | A | Microscopy | Daily | 3rd day | Clinical history especially site, x-ray is required. Doctors contact number if available. |
|
| 172 | B034 | Biopsy Slide And Block Preparation 2 | 400 | Tissue in 10% buffered formalin | A | Microscopy | Daily | 3rd day | ||
| 173 | B035 | Biopsy Slide And Block Preparation 3 | 600 | Tissue in 10% buffered formalin | A | Microscopy | Daily | 3rd day | ||
| 174 | B036 | Biopsy Slide And Block Preparation 4 | 800 | Tissue in 10% buffered formalin | A | Microscopy | Daily | 3rd day | ||
| 175 | B037 | Biopsy Slide And Block Preparation 5 | 1000 | Tissue in 10% buffered formalin | A | Microscopy | Daily | 3rd day | ||
| 176 | B038 | Biotinidase Defficiency (Quantitative) | 4950 | Serum (2 ml) | R/F | Spectrophotometry | 2, 4, 6 | Next Day | ||
| 177 | B039 | Bismuth (24 hrs Urine) | 6000 | 24 Hour Urine, 25 ml (No Preservative) | R/F | AAS | Daily | 13 Day | Urine Volume Required | |
| 178 | B040 | Bismuth (Blood) | 6000 | EDTA Whole Blood (5.0 ml) | R/F | ICPMS | Daily | 13 Day | ||
| 179 | B041 | Bismuth (Urine Spot) | 6000 | Urine, Spot (20.0 ml) (In Sterile Container) | R/F | AAS | Daily | 13 Day | ||
| 180 | B042 | BK/JC Polyoma Virus PCR, urine | 7500 | 15 ml of Spot Urine / 3 ml EDTA Blood | A | PCR | 5 | Fourth Day | ||
| 181 | B043 | BMT Sex Mismatch, XY Probe | 5600 | Whole blood (5.0 ml) / Bone Marrow from 2 Green Top (Sodium Heparin) tubes. | A | FISH | Daily | Eighth Day | ||
| 182 | B044 | BNP, (B- type Neutratic Peptide) | 1800 | EDTA Plasma (5 ml) | R/F | CLIA | Daily | Same Day | ||
| 183 | B045 | Bone Marrow Smear | 450 | Slides | A | Microscopy | Daily | Fourth Day | Send Peripheral smear along with clinical history | |
| 184 | B055 | BRCA 1 & BRCA 2 Profile Complete Gene Sequencing | 35000 | WB EDTA (5ml) | A | PCR | Daily | 25th Day | ||
| 185 | B048 | Bronchial Washings Analysis | 350 | Slides, Fluids (1 ml) | A | Microscopy | Daily 3 PM | Next Day | Clinical history required | |
| 186 | B049 | Brucella Antibodies by Agglutination, Serum | 630 | Serum (2 ml) | R | Agglutination | Daily | Fourth Day | ||
| 187 | B050 | Brucella IgG Antibodies | 1100 | Serum (1 ml) | R | ELISA | Daily | Third Day | ||
| 188 | B051 | Brucella IgM Antibodies | 1100 | Serum (1 ml) | R | ELISA | Daily | Third Day | ||
| 189 | B052 | BT/CT (Bleeding Time, Clotting Time) | 280 | Local procedure (Only for Walk-in Patient) | Manual Mathod | Daily | Same Day | For Walk- In patients only | ||
| 190 | B053 | BUN (Blood Urea Nitrogen) | 200 | Serum (1 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 191 | C001 | C Reactive Protein (CRP) Qualitative | 300 | Serum (1 ml) | A | Agglutination | Daily | Same Day | ||
| 192 | C002 | C Reactive Protein (CRP) Quantitative | 400 | Serum (1 ml) | A | Immunoturbidimetry | Daily | Same Day | ||
| 193 | C003 | C Reactive Protein high Sensitive (hSCRP) | 550 | Serum(1 ml) /Plasma EDTA (1ml) | A | Immunoturbidimetry | Daily | Same Day | ||
| 194 | C004 | C1 Esterase Inhibitor, Quantitative | 3200 | Serum (2 ml) | R/F | Nephelometry | 2 | Third Day | ||
| 195 | C005 | C3- Complement 3 | 480 | Serum (1 ml) | A | Nephelometry | Daily | Same Day | Labile Analyte | |
| 196 | C006 | C4- Complement 4 | 480 | Serum (1 ml) | A | Nephelometry | Daily | Next Day | Labile Analyte | |
| 197 | C007 | CA- 15.3 (Breast Cancer Marker) | 1000 | Serum (1 ml) | R/F | CLIA | Daily | Same Day | ||
| 198 | C008 | CA- 125 (Ovarian Cancer Marker) | 1000 | Serum (1 ml) | R/F | CLIA | Daily | Same Day | ||
| 199 | C009 | CA- 19.9 (Pancreatic Cancer Marker) | 1000 | Serum (1 ml) | R/F | CLIA | Daily | Same Day | ||
| 200 | C010 | CA- 72.4 (Gastric Cancer Marker) | 1600 | Serum (2 ml) | R/F | CLIA | 3, 6 | Third Day | ||
| 201 | C011 | CA- CYFRA 21-1 (Lung Cancer Marker) | 3500 | Serum (2.0 ml) | R/F | CLIA | 6 | Fourth Day | ||
| 202 | C012 | Cadmium (24 hrs Urine) | 3600 | 24 hrs Urine (25 ml) / Spot Urine | A | AAS | Daily | Seventh Day | 24 urine volume required | |
| 203 | C013 | Cadmium (WB-Heparin) | 3600 | WB-Heparin (3 ml) | A | AAS | Daily | Seventh Day | ||
| 204 | C014 | Calcitonin (Thyrocalcitonin) | 2300 | Serum (2 ml) | F | ELISA | Daily | Next Day | Labile Analyte. Overnight fasting is preffered | |
| 205 | C015 | Calcium Total, Serum | 120 | Serum (1 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 206 | C016 | Calcium Total, 24 Hr Urine | 120 | 24 hrs Urine (5 ml) | A | Spectrophotometry | Daily | Same Day | Collect Urine with 25 ml of 6N HCL to maintain pH below 3.0. Record 24 hours urine volume on TRF and sample container. |
|
| 207 | C017 | Calcium Total, Spot Urine | 120 | Urine(20 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 208 | C154 | Calcium Creatinine Ratio (Urine Random) | 240 | Urine (20 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 209 | C018 | C-ANCA (Serine Proteinase 3) | 1400 | Serum (2 ml) | A | ELISA | Daily | Same Day | ||
| 210 | C019 | Candida Albicans Antibodies | 5300 | Serum (2 ml) | A | Indirect Hemagglu- tination | Daily | Ninth Day | ||
| 211 | C151 | Canine Complete Blood Count | 300 | WB EDTA | A | Cell Counter & Microscopy | Daily | Same Day | ||
| 212 | C021 | Cannabinoids | 900 | Urine (5 ml) | A | Flow Chromato- graphic Immuno- assay | Daily | Same Day | ||
| 213 | C022 | Carbamazepine (Tegretol, Mazetol) | 800 | Serum (2 ml) | A | CLIA | Daily | Next Day | Do not use SST gel barrier tubes. Recommended specimen: Just before the next dose is due at steady state. | |
| 214 | C023 | Carcino Embryonic Antigen (CEA) | 650 | Serum (1 ml) | R/F | CLIA | Daily | Same Day | ||
| 215 | C164 | Carcino Embryonic Antigen (CEA) Fluid | 850 | Fluid (2 ml) | R/F | CLIA | Daily | Same Day | ||
| 216 | C024 | Cardiolipin Antibodies –IgA | 650 | Serum (1 ml) | A | ELISA | Daily | Next Day | ||
| 217 | C025 | Cardiolipin Antibodies –IgG | 650 | Serum (1 ml) | A | ELISA | Daily | Same Day | ||
| 218 | C026 | Cardiolipin Antibodies IgM | 650 | Serum (1 ml) | A | ELISA | Daily | Same Day | ||
| 219 | C027 | Catecholamines (24 Hrs Urine) | 3600 | 24hrs Urine (25 ml) | A | Column Chromatography | Daily | 3rd Day | 24 hours urine volume & clinical history required | |
| 220 | C028 | Catecholamines (Plasma) | 3600 | Plasma EDTA (2.0 ml) | R/F | HPLC | Daily | Third Day | ||
| 221 | C029 | CCP Antibodies (Anti Cyclic Citrullinated Peptide Antibody) | 1200 | Serum (1 ml) | R | CLIA | Daily | Same Day | ||
| 222 | C030 | CD 10 (Prognostic Cell Marker) | 2300 | WB EDTA/Bone Marrow/Body Fluids | A | Flowcytometry | Daily | Fourth Day | Clinical History Required | |
| 223 | C031 | CD 103 (Hairy Cell Marker) | 2300 | WB EDTA/Bone Marrow/Body Fluids | A | Flowcytometry | Daily | Fourth Day | Clinical History Required | |
| 224 | C032 | CD 11 | 2300 | WB EDTA/Bone Marrow/Body Fluids | A | Flowcytometry | Daily | Fourth Day | Clinical History Required | |
| 225 | C033 | CD 117 (Myeloid Cell Marker) | 2300 | WB EDTA/Bone Marrow/Body Fluids | A | Flowcytometry | Daily | Fourth Day | Clinical History Required | |
| 226 | C034 | CD 11c (Hairy Cell Marker/ NHL Marker) | 2300 | WB EDTA/Bone Marrow/Body Fluids | A | Flowcytometry | Daily | Fourth Day | Clinical History Required | |
| 227 | C035 | CD 13 (Myeloid Cell Marker) | 2300 | WB EDTA/Bone Marrow/Body Fluids | A | Flowcytometry | Daily | Fourth Day | Clinical History Required | |
| 228 | C036 | CD 14 (Monocytic Cell Marker) | 2300 | WB EDTA/Bone Marrow/Body Fluids | A | Flowcytometry | Daily | Fourth Day | Clinical History Required | |
| 229 | C037 | CD 15 (Myeloid Cell Marker) | 2300 | WB EDTA/Bone Marrow/Body Fluids | A | Flowcytometry | Daily | Fourth Day | Clinical History Required | |
| 230 | C038 | CD 16+56 Cancer Marker | 2300 | WB EDTA/Bone Marrow/Body Fluids | A | Flowcytometry | Daily | Fourth Day | Clinical History Required | |
| 231 | C039 | CD 19 (Pan B Cell Marker) | 2300 | WB EDTA/Bone Marrow/Body Fluids | A | Flowcytometry | Daily | Fourth Day | Clinical History Required | |
| 232 | C040 | CD 2 (Pan T Cell Marker) | 2300 | WB EDTA/Bone Marrow/Body Fluids | A | Flowcytometry | Daily | Fourth Day | Clinical History Required | |
| 233 | C041 | CD 20 (Pan B Cell Marker) | 2300 | WB EDTA/Bone Marrow/Body Fluids | A | Flowcytometry | Daily | Fourth Day | Clinical History Required | |
| 234 | C042 | CD 22 (Pan B Cell Marker) | 2300 | WB EDTA/Bone Marrow/Body Fluids | A | Flowcytometry | Daily | Fourth Day | Clinical History Required | |
| 235 | C043 | CD 23 (CLL Segregation Marker) | 2300 | WB EDTA/Bone Marrow/Body Fluids | A | Flowcytometry | Daily | Fourth Day | Clinical History Required | |
| 236 | C044 | CD 25 (Hairy Cell Marker/ NHL Marker) | 2300 | WB EDTA/Bone Marrow/Body Fluids | A | Flowcytometry | Daily | Fourth Day | Clinical History Required | |
| 237 | C045 | CD 3 Cytoplasmic | 2300 | WB EDTA/Bone Marrow/Body Fluids | A | Flowcytometry | Daily | Fourth Day | Clinical History Required | |
| 238 | C046 | CD 3 Surface | 2300 | WB EDTA/Bone Marrow/Body Fluids | A | Flowcytometry | Daily | Fourth Day | Clinical History Required | |
| 239 | C047 | CD 33 (Myeloid Cell Marker) | 2300 | WB EDTA/Bone Marrow/Body Fluids | A | Flowcytometry | Daily | Fourth Day | Clinical History Required | |
| 240 | C048 | CD 34 (Precursor Cell Marker) | 2300 | WB EDTA/Bone Marrow/Body Fluids | A | Flowcytometry | Daily | Fourth Day | Clinical History Required | |
| 241 | C049 | CD 38 (Plasma Cell / Prognostic CLL Marker) | 2300 | WB EDTA/Bone Marrow/Body Fluids | A | Flowcytometry | Daily | Fourth Day | Clinical History Required | |
| 242 | C050 | CD 4 (Helper T Cell Marker) | 1800 | WB EDTA/Bone Marrow/Body Fluids | A | Flowcytometry | Daily | Fourth Day | Clinical History Required | |
| 243 | C051 | CD 42a (Megakaryocytic Cell Marker) | 2300 | WB EDTA/Bone Marrow/Body Fluids | A | Flowcytometry | Daily | Fourth Day | ||
| 244 | CA052 | CD 45 (Leukocyte Common Antigen) | 2300 | WB EDTA/Bone Marrow/Body Fluids | A | Flowcytometry | Daily | Fourth Day | Clinical History Required | |
| 245 | C053 | CD 5 (T Cell/ B Cell Subset) | 2300 | WB EDTA/Bone Marrow/Body Fluids | A | Flowcytometry | Daily | Fourth Day | Clinical History Required | |
| 246 | C054 | CD 61 (Megakaryocytic Cell Marker) | 2300 | WB EDTA/Bone Marrow/Body Fluids | A | Flowcytometry | Daily | Fourth Day | Clinical History Required | |
| 247 | C055 | CD 7 (Pan T Cell/ Early Myeloid Cell Marker) | 2300 | WB EDTA/Bone Marrow/Body Fluids | A | Flowcytometry | Daily | Fourth Day | Clinical History Required | |
| 248 | C056 | CD 79a (B Lymphoid Cell Marker) | 2300 | WB EDTA/Bone Marrow/Body Fluids | A | Flowcytometry | Daily | Fourth Day | Clinical History Required | |
| 249 | C057 | CD 8 (Suppressor T Cell Marker) | 1800 | WB EDTA/Bone Marrow/Body Fluids | A | Flowcytometry | Daily | Fourth Day | Clinical History Required | |
| 250 | C058 | CD Marker -Any two marker | 3600 | WB EDTA/Bone Marrow/Body Fluids | A | Flowcytometry | Daily | Fourth Day | Clinical History | |
| 251 | C059 | CD MPO (Myloid Cell Marker) | 2300 | WB EDTA/Bone Marrow/Body Fluids | A | Flowcytometry | Daily | Fourth Day | Clinical history required | |
| 252 | C060 | CD3/CD4/CD8 | 2300 | WB EDTA/Bone Marrow/Body Fluids | A | Immunopheno- typing | Daily | Fourth Day | Clinical History Required | |
| 253 | CA061 | CD3/CD4-Absolute | 2300 | WB-EDTA / Heparin + Smear | A | Flowcytometry | Daily | Fourth Day | ||
| 254 | C062 | CD4 absolute count & percent | 1800 | WB-EDTA (3 ml) | A | Immunopheno- typing | Daily | Fourth Day | Clinical History Required | |
| 255 | C063 | CD79b | 2300 | WB-EDTA (3 ml) | A | Flowcytometry | Daily | Fourth Day | Clinical History Required | |
| 256 | C064 | CD8-Absolute Count & Percentage | 1800 | WB-EDTA (3 ml) | A | Flowcytometry | Daily | Fourth Day | Clinical History Required | |
| 257 | C165 | CD 55 | 1800 | WB-EDTA (3 ml) | A | Flowcytometry | Daily | Fourth Day | Clinical History Required | |
| 258 | C166 | CD 58 | 1800 | WB-EDTA (3 ml) | A | Flowcytometry | Daily | Fourth Day | Clinical History Required | |
| 259 | C167 | CD 59 | 1800 | WB-EDTA (3 ml) | A | Flowcytometry | Daily | Fourth Day | Clinical History Required | |
| 260 | C168 | Cell Block | 500 | Fluid (3ml) | A | Microscopy | Daily | Third Day | ||
| 261 | C065 | Ceruloplasmin | 1000 | Serum (2 ml) | A | Nephelometry | Daily | Same Day | ||
| 262 | C066 | Chikungunya Virus Antibody, IgM Rapid | 650 | Serum (2mL) | A | IC | Daily | Same Day | ||
| 263 | C157 | Chikungunya Virus Antibody, IgM, ELISA | 650 | Serum (2mL) | A | ELISA | Daily | Same Day | ||
| 264 | C162 | Chikungunya Virus PCR | 4000 | WB EDTA | A | PCR | Daily | Third Day | ||
| 265 | C067 | Chlamydia DNA Detector | 4500 | Urine/ Fluid / Eye Swab Pererably BD universal vial transport swab should be used 1.0 ml fluid/ 1 Swab | A | PCR | 1 | Fifth Day | ||
| 266 | C068 | Chlamydia Trachomatis IgG Antibodies | 1400 | Serum (2 ml) | R | ELISA | Daily | Fourth Day | ||
| 267 | C069 | Chlamydia Trachomatic IgM Antibodies | 1400 | Serum (2 ml) | R | ELISA | Daily | Fourth Day | ||
| 268 | C070 | Chlamydia Pneumoniae IgA Antibodies | 2600 | Serum (2.0 ml) | R | ELISA | 1, 6 | Next Day | ||
| 269 | C071 | Chlamydia Pneumoniae IgG Antibodies | 2000 | Serum (2 ml) | R | ELISA | 2 | Fourth Day | ||
| 270 | C072 | Chlamydia Pneumoniae IgM Antibodies | 2000 | Serum (2 ml) | R | ELISA | 2 | Fourth Day | ||
| 271 | C073 | Chloride, Spot Urine | 150 | Random Urine (30 ml) | A | ISE | Daily | Same Day | ||
| 272 | C074 | Chloride, Serum | 150 | Serum (1 ml) | A | ISE | Daily | Same Day | ||
| 273 | C158 | Chloride (CSF) | 200 | CSF (2 ml) | A | ISE | Daily | Same Day | ||
| 274 | C169 | Chloride (Urine 24 hrs) | 200 | Urine (24 Hrs) (25 ml) | A | ISE | Daily | Same Day | 24 hour urine volume required | |
| 275 | C076 | Cholesterol HDL | 200 | Serum (1 ml) | A | Spectrophotometry | Daily | Same Day | 12-14 hour fasting required | |
| 276 | C077 | Cholesterol LDL | 200 | Serum (1 ml) | A | Spectrophotometry | Daily | Same Day | 12-14 hour fasting required | |
| 277 | C078 | Cholesterol LDL -Direct, serum | 300 | Serum (2 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 278 | C079 | Cholesterol Total | 130 | Serum (1 ml) | A | Spectrophotometry | Daily | Same Day | 12-14 hour fasting required | |
| 279 | C080 | Cholinesterase | 800 | Serum (2 ml) | A | Biochemical | Daily | Third Day | ||
| 280 | C081 | Chromium | 3600 | WB EDTA (3 ml) | A | AAS | Daily | Fifth Day | ||
| 281 | C082 | Chromium | 3600 | Serum (1 ml) | A | AAS | Daily | Fifth Day | ||
| 282 | C083 | Chromium | 3600 | 24 hrs Urine (5 ml) | A | AAS | Daily | Fifth Day | 24 hours urine volume required | |
| 283 | C084 | Chromogranin A | 5900 | EDTA PCR | R | ELISA | 1, 5 | Third Day | ||
| 284 | C085 | Chromosome analysis (amniotic fluid) | 11000 | Amniotic Fluid (Sterile Tube – 30 ml) | A | Karyotyping | Daily | 3 Weeks | ||
| 285 | C086 | Chromosome analysis (Bone Marrow) | 6000 | Bone Marrow Aspirate (Na- Heparin – 3 ml) | A | Karyotyping | Daily | 3 Weeks | Sample collection by strict aseptic method. In case of culture growth failure, fresh sample/back up sample may be required. | |
| 286 | C087 | Chromosome analysis (WB-Heparin) | 3600 | WB-Na Heparin (3 ml) | A | Karyotyping | Daily | 3 Weeks | ||
| 287 | C088 | Chromosome analysis (fetal cord blood) | 6000 | Fetal Cord Blood (WB-Na Heparin- 3 ml) | A | Karyotyping | Daily | 3 Weeks | ||
| 288 | C089 | Chromosome analysis (Structural and Numerical Abberations) | 6000 | Fetal Heart Blood (WB-Na Heparin-3 ml) | A | Karyotyping | Daily | 3 Weeks | ||
| 289 | C090 | Chromosome analysis (Structural and Numerical Abberations) | 6500 | Products of Conception (POC) (Sterile Container) | A | Karyotyping | Daily | 3 Weeks | ||
| 290 | C091 | Chromosome analysis (Structural and Numerical Abberations) | 10500 | Solid Tumour (Tumour Tissue in Sterile Container) | A | Karyotyping | Daily | 3 Weeks | ||
| 291 | C160 | Chromosomal Breakage Analysis | 10500 | WB-Na Heparin (3 ml) | A | Karyotyping | Daily | 20th Day | ||
| 292 | C170 | Chromosomal Analysis -High Resolution Banding | 6000 | WB-Na Heparin (3 ml) | A | Karyotyping | Daily | 20th Day | ||
| 293 | C092 | Circulating Immune Complex (CIC) IgM | 5000 | Serum (3 ml) | R | ELISA | Daily | Tenth Day | Labile Analyte | |
| 294 | C161 | Citrate (24 Hrs) Urine | 1400 | Urine (20 ml) of 24 Hrs | A | Spectrophotometry | Daily 3 Pm | Next Day | 20 ml of 24 hours urine in 6N HCL | |
| 295 | C163 | Clostridium Difficile Toxin A & B, Stool | 2500 | Stool (10 gms) | A | IC | Daily | Third Day | Fresh Sample | |
| 296 | C171 | Clostridium Difficile assay from stool | 3600 | Stool (10 gms) | A | PCR | Daily | Third Day | Fresh Sample | |
| 297 | C096 | Cobalt, 24 HRS Urine | 3900 | 24 Hour Urine 25 ml (No Preservative) | R | ICPMS | Daily | Fifth Day | ||
| 298 | C097 | Cobalt, Blood | 3900 | EDTA Whole Blood (5.0 ml) | R | ICPMS | Daily | Fifth Day | ||
| 299 | C098 | Cobalt, Urine Spot | 3900 | Urine, Spot (20.0 ml) (In Sterile Container) | R | ICPMS | Daily | Fifth Day | ||
| 300 | C099 | Cocaine | 800 | Urine (5 ml) | A | Flow Chromatographic Immunoassay | Daily | Same Day | ||
| 301 | C100 | Complement Total (CH 50) | 3900 | Serum (3 ml) | R | ELISA | 3 | Fifth Day | ||
| 302 | C101 | Complete Blood Count (CBC) | 300 | WB-EDTA (3 ml) | A | Cell Counter & Microscopy | Daily | Same Day | ||
| 303 | C102 | Complete Blood Count (CBC)+ESR | 340 | WB-EDTA (3 ml) | A | Cell Counter & Microscopy | Daily | Same Day | ||
| 304 | C103 | Complete Blood Count (CBC)+PS+ESR | 380 | WB-EDTA (3 ml) | A | Cell Counter & Microscopy | Daily | Same Day | ||
| 305 | C153 | Complete Blood Count (CBC EXT.) | 350 | WB-EDTA (3 ml) | A | Cell Counter & Microscopy | Daliy | Same Day | ||
| 306 | C104 | Coomb’s Test (Direct) (DCT) | 370 | WB-EDTA (3 ml) | A | Gel Microtyping | Daily | Same Day | Labile Analyte | |
| 307 | C105 | Coomb’s Test (Indirect) (ICT) | 400 | Serum (1 ml) | A | Gel Microtyping | Daily | Same Day | Labile Analyte | |
| 308 | C106 | Copper, Blood | 1000 | Serum (1 ml) | A | Spectrophotometry | Daily | Next Day | ||
| 309 | C107 | Copper (24 hr urine) | 1500 | 24 hrs Urine (30ml) | A | Spectrophotometry | Daily | Next Day | 24 hours urine volume required | |
| 310 | C180 | Copper (Random Urine) | 1500 | Urine(30 ml) | A | Spectrophotometry | Daily | Next Day | ||
| 311 | C108 | Cortisol (Evening) | 550 | Serum (1 ml) | A | CLIA | Daily | Same Day | ||
| 312 | C109 | Cortisol (Morning) | 550 | Serum (2 ml) | A | CLIA | Daily | Same Day | ||
| 313 | C172 | Cortisol Free (24 Hrs Urine) | 700 | Urine 10 ml of 24 Hrs urine | A | CLIA | Daily | Next Day | ||
| 314 | C181 | COVID-19 IgG Ab Test | 1500 | Serum (2 ml) | R | CLIA | Daily | Same Day | ||
| 315 | C182 | Covid-19 Total Ab (Anti SARS Cov2) | 600 | Serum (2 ml) | R | CLIA | Daily | Same Day | ||
| 316 | C183 | COVID-19 (SARS-Cov-2) RT-PCR | 800 | Nasopharyngeal & Oropharyngeal swabs | A | Real Time PCR | Daily | Same Day | ||
| 317 | C110 | C-Peptide Fasting | 900 | Serum (2 ml) | A | ELISA | Daily | Next Day | In Fasting | |
| 318 | C111 | C-Peptide PP | 900 | Serum (2 ml) | A | ELISA | Daily | Next Day | ||
| 319 | C112 | CPK- MB (Creatine Kinase- MB) | 410 | Serum (2 ml) | R | Spectrophotometry | Daily | Same Day | ||
| 320 | C113 | CPK- NAC (Creatinine Phospho Kinase) | 370 | Serum (2 ml) | R | Spectrophotometry | Daily | Same Day | ||
| 321 | C114 | Creatinine, Random Urine | 120 | Urine Random | A | Spectrophotometry | Daily | Same day | ||
| 322 | C115 | Creatinine , Serum | 120 | Serum (2 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 323 | C116 | Creatinine | 120 | 24 hrs Urine (5 ml) | A | Spectrophotometry | Daily | Same Day | 24 hours urine volume required | |
| 324 | C173 | Creatinine Fluid | 120 | Fluid (2 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 325 | C117 | Creatinine Clearance Test | 350 | Serum (1 ml) & 24 hrs Urine(5 ml) | A | Spectrophotometry | Daily | Same Day | 24 Hours Urine Volume required | |
| 326 | C118 | Cryoglobulins (Qualitative), Serum | 950 | Serum (3 ml) | R | Biochemical | Daily | Third Day | Collect Blood In Prewarmed Red Top Tube And rewarmed Syringe |
|
| 327 | C119 | Cryptococcus Neoformans DNA Detector | 10500 | WB- EDTA(3ml) / Sputum / CSF(2ml) / Fluids(3ml) / Tissue(1gm) | A | PCR | Daily | Twelth Day | ||
| 328 | C120 | Cryptococcus Antigen (Qualitative), Serum | 1900 | Serum (1 ml) | A | Agglutination | Daily | Third Day | ||
| 329 | C121 | Cryptococcus Antigen (Qualitative), CSF | 1900 | CSF (1 ml) | A | Agglutination | Daily | Third Day | ||
| 330 | C174 | CSF Index | 1500 | CSF 1 ml & Serum 1 ml | A | Biochemical | Daily | Third Day | ||
| 331 | C123 | Culture – Acid Fast Bacilli (AFB Bactac Culture) | 1000 | Body Fluid/ CSF/ Sputum/ Pus/ Urine (3ml) | A | Bactac MGIT | Daily | Report in 10th, 20th& 42 Days | ||
| 332 | C125 | Culture – Bactec/Rapid Blood Culture | 950 | WB- Heparin (5ml) | A | Bactec Flurocent Method | Daily | 2nd and 5th Day | ||
| 333 | C126 | Culture & Sensitivity- (Anaerobic Culture) | 900 | Any Specimen | A | Anaerobic Culture | Daily | 5th Day | Should be collected in fluid thioglycolate broth (except sputum/ bal, urine, stool, swabs from open wounds/ adjacent to skin or mucous membrane) | |
| 334 | C127 | Culture (Fungal) | 660 | Any Specimen | A | Microbiology | Daily | 15th Days | Urine samples need to be refrigerated. | |
| 335 | C128 | Culture & Sensitivity (Pus) | 450 | Pus (1 ml) | A | Microbiology | Daily | Third Day | Sample should be collected in sterile container. | |
| 336 | C129 | Culture & Sensitivity (Semen) | 450 | Semen (1mL) | A | Microbiology | Daily | Third Day | Sample should be collected in sterile container. | |
| 337 | C130 | Culture & Sensitivity (Sputum) | 450 | Sputum | A | Microbiology | Daily | Third Day | Sample should be collected in a sterile container and transported in a refrigerated condition. | |
| 338 | C131 | Culture & Sensitivity (Stool) | 450 | Stool (2 gm) | A | Microbiology | Daily | Third Day | Send sample in Cary-Blair transport medium | |
| 339 | C132 | Culture & Sensitivity (Urine) | 450 | Urine (5 ml) | A | Microbiology | Daily | Third Day | Urine to be collected in sterile container (send Refrigerated). Urine Vacutainer with preservatives (send Ambient) | |
| 340 | C133 | Culture & Sensitivity (Blood) | 560 | Whole Blood (5.0 ml) in Culture Bottle | A | Microbiology | Daily | Third Day &Seventh Day | Clinical history required.Collect blood in blood culture bottles There is separate bottle for adult and peadiatric patients. |
|
| 341 | C134 | Culture & Sensitivity (High Vaginal Swab-HVS) | 450 | Swab (HVS) | A | Microbiology | Daily | Third Day | Clinical History Required. | |
| 342 | C135 | Culture & Sensitivity (Swab) | 450 | Swab (ANY) | A | Microbiology | Daily | Third Day | Clinical History Required. | |
| 343 | C136 | Culture & Sensitivity (Tissue) | 550 | Tissue In Sterile Saline | A | Microbiology | Daily | Third Day | Clinical History Required. | |
| 344 | C137 | Culture & Sensitivity- Fluid (Any) | 450 | Fluid (2 ml), Bone marrow in broth | A | Microbiology | Daily | Third Day | Sample should be collected in sterile container | |
| 345 | C155 | Culture & Sensitivity (Milk) | 450 | Milk | A | Microbiology | Daily | Third Day | Sample should be collected in sterile container | |
| 346 | C156 | Culture & Sensitivity (Tip) | 450 | Tip | Microbiology | Daily | Third Day | Sample should be collected in sterile container | ||
| 347 | C176 | Culture & Sensitivity (Any Automated) | 600 | Urine (50 ml) | A | Microbiology | Daily | Third Day | Urine to be collected in sterile container (send Refrigerated). Urine Vacutainer with preservatives (send Ambient) | |
| 348 | C177 | Cryptosporidium Antigen Stool | 1800 | Stool | A | Immunochromato graphy | Daily | Third Day | ||
| 349 | C178 | Carbohydrate deficient Transferrin (CDT) | 2600 | Serum (1 ml) | R | Nephelometry | 2 | Third Day | includes Transferrin and % (CDT) | |
| 350 | C179 | CALR Mutation detection | 5400 | Whole Blood EDTA (3 ml) | R | PCR Sequencing | 6 | 7th Day | ||
| 351 | C138 | Cyclosporine -A(C2) Peak level | 2800 | WB-EDTA (3 ml) | R/F | LC-MS/MS | Daily | Fourth Day | Recommend specimen: 2 hours after the dose at steady stater | |
| 352 | C139 | Cyclosporine -A(CO) Trough level | 2800 | WB-EDTA (3 ml) | R/F | LC-MS/MS | Daily | Fourth Day | Recommend specimen: Just before the next dose is due at steady state | |
| 353 | C140 | Cystatin C | 1350 | Serum (1 ml) | R/F | Nephelometry | Daily | Third Day | ||
| 354 | C141 | Cysticercosis IgG Antibodies (Taenia Solium) | 1750 | Serum (1 ml) | F | ELISA | Daily | Next Day | ||
| 355 | C142 | Cytology (Fluid) | 380 | Any Fluid | A | Microscopy | Daily | Next Day | Clinical History Req. | |
| 356 | C143 | Cytology (Smear) | 380 | Smear | A | Microscopy | Daily | Next Day | ||
| 357 | C144 | Cytomegalovirus – IgG Antibodies (CMV-IgG) | 480 | Serum (1 ml) | A | ELISA | Daily | Same Day | ||
| 358 | C145 | Cytomegalovirus – IgG Avidity (CMV-IgG Avidity) | 900 | Serum (2 ml) | A | ELISA | Daily | Next Day | ||
| 359 | C146 | Cytomegalovirus – IgM Antibodies (CMV-IgM) | 480 | Serum (1 ml) | A | ELISA | Daily | Same Day | ||
| 360 | C147 | Cytomegalovirus DNA PCR (Qualitative) | 6300 | CSF (5 ml) | A | PCR | Daily | Third Day | ||
| 361 | C148 | Cytomegalovirus DNA PCR (Qualitative) | 6300 | WB-EDTA (3 ml) | A | PCR | Daily | Third Day | ||
| 362 | C149 | Cytomegalovirus DNA PCR (Qualitative) | 6300 | Urine (50 ml) | A | PCR | Daily | Third Day | ||
| 363 | C150 | Cytomegalovirus DNA PCR (Quantitative) | 6900 | WB-EDTA (3 ml) | A | PCR | Daily | Third Day | ||
| 364 | D001 | D- Dimer | 1250 | Plasma- Na Citrated (2 ml) | R | Nephelometry | Daily | Same Day | ||
| 365 | D002 | DEL 13q | 6150 | WB-Heparin (4 ml) or Heparinised Bone Marrow – Sodium heparin (2 ml) specimen to reach us in 24 hrs of collection | A | FISH | Daily | Sixth Day | Clinical history, blood picture (CBC Report) and medication of the patient on the TRF required | |
| 366 | D003 | Dengue IgG Rapid | 600 | Serum (2 ml) | A | Rapid Test/ IC | Daily | Same Day | ||
| 367 | D004 | Dengue IgM Rapid | 600 | Serum (2 ml) | A | Rapid Test/ IC | Daily | Same Day | ||
| 368 | D005 | Dengue – IgG (ELISA) | 600 | Serum (1 ml) | A | ELISA | Daily | Next Day | ||
| 369 | D006 | Dengue (IgG, IgM) Rapid | 1000 | Serum (2 ml) | A | Rapid Test/ IC | Daily | Same Day | ||
| 370 | D007 | Dengue – IgM (ELISA) | 600 | Serum (1 ml) | A | ELISA | Daily | Next Day | ||
| 371 | D008 | Dengue Ns 1 Antigen (ELISA) | 600 | Serum (2 ml) | A | ELISA | Daily | Next Day | ||
| 372 | D009 | Dengue Ns 1 Antigen (Rapid) | 600 | Serum (2 ml) | A | Rapid Test/ IC | Daily | Same Day | ||
| 373 | D022 | Dengue Combo Rapid (Dengue IgG, IgM, NS1) | 1500 | Serum (2 ml) | A | Rapid Test/ IC | Daily | Same Day | ||
| 374 | D010 | Dengue RNA Virus (Qualitative) | 4900 | WB-EDTA (3 ml) | A | Real Time PCR | Daily | Third Day | ||
| 375 | D011 | DHEA (Dehydroepiandrosterone) | 2300 | Serum (2 ml) | A | ELISA | Daily | Third Day | Clinical history required | |
| 376 | D012 | DHEA -So4 (Dehydroepiandrosterone Sulphate) | 850 | Serum (2 ml) | A | CLIA | Daily | Same Day | Clinical history required | |
| 377 | D013 | Digoxin (Lanoxin) | 800 | Serum (1 ml) | R | CLIA | Daily | Third Day | Do not use SST gel barrier tubes. Separate serum within 2 hours of collection. Trough: Just before the next dose is due at steady. Peak: 6-8 hours after dose. | |
| 378 | D014 | Dihydrotestosterone (DHT) | 2100 | Serum (2 ml) | R/F | ELISA | 3, 6 | Third Day | ||
| 379 | D015 | DLC (Differential Leuko- cyte Count) | 120 | WB-EDTA (3 ml) | A | Cell Counter | Daily | Same Day | ||
| 380 | D016 | DLC (Differential Leukocyte Count) (Fluid) | 120 | Fluids (any, 2 ml) | A | Microscopy | Daily | Same day | ||
| 381 | D021 | DMD Test Duchenne / Becker Muscular Dystrophy, Blood | 10000 | WB EDTA | A | MLPA | 6 | 7th Day | ||
| 382 | D017 | DNA Ploidy & Cell Cycle Analysis | 7000 | Paraffin Block (Only Breast Tumor) | A | Flowcytometry | Daily | 14th Day | Clinical history required | |
| 383 | D018 | dsDNA (Anti Double Stranded DNA) Antibody titer (Quantitative) | 2500 | Serum (1 ml) | A | IFA | Daily | Third Day | ||
| 384 | D019 | dsDNA (Anti Double Stranded DNA) | 1100 | Serum (1 ml) | A | ELISA | Daily | Next Day | ||
| 385 | D023 | Dysmorphic RBC | 100 | Urine (10 ml) | A | Microscopy | Daily | Same Day | ||
| 386 | E001 | Echinococcus Detection | 900 | Hydatid cyst Fluid / Urine (1 ml) | A | Microscopy | Daily | Third Day | ||
| 387 | E002 | Echinococcus IgG Antibodies (Hydatid Serology) | 1500 | Serum (1 ml) | A | ELISA | Daily | 3rd Day | ||
| 388 | E003 | Ecstasy MDMA Qualitative | 900 | Urine (10 ml) | A | Flow Chromatographic Immunoassay | Daily | Next Day | ||
| 389 | E004 | eGFR (estimated Glomerular Filtration Rate) | 300 | Serum (1 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 390 | E005 | EGFR Gene Amplification | 8200 | Tumor Positive Block/FFPES & Slides | A | FISH | 3, 6 | Twelfth Day | ||
| 391 | E006 | EGFR Mutation Analysis By PCR (Exon 18, 19, 20, 21) 4 Exons | 11000 | Tumor Positive Block/FFPES & Slides | A | PCR-Sequencing | 3, 6 | Ninth Day | Clinical History, If Tissue Received; Tissue Processing will be charged separately | |
| 392 | E007 | Entamoeba Histolytica Antibodies (Amoebic Serology) IgG | 950 | Serum (2 ml) | A | ELISA | Daily | Same Day | ||
| 393 | E008 | Epstein Barr Virus (VCA) IgG Antibodies | 1500 | Serum (1 ml) | A | CLIA | Daily | Fourth Day | ||
| 394 | E009 | Epstein Barr Virus (VCA) IgG Antibodies IFA | 1700 | Serum (2 ml) | A | IFA | Daily | Fourth Day | ||
| 395 | E010 | Epstein Barr Virus (VCA) IgM Antibodies | 1500 | Serum (1 ml) | A | CLIA / ELISA | Daily | Fourth Day | ||
| 396 | E018 | Epstein Barr Virus (EBV) DNA PCR- CSF | 6000 | CSF (2 ml) | A | PCR | Daily | 5th Day | ||
| 397 | E019 | Epidermal (Pemphigus) Antibody | 2900 | Serum (2 ml) | A | IFA | Daily | Third Day | ||
| 398 | E011 | Erythrocyte Sedimentation Rate (ESR) | 120 | WB-EDTA (3 ml) | A | WG (Wester Gren) / Capillary Pho- tometry | Daily | Same Day | ||
| 399 | E012 | Erythropoietin (EPO) | 1800 | Serum (1 ml) | A | CLIA | Daily | Third Day | Clinical history required | |
| 400 | E013 | Escherichia Coli K1 Antigen | 1800 | Serum (1 ml) | A | Latex particle agglutination | Daily | Third Day | ||
| 401 | E014 | Escherichia Coli K1 Antigen | 1800 | CSF (1.0 ml) in plain vacutainer/ Sterile vial (1.0) ml) | A | Latex particle agglutination | Daily | Third Day | ||
| 402 | E015 | Escherichia Coli K1 Antigen | 1800 | Urine in Plain Vaccutainer / Sterile vial (2.0 ml) | A | Latex particle agglutination | Daily | Third Day | ||
| 403 | E016 | Estradiol (E2) | 520 | Serum (1 ml) | A | CLIA | Daily | Same Day | ||
| 404 | E017 | Estriol Unconjugated (uE3) | 1000 | Serum (2 ml) | A | CLIA | Daily | Same Day | Mention Age And LMP | |
| 405 | E020 | Everolimus, Blood | 5000 | WB EDTA | A | LCMS | 2, 6 | 4th Day | ||
| 406 | F001 | Factor II (Prothrombin) Mutation Detection | 6800 | WB- EDTA (3 ml) | R/F | PCR | Daily | 4th Day | ||
| 407 | F002 | Factor VII Functional | 4800 | 4 ml Platelet Poor Plasma (PPP) from 2 Soidum Citrate | R/F | Photo- Optical Clot Detection | Daily | 12th Day | Aliquote PPP is 2 transport vial and Freeze. Over night fasting preferred | |
| 408 | F003 | Factor-IX Screening | 2700 | Plasma Citrated (1 ml) | R/F | Clotting (Coagu- lometry) | Daily | Third Day | Ensure Platelet Poor Plasma. Labile Analyte | |
| 409 | F004 | Factor-V (Leiden Mutation) Screening | 4700 | WB- EDTA (3 ml) | R/F | RT PCR | 2, 5 | Seventh Day | Clinical history required | |
| 410 | F005 | Factor-V Screening | 3200 | Plasma Citrated (1 ml) | R/F | Clotting (Coagulometry) | 2, 5 | Third Day | Ensure Platelet Poor Plasma. Labile Analyte | |
| 411 | F006 | Factor-VIII Activity | 3000 | Plasma Citrated (1 ml) | R/F | Clotting (Coagulometry) | Daily | Third Day | Ensure Platelet Poor Plasma. Labile Analyte | |
| 412 | F041 | Factor VIII Inhibitor Study | 11000 | Plasma Citrated (1 ml) | R/F | Clotting (Coagulometry) | Daily | Fourth Day | Ensure Platelet Poor Plasma. Labile Analyte | |
| 413 | F042 | Factor XIII Activity | 2200 | Plasma Citrated (1 ml) | R/F | Clotting (Coagulometry) | 2 nd & 4th Friday | Fourth Day | Ensure Platelet Poor Plasma. Labile Analyte | |
| 414 | F007 | Fat Globulin (Stool) | 120 | Stool (1 gm) | A | Microscopy | Daily | Same Day | ||
| 415 | F039 | Fat Globulin (Urine) | 150 | Urine (10 ml) | A | Microscopy | Daily | Same Day | ||
| 416 | F008 | FDP (Fibrinogen Degradation Product) (Rapid) | 1100 | Plasma Citrated (1 ml) | R/F | Slide Agglutination | Daily | Same Day | ||
| 417 | F009 | FDP(DR-70) | Discontinue | |||||||
| 418 | F044 | Febrile Agglutination Test | 1600 | Serum (2 ml) | A | Agglutination | Daily | Fourth Day | ||
| 419 | F045 | Fractional Excretion of Sodium | 750 | Serum (2 ml) and Urine (30 ml) | A | Spectrophotometry | Daily | next day | ||
| 420 | F046 | Fecal Elastase | 6500 | Stool (10 gms) | A | Enzyme Immunoassay | 6 | 3rd day | ||
| 421 | F010 | Ferritin | 680 | Serum (2 ml) | A | CLIA | Daily | Same Day | ||
| 422 | F011 | Fibrinogen | 850 | Plasma Citrated (2 ml) | R/F | Clotting (Coagulometry) | Daily | 3rd Day | ||
| 423 | F043 | Fecal Calprotectin | 2800 | Stool (20 gms) | R/F | EIA | 3, 6 | Fifth Day | ||
| 424 | F012 | FLT3 ITD & D835 Mutation Analysis | 7800 | 6 -8 ml Whole Blood in 2 EDTA Vacutainers | F | PCR | Daily | 10th Day | ||
| 425 | F013 | FLT3 ITD & D835 Mutations and NPM1 Exon 12 Mutation Analysis | 7800 | 5 ml Whole Blood or 3-4 ml BoneSame Da Marrow in 2 EDTA Vacutainers. | F y | RFLP & Real Time PCR | Daily | 10th Day | ||
| 426 | F014 | Fluid Analysis (Any other Fluid) | 400 | Any Fluid (20 ml) | A | Spectrophotometry /Microscopy | Daily | Same Day | Clinical history required | |
| 427 | F015 | Fluid Analysis (CSF) | 400 | CSF (10 ml) | A | Spectrophotometry /Microscopy | Daily | Same Day | Clinical history required | |
| 428 | F016 | Fluid Analysis (Pleural Fluid) | 400 | Pleural Fluid (20 ml) | A | Spectrophotometry /Microscopy | Daily | Same Day | Clinical history required | |
| 429 | F017 | Fluid Analysis (Synovial) | 400 | Synovial Fluid (20 ml) | A | Spectrophotometry /Microscopy | Daily | Same Day | Clinical history required | |
| 430 | F018 | Fluid Analysis (Ascitic Fluid) | 400 | Ascitic Fluid Analysis (20 ml) | A | Spectrophotometry /Microscopy | Daily | Same Day | Clinical history required | |
| 431 | F019 | Fluid Analysis (Pericardial Fluid) | 400 | Pericardial Fluid (20 ml) | A | Spectrophotometry /Microscopy | Daily | Same Day | Clinical history required | |
| 432 | F020 | Fluid Analysis Comprehensive (Fluid Analysis, AFB Stain, Gram Stain, Cytology, ADA | 1300 | Any Fluid (20 ml) | A | Spectrophotometry /Microscopy | Daily | Same Day | Clinical history required | |
| 433 | F021 | Fluid Cytology | 380 | Fluids (20 ml) | A | Microscopy | Daily | Next Day | Clinical history required | |
| 434 | F022 | FMC 7 (Prognostic CLL/ NHL Marker) | 2400 | WB Heparin/Bone Marrow Heparin/ Body Fluids Heparinised | A | Flowcytometry | Daily | Fifth Day | Clinical history required | |
| 435 | F023 | FNAC (Fine Needle Aspiration Cytology) | 650 | Slides | A | Microscopy | Daily | Next Day | Clinical history required | |
| 436 | F024 | FNAC (For Walk in Patient) | 800 | Walk in patient | A | Microscopy | Daily | Next Day | Clinical history required | |
| 437 | F040 | FNAC (Fine Needle Aspiration Cytology) 2 Sites | 1000 | Slides | A | Microscopy | Daily | Next Day | Clinical history required | |
| 438 | F025 | Folic Acid | 800 | Serum (1 ml) | A | CLIA | Daily | Same Day | Protect the tube from direct light | |
| 439 | F026 | Fragile-X- Chromosomal Analysis | 6200 | WB-Na Heparin (3 ml) | A | Karyotyping | Daily | 3 Weeks | Clinical history required | |
| 440 | F027 | Free Beta HCG, serum | 1200 | Serum (2 ml) | A | CLIA | Daily | Same Day | ||
| 441 | F029 | Free Kappa Light Chains (Nephlometry) | 2600 | Serum (2 ml) | R/F | Nephlometry | Daily | Third Day | ||
| 442 | F031 | Free Lambda Light Chains (Nephlometry) | 2600 | Serum (2 ml) | R/F | Nephlometry | Daily | Third Day | ||
| 443 | F032 | Free Light Chain (Kappa & Lambda) (Nephlometry) | 4800 | Serum (2 ml) | R/F | Nephlometry | Daily | Third Day | ||
| 444 | F034 | Fructosamine | 1000 | Serum (3 ml) | R/F | Spectrophotometry | Daily | Third Day | ||
| 445 | F035 | Fructose (Semen) | 300 | Full quantity of Semen sample in sterile container. | R/F | Biochemical | Daily | Same Day | ||
| 446 | F036 | FSH (Follicle Stimulating Hormone) | 450 | Serum (1 ml) | A | CLIA | Daily | Same Day | ||
| 447 | F037 | FT3 (Trilodothyronine- Free) | 300 | Serum (1 ml) | A | CLIA | Daily | Same Day | ||
| 448 | F038 | FT4 (Thyroxine- Free) | 300 | Serum (1 ml) | A | CLIA | Daily | Same Day | ||
| 449 | G001 | G6PD Deficiency (Quantitative) | 850 | Whole Blood EDTA (3 ml) | A | Spectrophotometry | Daily | Next Day | ||
| 450 | G002 | G6PD Qualitative Test | 540 | Whole Blood EDTA (3 ml) | A | Visual/ Manual | Daily | Same Day | ||
| 451 | G003 | GAD- 65 IgG (Glutamic Acid Decarboxylase-65) | 6800 | Serum (3 ml) | R/F | ELISA / CLIA | Daily | Fourth Day | ||
| 452 | G004 | GAD-65 IFA (Type I Diabetes) | 6700 | Serum (3 ml) | R/F | IFA | 2 | Fourth Day | ||
| 453 | G005 | Galactomannan (Aspergillus Antigen) | 5700 | Serum (2 ml), | R/F | ELISA | Daily | Third Day | ||
| 454 | G006 | Gastrin | 1450 | Fasting Serum (1 ml) | R/F | CLIA | 1, 2, 3 | Third Day | Clinical history required | |
| 455 | G007 | GGT (Gamma Glutamyl Transferase) | 240 | Serum (1 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 456 | G008 | Globulin | 120 | Serum (1 ml) | A | Calculated | Daily | Same Day | ||
| 457 | G009 | Glomerular Basement Membrane IgG Antibodies (ANTI GBM) | 1850 | Serum (2 ml) | A | ELISA | 3 | Fourth Day | ||
| 458 | G010 | Glucose, Fluid | 120 | Fluid (1ml) | A | Spectrophotometry | Daily | Same Day | Body fluid in a sterile screw capped container. |
|
| 459 | G011 | Glucose Challenge Test (GCT) | 100 | NaF Plasma (1 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 460 | G012 | Glucose Fasting (Blood Sugar Fasting) | 70 | NaF Plasma (1 ml) | A | Spectrophotometry | Daily | Same Day | 10-12 hours fasting required | |
| 461 | G013 | Glucose Fating + Post Prandial | 130 | NaF Plasma (1 ml) | A | Spectrophotometry | Daily | Same Day | 10-12 hours fasting required | |
| 462 | G014 | Glucose Post Prandial (Blood Sugar Post Prandial) | 70 | NaF Plasma (1 ml) | A | Spectrophotometry | Daily | Same Day | 2 hours after meal (rich in carbohydrates) | |
| 463 | G015 | Glucose Random (Blood Sugar Random) | 70 | NaF Plasma (1 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 464 | G025 | Glucose Tolerance Test (GTT) 2 Sample | 150 | NaF Plasma (1 ml of each sample) | A | Spectrophotometry | Daily | Same Day | ||
| 465 | G024 | Glucose Tolerance Test (GTT) 3 Sample | 250 | NaF Plasma (1 ml of each sample) | A | Spectrophotometry | Daily | Same Day | ||
| 466 | G016 | Glucose Tolerance Test (GTT) 5 Sample | 350 | NaF Plasma (1 ml of each sample) | A | Spectrophotometry | Daily | Same Day | ||
| 467 | G017 | Glycophorin -A (Erythroid Cell Marker) | 2400 | WB Heparin/Bone Marrow Heparin/ Body Fluids Heparinised (3ml) | A | Flowcytometry | Daily | Fourth Day | Clinical history required | |
| 468 | G018 | Gonococcai | 500 | Sputum/Body Flood/ Cyto Smear | A | Microscopy | Daily | Third Day | ||
| 469 | G019 | Gram Stain – Smear | 220 | Any Specimen / Slides | A | Microscopy | Daily | Same Day | ||
| 470 | G020 | Growth Hormone (HGH) | 800 | Serum (2 ml) | R/F | ELISA | Daily | Next Day | ||
| 471 | G026 | Gm1 Gangliosidosis Quantitative, Blood | 2500 | 10 ml (7.5 ml min.) whole blood from 3 Lavender Top (EDTA) | R | Enzyme Assay | Daily | 5th day | ||
| 472 | G027 | Gm2 Gangliosidosis Quantitative, Blood; Tay Sachs & Sandhoff Disease | 3300 | 10 ml (7.5 ml min.) whole blood from 3 Lavender Top (EDTA) | r | Enzyme Assay | Daily | 5th day | ||
| 473 | H081 | H1N1 (SWINE FLU) | 4500 | Nasal Swab | A | Real Time PCR | Daily | Third Day | ||
| 474 | H001 | Haemophilus Influenzae B Antigen (Serum) | 1400 | Serum (2 ml) | A | Latex Particle Agglutination | Daily | 5th Day | ||
| 475 | H002 | Haemophilus Influenzae B Antigen (Urine) | 1400 | Urine in Sterile Vial/ Vaccutainer (3 ml) | A | Latex Particle Agglutination | Daily | Third Day | ||
| 476 | H003 | Haemophilus Influenzae B Antigen (CSF) | 1400 | CSF (2 ml) | A | Latex Particle Agglutination | Daily | Third Day | ||
| 477 | H004 | Haptoglobin | 1800 | Serum (2 ml) | A | Nephelometry | Daily | Fourth Day | ||
| 478 | H005 | Haptoglobin Genotyping | 5100 | EDTA Whole Blood (2 ml) | A | PCR | 1, 4 | Ninth Day | ||
| 479 | H006 | HB, TLC, DLC | 180 | WB-EDTA (3 ml) | A | Cell Counter | Daily | Same Day | ||
| 480 | H007 | HB, TLC, DLC, ESR | 200 | WB-EDTA (3 ml) | A | Cell Counter | Daily | Same Day | ||
| 481 | H008 | HbA1c (Glycated hemoglobin) | 380 | WB-EDTA (3 ml) | A | HPLC | Daily | Same Day | ||
| 482 | H009 | Helicobacter Pylori (H.pylori) Antigen Stool | 1300 | Stool In Sterile Container | A | Immunochromato graphy | Daily | Same Day | ||
| 483 | H010 | Helicobacter Pylori (H.pylori) IgA Antibodies | 1600 | Serum (3 ml) | A | ELISA | Daily | Next Day | ||
| 484 | H011 | Helicobacter Pylori (H.pylori) IgG Antibodies | 1600 | Serum (1 ml) | A | ELISA | Daily | Next Day | ||
| 485 | H012 | Helicobacter Pylori (H.pylori) IgM Antibodies | 1600 | Serum (1 ml) | A | ELISA | Daily | Next Day | ||
| 486 | H013 | Hemoglobin | 100 | WB-EDTA (3 ml) | A | Cell Counter | Daily | Same Day | ||
| 487 | H014 | Hemoglobin HPLC/ Electrophoresis | 800 | WB-EDTA (3 ml) | A | HPLC | Daily 3 PM | Same Day | Clinical history with age required | |
| 488 | H015 | Hemosiderin- Urine in Liquid Based Cytology | 1800 | 10 ml Urine | A | Microscopy | Daily | Fifth Day | ||
| 489 | H017 | Hepatitis A virus IgG Antibodies (HAV IgG) | 900 | Serum (1 ml) | A | ELISA | Daily 3 PM | Next Day | ||
| 490 | H018 | Hepatitis A virus – IgM Antibodies (HAV IgM) | 900 | Serum (1 ml) | A | ELISA | Daily 3 PM | Same Day | ||
| 491 | H019 | Hepatitis A virus – Total Antibodies (HAV-Total) | 1000 | Serum (1 ml) | A | ELISA | Daily 3 PM | Next Day | ||
| 492 | H020 | Hepatitis B core antigen – Total Antibodies (HBC) | 800 | Serum (1 ml) | A | CLIA | Daily 3 PM | Next Day | ||
| 493 | H021 | Hepatitis B core antigen – IgM Antibodies (HBC-IgM) | 800 | Serum (1 ml) | A | ELISA | Daily 3 PM | Same Day | ||
| 494 | H022 | Hepatitis B envelope Antibodies (HBe -Ab) | 700 | Serum (1 ml) | A | ELISA | Daily 3 PM | Same Day | ||
| 495 | H023 | Hepatitis B envelope antigen (HBe-Ag) | 700 | Serum (1 ml) | A | ELISA | Daily 3 PM | Same Day | ||
| 496 | H025 | Hepatitis B Surface Antibody (CLIA) | 1200 | Serum (2 ml) | A | CLIA | Daily 3 PM | Next day | ||
| 497 | H026 | Hepatitis B Surface Total Antibody (Elisa) | 600 | Serum (1 ml) | A | ELISA | Daily 3 PM | Same Day | ||
| 498 | H028 | Hepatitis B Surface antigen (HBs Ag)/ CLIA | 400 | Serum (1 ml) | A | CLIA | Daily 3 PM | Same Day | ||
| 499 | H029 | Hepatitis B surface antigen (HBs Ag)/ Australia Antigen (Rapid) | 300 | Serum (1 ml) | A | Rapid Test/ IC | Daily 3 PM | Same Day | ||
| 500 | H031 | Hepatitis B Virus (HBV) Genotyping | 8500 | Serum, EDTA- Plasma (2.0 ml), (2.0 ml) | R/F | PCR-Sequencing | Daily 3 PM | Seventh Day | ||
| 501 | H032 | Hepatitis B Virus DNA Detector, Liver Tissue | 5800 | Needle Biopsy Liver Tissue 1 NOs. | R/F | PCR | Daily | 10th Day | 1cm collection of needle biopsy in STerile normal saline with observance of STrict aseptic precautions | |
| 502 | H033 | Hepatitis B Virus DNA PCR (Qualitative) | 3400 | WB-EDTA (3 ml) | R/F | Real Time PCR | Daily | Third Day | ||
| 503 | H034 | Hepatitis B Virus DNA PCR (Quantitative) | 5800 | WB-EDTA (3 ml) | R/F | Real Time PCR | Daily | Third Day | ||
| 504 | H035 | Hepatitis C virus – Total Antibodies (HCV) | 700 | Serum (1 ml) | A | CLIA | Daily 3 PM | Same Day | ||
| 505 | H079 | Hepatitis C Virus IgG | 700 | Serum (1 ml) | A | CLIA / ELISA | Daily | Next Day | ||
| 506 | H080 | Hepatitis C Virus IgM | 700 | Serum (1 ml) | A | CLIA / ELISA | Daily | Next Day | ||
| 507 | H036 | Hepatitis C Virus (HCV Rapid) | 480 | Serum (2 ml) | A | Rapid Test/ IC | Daily | Same Day | ||
| 508 | H038 | Hepatitis C Virus (HCV) Genotyping | 9000 | EDTA Plasma (5 ml) | R/F | Real Time PCR | Daily | 7th Day | ||
| 509 | H039 | Hepatitis C Virus RNA PCR (Qualitative) | 4000 | WB-EDTA (3 ml) | R/F | Real Time PCR | Daily | Third Day | ||
| 510 | H040 | Hepatitis C Virus RNA PCR (Quantitative) | 6700 | WB-EDTA (3 ml) | R/F | Real Time PCR | Daily | Third Day | ||
| 511 | H041 | Hepatitis Delta Virus (HDV) RT-PCR | 7500 | EDTA Plasma (5 ml) | R/F | RT PCR | 4 | Fifth Day | ||
| 512 | H042 | Hepatitis Delta Virus (HDV) Total Antibodies | 2100 | Serum (2.0 ml) | A | ELISA | 1 | Third Day | ||
| 513 | H043 | Hepatitis E virus – IgGAntibodies (HEV IgG) | 1400 | Serum (1 ml) | A | ELISA | Daily 3 PM | Next Day | ||
| 514 | H044 | Hepatitis E virus –IgM Antibodies (HEV IgM) | 1400 | Serum (1 ml) | A | ELISA | Daily | Same Day | ||
| 515 | H045 | Her2/neu oncogene amplification By FISH | 12000 | One Paraffin embedded tissue block with H & E Stained tumor marked slide and with previous Histopath & IHC Reports | A | FISH | Daily | 15th Day | ||
| 516 | H048 | HIV I & II Antibody Quantitative | 400 | Serum (1 ml) | A | ELISA/CLIA | Daily | Same Day | Duely signed consent form must accompany the TRF | |
| 517 | H049 | HIV I & II Serology (Rapid) | 350 | Serum (1 ml) | A | Rapid Test/ IC | Daily | Same Day | Duely signed consent form must accompany the TRF | |
| 518 | H050 | HIV RNA PCR (Quantitative/Viral Load) | 5500 | WB-EDTA (3 ml) | R/F | Real Time PCR | Daily | Third Day | ||
| 519 | H051 | HIV RNA PCR (Qualitative) | 3200 | WB-EDTA (3 ml) | R/F | Real Time PCR | Daily | Third Day | ||
| 520 | H052 | HIV-1 Drug Resistance Test | 17000 | EDTA-Plasma (5 ml) | F | PCR-Sequencing | 6 | Eleventh Day | ||
| 521 | H053 | HIV-DUO Antigen & Antibody Screen(IVth Gen), Serum | 600 | Serum (3 ml) | R/F | CLIA | Daily | Same Day | ||
| 522 | H054 | HLA A, B, C, DR & DQ DNA Typing For Bone Marrow Transplantation (Single Person) | 18000 | WB-EDTA (4 ml) | R/F | PCR | Daily | Fourth Day | ||
| 523 | H084 | HLA A, B, C, DR & DQ DNA Typing For Bone Marrow Transplantation (1 Patient, 1 donar) | 35000 | WB-EDTA (4 ml) | R/F | PCR | Daily | Fourth Day | ||
| 524 | H055 | HLA A, B, DR DNA Typing For Kidney Transplantation | 13000 | WB-EDTA (4 ml) | R/F | PCR | Daily | Fourth Day | ||
| 525 | H056 | HLA typing panel- Molecular A, B C loci Class I – Molecular typing | 135000 | 4 ml EDTA / ACD Blood | A | PCR | Sat to Wed: 2pm | 4th day | ||
| 526 | H057 | HLA typing-Molecular Class I A Locus | 9900 | WB-EDTA (6 ml) | A | PCR-SSP | Sat to Wed: 2pm | 4th day | ||
| 527 | H058 | HLA typing-Molecular Class I B Locus | 9900 | WB-EDTA (6 ml) | A | PCR-SSP | Sat to Wed: 2pm | 4th day | ||
| 528 | H059 | HLA typing Molecular Class I C Locus | 9900 | WB-EDTA (6 ml) | A | PCR-SSP | Sat to Wed: 2pm | 4th day | ||
| 529 | H060 | HLA typing-Molecular Class II DQ Locus | 6500 | WB-EDTA (6 ml) | A | PCR-SSP | Sat to Wed: 2pm | 4th day | ||
| 530 | H061 | HLA typing-Molecular Class II DR Locus | 6500 | WB-EDTA (6 ml) | A | PCR-SSP | Sat to Wed: 2pm | 4th day | ||
| 531 | H063 | HLA-B27 (Flowcytometry) | 1800 | WB-EDTA (3 ml) | R/F | Flowcytometry | Daily | Third Day | ||
| 532 | H064 | HLA-B27 (PCR) | 2800 | WB-EDTA (3 ml) | R/F | PCR | Daily | Third Day | ||
| 533 | H085 | HLA Typing – molecular B 51 Locus | 12000 | WB-EDTA (3 ml) | A | PCR | Sat to Wed: 2pm | Fifth Day | ||
| 534 | H086 | HLA B 7 | 5700 | WB-EDTA (3 ml) | A | PCR | Daily | Third Day | ||
| 535 | H087 | Homa Index | 1200 | Serum (3ml) and 2ml Floride plasma (infasting) | A | CMIA | Daily | Next Day | fasting | |
| 536 | H092 | Hemosiderin, Urine | 500 | Urine 30 ml | A | Prussian Blue Reaction | Daily | Third Day | ||
| 537 | H065 | Homocysteine | 900 | Serum (1mL)/ Plasma (1ml) | A | CLIA | Daily | Same Day | Separate Serum within 40 min of collection. Over night fasting required | |
| 538 | H066 | HPV DNA Detector With Thin Prep | 3000 | LBC Container | A | PCR, Liquid Base Cytology | Daily | Fourth Day | Clinical history required | |
| 539 | H067 | HPV DNA PCR | 2500 | LBC Container | A | PCR | Daily | Fourth Day | ||
| 540 | H068 | HSV 1& 2 DNA PCR (Qualitative) | 4300 | Tissue Scrape | A | PCR | 4 | Fourth Day | ||
| 541 | H069 | HSV 1& 2 DNA PCR (Qualitative) | 4300 | CSF (3 ml) | A | Real Time PCR | 2 | Fourth Day | ||
| 542 | H070 | HSV 1& 2 DNA PCR (Qualitative) | 4300 | WB-EDTA (3 ml) | A | Real Time PCR | 2 | Fourth Day | ||
| 543 | H071 | HSV-1 IgG Antibodies | 460 | Serum (1 ml) | A | ELISA | Daily | Same Day | ||
| 544 | H072 | HSV-1 IgM Antibodies | 460 | Serum (1 ml) | A | ELISA | Daily | Same Day | ||
| 545 | H073 | HSV-1&2 IgG Antibodies | 680 | Serum (1 ml) | A | ELISA | Daily | Same Day | ||
| 546 | H074 | HSV-1&2 IgM Antibodies | 680 | Serum (1 ml) | A | ELISA | Daily | Same Day | ||
| 547 | H075 | HSV-2 IgG Antibodies | 460 | Serum (1 ml) | A | ELISA | Daily | Same Day | ||
| 548 | H076 | HSV-2 IgM Antibodies | 460 | Serum (1 ml) | A | ELISA | Daily | Same Day | ||
| 549 | H077 | HTLV I & II Antibodies | 4800 | Serum (1 ml) | A | ELISA | 6 | Fifth Day | ||
| 550 | H078 | h-tTG/DGP | 2500 | Serum (2 ml) | A | ELISA | 3 | Third Day | ||
| 551 | I001 | IgD Heavy Chain (SURFACE) | 4300 | Whole Blood (3.0 ml) in 1 Lavender Top (EDTA) Tube and Whole Blood (3.0 ml) in 1 Green Top (Sodium Heparin) Tube or Heparinized Bone Marrow(2.0 ml). | A | Flowcytometry | Daily | Third Day | ||
| 552 | I002 | IgE Total, Serum | 650 | Serum (1 ml) | A | CLIA | Daily | Same Day | ||
| 553 | I003 | IGF Binding Protein-3 (IGF BP-3) | 3300 | Serum (2 ml) | F | CLIA | Daily | Third Day | Age & Sex of the patient is mandatory for reporting | |
| 554 | I004 | IGF- I (Somatomedin-C) | 3600 | Serum (2 ml) | A | CLIA | Daily | 3rd Day | Fasting Required | |
| 555 | I005 | IGF-1 (Insulin Like Growth Factor-1) | 2400 | Serum (2 ml) 555 | A | CLIA | 2, 4, 6 | Next Day | ||
| 556 | I006 | IgG Heavy Chain (SURFACE) | 4000 | Whole Blood (3.0 ml) in 1 Lavender Top (EDTA) tube and Whole Blood (3.0 ml) in 1 Green Top (Sodium Heparin) Tube or Heparinized Bone Marrow(2.0 ml). | A | Flowcytometry | Daily | Third Day | ||
| 557 | I063 | IgG 4 Sub Class | 4900 | Serum (3ml) Fasting | A | ELISA | 3, 6 | Third Day | Fasting sample required | |
| 558 | I007 | IgM Cytoplasmic (Pre- B Cell ALL Prognostic Marker/ Clonal Restriction Marker) | 3300 | WB Heparin/Bone Marrow Heparin/ Body Fluids Heparinised | A | Flowcytometry | Daily | Third Day | Clinical history required | |
| 559 | I008 | IgM Surface (Clonal Restriction Marker/ B Cell Maturity Marker) | 3300 | WB Heparin/Bone Marrow Heparin/ Body Fluids Heparinised | A | Flowcytometry | Daily | Third Day | Clinical history required | |
| 560 | I009 | IHC Cyclin D1 | 2200 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | Sixth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 561 | I010 | IHC Estrogen Progestetrone Receptor (ER PR) | 3800 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | 7th Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 562 | I011 | IHC Marker C Kit (CD117) | 2200 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | Sixth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 563 | I012 | IHC Marker CD 15 | 2200 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | Sixth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 564 | I013 | IHC Marker CD 30 | 2200 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | Sixth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 565 | I014 | IHC Marker CD 99 | 2200 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | Sixth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 566 | I015 | IHC Marker CD10 | 2200 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | Sixth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 567 | I016 | IHC Marker CD20 | 2200 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | Sixth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 568 | I064 | IHC Marker (Single) Any | 2200 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | Sixth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 569 | I017 | IHC Marker Epithelial Membrane antigen | 2200 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | Sixth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 570 | I018 | IHC Marker for Kappa light chain | 2200 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | Sixth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 571 | I019 | IHC Marker for Ki-67 Antigen | 2200 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | Sixth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 572 | I020 | IHC Marker for Lambda light chain | 2200 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | Sixth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 573 | I021 | IHC Marker Glial fibrillary acid protein (IHC GFAP) | 2200 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | Sixth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 574 | I022 | IHC Marker Her2Neu | 2200 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | Sixth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 575 | I023 | IHC Marker HMB45 | 2200 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | Sixth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 576 | I024 | IHC Marker Myoglobulin | 2200 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | Sixth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 577 | I025 | IHC Marker NSE (Neuron Specific Enclose) | 2200 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | Sixth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 578 | I026 | IHC Marker p53 protein | 2200 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | Sixth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 579 | I027 | IHC Marker Pancytokeratin (Pan ck) | 2200 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | Sixth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 580 | I028 | IHC Marker S100 | 2200 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | Sixth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 581 | I029 | IHC Marker Synaptophysin | 2200 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | Sixth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 582 | I030 | IHC Marker Thyroglobulin | 2200 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | Sixth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 583 | I031 | IHC Marker Vimentin | 2200 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | Sixth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 584 | I032 | IHC Markers Actin Smooth Antigen | 2200 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | Sixth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 585 | I033 | IHC Markers BCL 2 oncoprotein | 2200 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | Sixth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 586 | I034 | IHC Markers CD 68 | 2200 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | Sixth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 587 | I035 | IHC Markers CD3 | 2200 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | Sixth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 588 | I036 | IHC Markers Chromogranin A | 2200 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | Sixth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 589 | I037 | IHC Markers Cytokeratin 8 | 2200 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | Sixth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 590 | I038 | IHC Markers Cytokeratin 8 HMW | 2200 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | Sixth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 591 | I039 | IHC Markers Cytokeratin 8 LMW | 2200 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | Sixth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 592 | I040 | IHC Markers Desmin | 2200 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | Sixth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 593 | I066 | IHC Markers (Special Review & Complete Markers) | 7200 | Tissue in buaffered formalin/Paraffn Blocks | A | IHC | Daily | Sixth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 594 | I065 | Immature Platelets Fraction | 1000 | WB-EDTA (3 ml) | A | Fluorescent Flowcytometry | Daily | 4th Day | ||
| 595 | I068 | Interleukin 6 (IL6) | 2500 | EDTA Plasma Serum (2 ml) (Preferable) | R/F | CLIA | Daily | Same Day | Separate serum / plasma within 2 hours of collection in a plastic vial immediately with cold chain maintained |
|
| 596 | I041 | Immunoglobulin- A (IgA) | 550 | Serum (2 ml) | A | Nephelometry | Daily | Same Day | ||
| 597 | I042 | Immunoglobulin Fixation Electrophoresis | 6000 | Serum (4 ml) | A | Electrophoresis | 2, 6 | Fourth Day | Fasting sample required | |
| 598 | I043 | Immunoglobulin- G (IgG) | 550 | Serum (2 ml) | A | Nephelometry | Daily | Same Day | ||
| 599 | I044 | Immunoglobulin- M (IgM) | 550 | Serum (2 ml) | A | Nephelometry | Daily | Same Day | ||
| 600 | I045 | Indian Ink | 280 | CSF (1ml) | A | Microscopy | Daily | Next Day | ||
| 601 | I046 | Infectious Mononucleosis {Heterophile Antibodies (HA)} | 1100 | Serum (3 ml) | A | Latex Particle Agglutination | Daily | Third Day | ||
| 602 | I047 | Influenza Virus- A (IgG) | 2400 | Serum (2 ml) | R/F | ELISA | 1 | Next Day | ||
| 603 | I048 | Influenza Virus- A (IgM) | 2400 | Serum (2 ml) | R/F | ELISA | 1 | Next Day | ||
| 604 | I049 | Influenza Virus- B (IgG) | 2400 | Serum (2 ml) 601 | R/F | ELISA | 1 | Next Day | ||
| 605 | I050 | Influenza Virus- B (IgM) | 2400 | Serum (2 ml) | R/F | ELISA | 1 | Next Day | ||
| 606 | I051 | Inhibin- A (Pregnancy) | 1400 | Serum (2 ml) | R/F | CLIA | Daily | Same Day | ||
| 607 | I052 | Inhibin- A (Tumer Marker) | 1400 | Serum (2 ml) | R/F | CLIA | Daily | Same Day | ||
| 608 | I053 | Inhibin- B | 2000 | Serum (2 ml) | R/F | ELISA | 2, 6 | 3rd Day | ||
| 609 | I054 | Insulin Fasting | 650 | Serum (1 ml) | R | CLIA | Daily | Same Day | Overnight fasting sample required | |
| 610 | I055 | Insulin Post Prandial | 650 | Serum (1 ml) | R | CLIA | Daily | Same Day | ||
| 611 | I056 | Insulin Random | 650 | Serum (1 ml) | R | CLIA | Daily | Same Day | ||
| 612 | I057 | Insulin Antibodies | 2100 | Serum (3 ml) | R | ELISA | 1 | Third Day | ||
| 613 | I058 | Intrinsic Factor IgG by IFA | 2700 | Serum (3 ml) | R | IFA | 2, 6 | Third Day | ||
| 614 | I059 | Ionized Calcium | 400 | Serum (1 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 615 | I060 | IRMA (Imatinib Resistance Mutation Analysis) | 11000 | 6ml EDTA Blood | R | RT-PCR & Se- quencing | Daily | 15th Day | ||
| 616 | I061 | Iron | 250 | Serum (1 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 617 | I062 | Iron Panel Basic(Iron, TIBC & Trans.Saturation) | 500 | Serum (2ml) | A | Spectrophotometry | Daily | Same Day | ||
| 618 | J001 | JAK2 V617F Mutation Study | 6000 | EDTA Whole Blood 5 ml/ EDTA Bone Marrow 5ml | A | PCR | Daily | 5th Day | ||
| 619 | J003 | JAK2 Mutation Exon 12 | 6500 | EDTA Whole Blood 5 ml/ EDTA Bone Marrow 5 ml | A | PCR / Sequencing | 2 | 10th Day | Indicated for suspected cases of Polycythemia Vera where Jak2 V617F is Negative | |
| 620 | J002 | Jo-1 Antibodies | 1600 | Serum (2 ml) | A | ELISA | 2, 4, 6 | Third Day | Mention ANA Findings If Available | |
| 621 | K001 | Kappa/Lambda (Clonal Restriction/ B Cell Maturity Marker) /Chronic leukemia panel | 10000 | WB-EDTA (3 ml) | A | Flowcytometry | Daily | Fifth Day | Clinical history required | |
| 622 | K002 | KOH Preparation for Fungus (Wet Mount) | 350 | Any Specimen | A | Microscopy | Daily | Next Day | ||
| 623 | K003 | KRAS Gene Mutation | 9000 | Formalin-fixed paraffin embedded tissue blocks. | A | PCR | Daily | 10-15 days | Clinical History Require | |
| 624 | K004 | Kidney Panel-2 With eGFR (Urea, Creatinine, Uric Acid, Na, K, CL, Calcium, Phosphorous, eGFR) | 700 | Serum (2ml) | A | Spectrophotometry | Daily | Same Day | ||
| 625 | L001 | Lactate (CSF) | 900 | CSF (2 ml) | R/F | Spectrophotometry | Daily | Third Day | Labile Analyte | |
| 626 | L002 | Lactate (NaF Plasma) | 900 | NaF Plasma (2 ml) | R/F | Spectrophotometry | Daily | Third Day | Labile Analyte. Collect sample without applying tourniquet, separate plasma within 2 hours of collection. | |
| 627 | L003 | Lamotrigine | 6000 | 3 ml EDTA Plasma | F | HPLC | 6 | Seventh Day | Clinical history, Height, weight, collection time and date is mandatory | |
| 628 | L028 | LAP (Leucocyte Alkaline Phosphatase) Score | 1000 | Fixed Blood Smears(s) From Finger Prick & EDTA | A | Staining | Daily | 4th Day | ||
| 629 | L004 | LDH (Lactate Dehydrogenase) | 300 | Serum (1 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 630 | L027 | LDH (Lactate Dehydrogenase) Fluid | 350 | Fluid (2ml) | A | Spectrophotometry | Daily | Same Day | ||
| 631 | L005 | LE Cell | 300 | EDTA (3 mL) / Hepsin | A | Microscopy | Daily | 3rd Day | ||
| 632 | L006 | Lead | 2000 | EDTA (3 mL) | A | AAS | Daily | Fifth Day | ||
| 633 | L007 | Lead (Urine) | 2000 | 24 HR Urine (5 ml) | A | AAS | Daily | Fifth Day | 24 Hr Urine volume required | |
| 634 | L008 | Legionella Pneumophila Antigen detection Urine | 2900 | 10 ml of Spot Urine | A | Immunochromato graphy | DAILY | Fourth Day | ||
| 635 | L009 | Leishmania Donovani antibodies (KALA-AZAR) IgM | 1900 | Serum (2 ml) | A | IC | Daily | Next Day | ||
| 636 | L010 | Leishmania Donovani bodies detection (KALA- AZAR) | 1200 | WB EDTA | A | Microscopy | Daily | Third Day | Clnical History required | |
| 637 | L011 | Leishmania Donovani bodies detection (KALA- AZAR) | 1200 | Slides of BM aspirate | A | Microscopy | Daily | Third Day | Clnical History required | |
| 638 | L029 | Leptin | 5000 | Serum (3ml) | A | EIA | 6 | Fifth Day | ||
| 639 | L012 | Leptospira Detection (Urine) | 750 | Spot Urine (10 ml) | A | Darkfield Micros- copy | Daily | Third Day | Fresh Sample Required | |
| 640 | L013 | Leptospira Detection (WB Heparin) | 750 | WB-Heparin (3 ml) | A | Darkfield Micros- copy | Daily | Third Day | Fresh Sample Required | |
| 641 | L014 | Leptospira DNA PCR | 2700 | 5 ml blood in EDTA vacutainer/ 10 ml urine in sterile container | R | Real Time PCR | 2, 6 | Seventh Day | ||
| 642 | L015 | Leptospirosis – IgG Antibodies | 1400 | Serum (2 ml) | A | ELISA | Daily | Next Day | ||
| 643 | L016 | Leptospirosis – IgM Antibodies | 1400 | Serum (2 ml) | A | ELISA | Daily | Next Day | ||
| 644 | L017 | LH (Leutinising Hormone) | 480 | Serum (1 ml) | A | CLIA | Daily | Same Day | ||
| 645 | L018 | LH FSH Ratio (LH, FSH and Ratio) | 900 | Serum (2 ml) | A | CLIA | Daily | Same day | ||
| 646 | L019 | Lipase | 480 | Serum (1 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 647 | L020 | Lipoprotein- a/Lp- (a) | 900 | Serum (2 ml) | A | Nephelometry | Daily | Same Day | Overnight fasting sample required | |
| 648 | L021 | Lithium (Li) | 520 | Serum (1 ml) | A | ISE | Daily | Next Day | ||
| 649 | L022 | LKM-1 Antibodies (Liver Kidney Microsome Antibody) | 1800 | Serum (1 ml) | A | ELISA | Daily | Third Day | ||
| 650 | L023 | LKM-1 Antibodies (Liver Kidney Microsome Antibody)-IFA | 2000 | Serum (2 ml) | A | IFA | 2, 6 | Third Day | ||
| 651 | L024 | Lupus Anticoagulant | 1200 | Plasma Citrated (1 ml) | R/F | DRVVT | Daily 3 PM | Same Day | Ensure Platelet Poor Plasma | |
| 652 | L025 | Lymes Disease (Borrelia Burgdorferi IgG) | 2000 | Serum (2 ml) | A | ELISA | 4 | Third Day | ||
| 653 | L026 | Lymes Disease (Borrelia Burgdorferi IgM) | 2000 | Serum (2 ml) | A | ELISA | 4 | Third Day | ||
| 654 | L030 | Leukemia Translocation Panel By Blood | 9800 | 3 ml EDTA Whole Blood | A | Multiplex PCR | 3 | 10th Day | ||
| 655 | L031 | Levetiracetam | 7000 | 3 mL (1 mL min.) serum from 1 Red Top | R | LC-MS/MS | 1 | 8th day | Drug Dosage | |
| 656 | M001 | Magnesium (24 Hr Urine) | 450 | 24 hrs Urine(5 ml) | A | Spectrophotometry | Daily | Same Day | Do not use preservatives. Record 24 hours urine volume on TRF and sample container. | |
| 657 | M002 | Magnesium (Serum) | 450 | Serum (1 ml) | A | Spectrophotometry | Daily | Same Day | Fasting sample required | |
| 658 | M060 | Magnesium (Random Urine) | 450 | Urine(5 ml) | A | Spectrophotometry | Daily | Same Day | Do not use preservatives. Record 24 hours urine volume on TRF and sample container. | |
| 659 | M003 | Malaria Antigen (PV & PF) | 400 | WB-EDTA (3 ml) | A | IC | Daily | Same Day | ||
| 660 | M004 | Malaria Parasite (MP- Slide) | 120 | WB-EDTA (3 ml), Slides | A | Microscopy | Daily | Same Day | ||
| 661 | M005 | Malaria PCR | 3200 | EDTA (3 ml) | A | PCR | Daily | Fifth Day | ||
| 662 | M006 | Malignant Cell | 380 | Any Speciemen | A | Microscopy | Daily | Next day | Clinical history, Site of biopsy, Doctors phone No. | |
| 663 | M007 | Mantoux Test, Tuberculin Skin Test | 180 | For walkin Patient Only | A | Intradermal skin test | Daily | Confirm with Lab | ||
| 664 | M008 | Marijuana (THC) | 800 | Urine (5 ml) | A | Flow Chromato- graphic Immuno- assay | Daily | Third day | ||
| 665 | M009 | MCH (Mean Corpuscular Hemoglobin) | 120 | Whole Blood EDTA (3 ml) | A | Cell Counter | Daily | Same day | ||
| 666 | M010 | MCHC (Mean Corpuscular Concentration) | 120 | Whole Blood EDTA (3 ml) | A | Cell Counter | Daily | Same day | ||
| 667 | M011 | MCV (Mean CorpuscularVolume) | 120 | Whole Blood EDTA (3 ml) | A | Cell Counter | Daily | Same day | ||
| 668 | M012 | Measles (Rubeola) IgM Antibodies | 1400 | Serum (2 ml) / CSF | A | CLIA | 1, 3, 5 | Next Day | ||
| 669 | M013 | Measles (Rubeola) IgG Antibodies | 1400 | Serum (2 ml) / CSF | A | CLIA | 1, 3, 5 | Next Day | ||
| 670 | M014 | Measles PCR | 4000 | WB-EDTA (3 ml) | A | Real Time PCR | 1, 3, 5 | Seventh Day | ||
| 671 | M015 | Mercury-Blood | 4300 | WB-EDTA (3 ml) | A | ICP-AES/ICP-MS | Daily | 8th Day | ||
| 672 | M016 | Mercury-Urine | 4300 | 24 hrs Urine (30 ml) | A | AAS | Daily | 8th Day | ||
| 673 | M017 | Metachromatic Leucodystrophy, Quantitative, Blood | 2600 | 10 ml Whole Blood from 3 EDTA containers OR 10 ml Whole Blood from 3 Sodium Heparin | A | Spectrophotometry | Daily | Fifth Day | Clinica History Required | |
| 674 | M018 | Metanephrine-Free, Plasma | 2500 | 3 ml of EDTA Plasma | A | ELISA | Daily | Fourth Day | ||
| 675 | M019 | Metanephrines, 24 Hr Urine | 2200 | 24 Hours Urine (30 ml) | A | HPLC Column Chromatography | Daily | Fourth Day | Use HCL As Preservative urine volume req. | |
| 676 | M020 | Meth Haemoglobin Estimation | 1000 | 3 ml of EDTA Blood | A | Spectrophotometry | Daily | Fourth Day | ||
| 677 | M021 | Methadone Dolophine (Urine) | 800 | Urine (30 ml) | A | Flow Chromatographic Immunoassay | Daily | Third Day | ||
| 678 | M022 | Methamphetamines | 1100 | Urine (30 ml) | A | Flow Chromatographic Immunoassay | Daily | Third Day | ||
| 679 | M023 | Methaqualone | 1000 | Urine (30 ml) | A | Flow Chromatographic Immunoassay | Daily | Same Day | ||
| 680 | M024 | Methyl Malonic Acid, (Urine) | 1000 | Urine (30 ml) | A | Biochemical | Daily | Fifth Day | ||
| 681 | M025 | Microalbumin (24 Hour Urine) | 380 | 24 Hr Urine (30 ml) | A | Spectrophotometry | Daily | Same Day | 24 hours urine volume required | |
| 682 | M026 | Microalbumin (Urine Random) | 380 | Urine (30 ml) | A | Spectrophotometry | Daily | Same day | ||
| 683 | M027 | Microalbumin / Creatinine Ratio | 425 | Urine (30 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 684 | M057 | Microalbumin / Creatinine Ratio (24 Hrs Urine) | 425 | Urine (30 ml) | A | Spectrophotometry | Daily | Same Day | 24 hours urine volume required |
|
| 685 | M028 | Microfilaria Detection Slide | 500 | WB-EDTA (3 ml) | A | Microscopy | Daily | Sa e Day | ||
| 686 | M029 | Microfilarial Antibody Detection (Filaria) (Wuchereria Bancrofti) | 1300 | Serum (2 ml) | A | IC | Daily | Same Day | ||
| 687 | M030 | Microfilarial Antigen Detection (Filaria (Wuchereria Bancrofti) | 1000 | WB-EDTA (3 ml) | A | ELISA | Daily | Third Day | ||
| 688 | M031 | Protein (Microprotein) (Random Urine) | 300 | Random Urine (30 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 689 | M058 | Microprotein (CSF) | 350 | CSF (2 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 690 | M032 | Mono Spot Test for Infectious Mononucleosis | 780 | Serum (2ml) | A | Agglutination | Daily | Third Day | ||
| 691 | M033 | Morphine/Heroin | 900 | Urine (5 ml) | A | Flow Chromatographic Immunoassay | Daily | Next Day | ||
| 692 | M034 | MPV (Mean Platelet Volume) | 120 | Whole Blood EDTA (3 ml) | A | Cell Counter | Daily | Same day | ||
| 693 | M060 | MRD Panel Flowcytometry | 1000 | WB EDTA | A | Flowcytometry | Daily | Fourth Day | ||
| 694 | M056 | MTHFR Mutations C677T / A12 98C Mutations | 6500 | Whole Blood EDTA (3 ml) | A | Real Time PCR & Sequencing | 1, 4 | 7th day | ||
| 695 | M035 | Mumps IgG Antibodies | 1400 | Serum (2ml) | AA | CLIA | Daily | Third Day | ||
| 696 | M036 | Mumps IgM Antibodies | 1400 | Serum (2ml) | A | CLIA | Daily | Third Day | ||
| 697 | M061 | Musk (Muscles Specific Kinase) Antibody | 6600 | Serum (3ml) | A | RIA | 6 | Fourth Day | ||
| 698 | M043 | Mycobacterium tuberculosis (TB)“DNA PCR (Qualitative) | 1800 | Pleural fluid (30 ml) | R | PCR | Daily | Third Day | ||
| 699 | M044 | Mycobacterium tuberculosis (TB)“DNA PCR (Qualitative) | 1800 | CSF (10 ml) | R | PCR | Daily | Third Day | ||
| 700 | M045 | Mycobacterium tuberculosis (TB)“DNA PCR (Qualitative) | 1800 | Urine (30 ml) | R | PCR | Daily | Third Day | ||
| 701 | M046 | Mycobacterium tuberculosis (TB)“DNA PCR (Qualitative) | 1800 | Ascitic fluid (30 ml) | R | PCR | Daily | Third Day | ||
| 702 | M047 | Mycobacterium tuberculosis (TB)“DNA PCR (Qualitative) | 1800 | Synovial fluid (30 ml) | R | PCR | Daily | Third Day | ||
| 703 | M048 | Mycobacterium tuberculosis (TB)“DNA PCR (Qualitative) | 1800 | Sputum | R | PCR | Daily | Third Day | ||
| 704 | M049 | Mycobacterium tuberculosis (TB)“DNA PCR (Qualitative) | 1800 | WB-EDTA (3 ml) 698 | R | PCR | Daily | Third Day | ||
| 705 | M050 | Mycobacterium tuberculosis (TB)“DNA PCR (Qualitative) | 1800 | Positive Culture Isolate | R | PCR | Daily | Third Day | ||
| 706 | M051 | Mycobacterium tuberculosis (TB)“DNA PCR (Qualitative) | 1800 | Any Other specimen | R | PCR | Daily | Third Day | ||
| 707 | M052 | Mycoplasma Pneumoniae IgG Antibodies | 2300 | Serum (2 ml) | A | ELISA | 2 | Fourth Day | ||
| 708 | M053 | Mycoplasma Pneumoniae IgM Antibodies | 2300 | Serum (2 ml) | A | ELISA | 2 | Fourth Day | ||
| 709 | M054 | Myoglobin (Serum) | 1500 | Serum (2 ml) | A | CLIA | Daily | Third Day | ||
| 710 | M055 | Myoglobin (Spot Urine) | 1000 | 30 ml of Urine | A | CLIA | Daily | Third Day | Myoglobin Is Unstable In Urine Hence Add 10% Na2Co3 To Adjust Ph To 8-9. | |
| 711 | M062 | MDS (Myelodysplastic Syndrome) Panel By FISH (5q, 7q, 8q, 20q) | 9500 | 3 ml Bone Marrow / Blood in Na Heparin Container | A | FISH | Daily | 1 Week | ||
| 712 | M063 | Meningitis panel IgM | 5000 | Serum | R | EIA | 1 | 5th Day | ||
| 713 | M064 | Meningitis panel IgG | 5000 | serum | R | EIA | 1 | 5th Day | ||
| 714 | N001 | Nickel | 3800 | 24 Hour Urine 25 ml / Serum | A | AAS | 3 | Third Day | Mention 24 Hours Urine Volume (No Preservative) | |
| 715 | N002 | Nicotin Metabolite | 1800 | Serum (2 ml) / Urine 30 ml | A | IC | Daily | Next Day | ||
| 716 | N010 | Nitroprusside Test, Qualitative Urine | 550 | Urine (30ml) Spot Urine | A | Biochemical | Daily | Fifth Day | ||
| 717 | N011 | Nitrosonaphthol Test, Qualitative Urine | 550 | Urine (30ml) Spot Urine | A | Biochemical | Daily | Fifth Day | ||
| 718 | N003 | NMDA Receptor Antibodies (NR1) | 7000 | Serum (3ml) / CSF (3ml) | A | IFA | 6 | Fourth Day | ||
| 719 | N004 | NMO (Aquaporin 4)-Neuromyelitis Optica Antibody | 4800 | Serum (3ml) / CSF (3ml) | A | ELISA | 3 | Third Day | ||
| 720 | N012 | Nocardia Stain | 700 | Sputum OR Tissue in Normal Saline | Microscopy | Daily | Third Day | |||
| 721 | N005 | Nor-epinephrine (Nor- Adrenaline) | 3200 | 50 ml of 24 Hours Urine / 2ml EDTA Plasma | A | HPLC | 1 | Fourth Day | Use 10 ml of 6M HCL As | |
| 722 | N006 | Nor-metanephrine-Free Urine 24H | 2400 | 30 ml of 24 Hours Urine. | A | ELISA | 2, 6 | Fifth Day | Use 10 ml of 6M HCL As Preservative |
|
| 723 | N016 | Nor-metanephrine-Free Plasma | 4400 | EDTA (3 ml) | A | ELISA | 2 | Fifth Day | ||
| 724 | N017 | NGAL | 3800 | EDTA Plasma (5 ml) | R | Immnoturbidom- etry | plz enquire before sending sample | clinical history | ||
| 725 | N007 | NPM1 Muation Detection (exon 12) | 5700 | 5 ml whole blood or 3-4 ml Bone Marrow in 2 EDTA Vacutainers. | A | RT-PCR & Sequencing | 2, 6 | 10th Day | Preservative | |
| 726 | N013 | NSCLC IHC Marker with reporting ALK(D5F3) Reflex Fish | 12000 | Tissue in Formaline OR Formaline Block | A | IHC stain and Microscopic Interpretation | Daily | 12 Day | History Required | |
| 727 | N014 | Neuron Specific Enolase (NSE) | 3300 | Serum (3ml) | A | ECLIA | 3, 6 | 4th Day | ||
| 728 | N008 | NT- Pro BNP (N-Terminal Pro B Type Natriuretic Peptide) | 2300 | EDTA Plasma (5 ml) | A | CLIA | Daily | Same Day | ||
| 729 | N015 | NTx N- Tellopeptide (Collagian Crosslinked) Urine 24 Hrs | 3450 | 10 ml of 24 hrs urine without preservative | A | EIA | 1 | Fourth Day | ||
| 730 | O001 | Opiates (Morphine)/Heroin | 800 | Urine (30 ml) | A | Flow Chromatographic Immunoassay | Daily | Same Day | ||
| 731 | O002 | Osmolality Serum | 850 | Serum (1 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 732 | O003 | Osmolality Urine | 850 | Urine (30 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 733 | O004 | Osmotic Fragility Test | 600 | WB-Na Heparin (3 ml) | A | Spectrophotometry | Daily | Next Day | Fresh Sample required | |
| 734 | O005 | Osteocalcin (N MID) | 3000 | Serum (2.0 ml) | F | CLIA | Daily | Third Day | Clinical History Reqired | |
| 735 | O006 | OT Swab Culture | 450 | OT Swabs | A | Aerobic culture | Daily | After 48 hrs | ||
| 736 | O007 | Oxalate (24 Hr Urine) | 2150 | 10 ml of 24 hours urine. Use 10ml of conc HCl as preservative | A | SPM | 2, 4 | Third Day | Mention 24 hrs. urine volume. | |
| 737 | O010 | Oligoclonal Band, by IEF Multiple Sclerosis CSF & Serum | 4600 | CSF (3ML) & Serum (3ml) | A | Electrophoresis GEL | 3, 6 | Fourth Day | ||
| 738 | P001 | P1NP (Intact N-Terminal Propeptide of Type I Procollagen), | 1900 | Serum (3ml) | A | CLIA | 2, 6 | Fourth Day | ||
| 739 | P002 | P-ANCA (Myeloperoxidase) | 1300 | Serum (2 ml) | A | ELISA | Daily | Next Day | ||
| 740 | P003 | PAP Smear | 400 | Slides | A | Microscopy | Daily | Next Day | Clinical history and age required | |
| 741 | P004 | PAP Smear Cytology LBC | 1200 | 10 mL in LBC Container | A | Liquid Based Cytology by Thin Prep | Daily | Next Day | Clinical history and age required | |
| 742 | P005 | PAPP-A (Pregnancy Associated Plasma Protein-A) | 1300 | Serum (2 ml) | A | CLIA | Daily | Same Day | Age, LMP Is Required. | |
| 743 | P006 | Paracetamol | 1250 | Serum/ Plasma, 2.0 mL (EDTA OR Heparin) | F | SPM | Daily | Fifth Day | ||
| 744 | P007 | Parietal Cell Antibody (APCA) | 2200 | Serum (2 mL) | R/F | IFA | Daily | Third Day | ||
| 745 | P008 | Parvovirus B19 DNA PCR | 3900 | EDTA-Plasma / WB- EDTA / Bone Marrow EDTA / Body Fluids | R | PCR | 1 | Sixth Day | ||
| 746 | P009 | Parvovirus B19 IgG | 2700 | Serum (2 ml) | A | ELISA | 1 | Fourth Day | ||
| 747 | P010 | Parvovirus B19 IgM | 2700 | Serum (2 ml) | A | ELISA | 1 | Fourth Day | ||
| 748 | P011 | PAS (Periodic Acid Schiff) Stain | 600 | WB- EDTA (3 ml) or 2 ml Bone Marrow – Na Heparin | A | Cytochemistry Special Stains | Daily | Fourth Day | Clinical history required | |
| 749 | P012 | PCV (Packed Cell Volume) or HCT | 100 | WB-EDTA (3 ml) | A | Cell Counter | Daily | Same Day | ||
| 750 | P013 | PCV + MCV+ MCH+ MCHC (RBC Indices) | 300 | WB-EDTA (3 ml) | A | Cell Counter | Daily | Same Day | ||
| 751 | P014 | Peripheral Blood Smear (PBS OR PBF) | 200 | WB-EDTA(3ml)/Slide | A | Microscopy | Daily | Same Day | Clinical History required | |
| 752 | P015 | Phencyclidine Phosphate (PCP) | 850 | Urine (30 ml) | A | Flow Chromatographic Immunoassay | Daily | 4th Day | ||
| 753 | P016 | Phenobarbital (Gardinal) | 950 | Serum (1 ml) | R/F | CLIA | Daily | Next Day | Do not use SST gel barrier tubes. Recommended specimen: Just before the next dose is due at steady state. | |
| 754 | P017 | Phenol | 2400 | 24 hrs Urine (50 ml) | R | Spectrophotometry | Daily | Third Day | 24 Urine volume required | |
| 755 | P018 | Phenylalanine (Neonatal Screening) | 550 | Blood Spot (2 Spots) | R | Delfia | 2, 6 | Fourth Day | ||
| 756 | P019 | Phenylketoneurea | 880 | 10 ml of Spot Urine | R | Ferric Chloride Test | Daily | Fourth Day | ||
| 757 | P020 | Phenytoin (Eptoin, Dilantin, Diphenylhydantoin) | 750 | Serum (1 ml) | R/F | CLIA | Daily 3 PM | Next Day | Do not use SST gel barrier tubes. Recommended specimen: Just before the next dose is due at steady state. | |
| 758 | P021 | Phospholipid IgG Antibodies | 750 | Serum (1 ml) | A | ELISA | Daily | Same Day | ||
| 759 | P022 | Phospholipid IgM Antibodies | 750 | Serum (1 ml) | A | ELISA | Daily | Same Day | ||
| 760 | P023 | Phosphorous (24 Hr Urine) | 250 | 24 hrs Urine (5 ml) | A | Spectrophotometry | Daily | Same Day | Do not use preservatives. Record 24 hours urine volume on TRF and sample container. | |
| 761 | P024 | Phosphorous (Serum) | 220 | Serum (1 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 762 | P025 | Plasminogen Activator Inhibitor-1 (PAI-1) SERPINE-1, 4G/5G | 17500 | WB-EDTA (3 ml) | F | ARMS PCR | 1 | 15th Day | Separate Plasma & freeze immediately. Do not Thaw. Over night fasting mandatory |
|
| 763 | P026 | Platelet Count | 120 | WB-EDTA (3 ml) | A | Cell Counter | Daily | Same Day | ||
| 764 | P027 | PML/RARA or t(15;17) by FISH | 4500 | Whole blood (5.0 ml)/ Bone Marrow from 2 Green Top (Sodium Heparin) tubes. | A | FISH | Daily | Eighth Day | ||
| 765 | P028 | PML/RARA or t(15;17) Qualitative by RT PCR | 4800 | 2-4ml Bone Marrow /6-8 ml Whole Blood in 2 EDTA Vacutainers. | R/F | RT-PCR | Daily | Third Day | ||
| 766 | P029 | PML/RARA or t(15;17) Quantitative by Real Time PCR | 6000 | 2-4ml Bone Marrow /6-8 ml Whole Blood in 2 EDTA Vacutainers. | R/F | Real Time-PCR | Daily | Fourth Day | ||
| 767 | P030 | Pneumocystis Carinii Detection | 2800 | 2 ml of Sputum/BAL Or Respiratory Fluid | R | Microscopy | Daily | Fourth Day | Type of fluid, clinical history, immune status is required | |
| 768 | P031 | Porphobilinogen (PBG) Qualitative | 800 | Urine (25 ml) | A | Manual Mathod | Daily | Third Day | ||
| 769 | P032 | Porphobilinogen (Quantitative) | 3800 | 10 ml of 24 hours urine in dark leakproof container. preservative | A | Column Chromatography | 2 | Fourth Day | Collect In Dark Coloured Bottle. Protect From Light. | |
| 770 | P033 | Porphyrins Total, Quantitative | 5800 | 10 ml Random Urine | A | Column Chroma- tography | 2 | 4th Day | Container wrapped completely with black paper or aluminium foil | |
| 771 | P034 | Potassium-24 Hrs Urine | 110 | 24 hrs Urine (30 ml) | A | ISE | Daily | Same Day | Do not use preservative | |
| 772 | P035 | Potassium-Serum | 110 | Serum (1 ml) | A | ISE | Daily | Same Day | Separate serum from cells within 30 minutes of collection. | |
| 773 | P036 | Pottasium-Urine Random | 110 | Urine Random (30 ml) | A | ISE | Daily | Same day | ||
| 774 | P037 | Pregnancy test | 150 | Urine (30 ml) | A | IC | Daily | Same Day | ||
| 775 | P038 | Procalcitonin (PCT) | 2200 | Serum (2 ml) | R/F | CLIA | Daily | Same Day | ||
| 776 | P039 | Progesterone (P4) | 520 | Serum (1 ml) | A | CLIA | Daily | Same Day | ||
| 777 | P040 | Prolactin (PRL) | 480 | Serum (1 ml) | A | CLIA | Daily | Same Day | ||
| 778 | P066 | Prolactin (PRL) Pooled Sample | 480 | Serum (1 ml) Pooled Samples | A | CLIA | Daily | Same Day | ||
| 779 | P041 | Propoxyphene Qualitative | 900 | Urine (5 ml) | A | Flow Chromatographic Immunoassay | Daily | Third Day | ||
| 780 | P042 | Prostatic Acid Phosphtase | Discontinue | |||||||
| 781 | P043 | Protein – Total | 120 | Serum (1 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 782 | P044 | Protein (24 Hrs Urine) | 150 | 24 hrs Urine (5 ml) | A | Spectrophotometry | Daily | Same Day | Required 24 hours urine volume | |
| 783 | P045 | Protein (CSF) | 150 | CSF (1.0 ml) | R/F | Spectrophotometry | Daily | Same Day | ||
| 784 | P046 | Protein (Fluid) | 150 | Fluid (10 mL) | A | Spectrophotometry | Daily | Same Day | Any Fluid Except CSF | |
| 785 | P047 | Protein /Creat Ratio (24 Hr Urine) | 300 | 24 hour urine (25 mL) | A | Spectrophotometry | Daily | Same Day | 24 Hour Urine Vol. Required | |
| 786 | P048 | Protein /Creat Ratio (Random Urine) | 300 | Urine Random (25 mL) | A | Spectrophotometry | Daily | Same Day | ||
| 787 | P049 | Protein+ Albumin+ AG Ratio | 250 | Serum – 2 mL | A | Spectrophotometry | Daily | Same Day | ||
| 788 | P050 | Protein C Activity | 3300 | Plasma Citrated (2 ml) | F | Chromogenic Assay | Daily | Third Day | ||
| 789 | P051 | Protein Electrophoresis (24 hr Urine) | 900 | 24 Hrs Urine (50 ml) | A | Electrophoresis | Daily | Third Day | ||
| 790 | P052 | Protein Electrophoresis (CSF) | 2100 | CSF (1.0 ml) | R | Electrophoresis | Daily | Third Day | ||
| 791 | P053 | Protein Electrophoresis (Serum) | 800 | Serum (1 ml) | A | Electrophoresis | Daily | Third Day | ||
| 792 | P054 | Protein S Activity | 3300 | Plasma Citrated (2 ml) | F | Clotting (Coagulometry) | Daily | Third Day | ||
| 793 | P055 | Prothrombin Time (PT) | 280 | Plasma Citrated (1 ml) | R | Clotting (Coagulometry) | Daily | Same Day | Sample from outstat ion-is not acceptable | |
| 794 | P056 | PSA- Free (Prostrate Specific Antigen Free) | 900 | Serum (1 ml) | A | CLIA | Daily 3 PM | Same Day | Do not draw sample within 7 days of Digital Rectal Examination (DRE) or Rectal Prostatic Ultrasonography. |
|
| 795 | P057 | PSA Free/ PSA Total Ratio | 1600 | Serum (1 ml) | A | CLIA | Daily | Same Day | ||
| 796 | P058 | PSA-Total (Prostrate Specific Antigen Total) | 640 | Serum (1 ml) | A | CLIA | Daily | Same Day | Do not draw sample within 7 days of Digital Rectal Examination (DRE) or Rectal Prostatic Ultrasonography. |
|
| 797 | P059 | PTH-Intact (Parathormone) | 950 | Serum (1 ml) | R/F | CLIA | Daily | Same Day | Labile Analyte | |
| 798 | P060 | Pyruvate (Pyruvic Acid) (Blood) | 2800 | Collect 2 mL Blood in 4ml cold 8% perchloric acid | F | Biochemical | Daily | Sixth Day | ||
| 799 | P062 | Phosphorous Urine Random | 220 | Urine (10 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 800 | P063 | Protein Urine Uristix | 150 | Urine (10 ml) | A | Dipstix | Daily | Same Day | ||
| 801 | P064 | Phodpholipase A2 Receptor Antibody (PLA2R) Quantitative | 5750 | Serum (3 ml) | A | EIA | Daily | Third Day | ||
| 802 | P065 | Phodpholipase A2 Receptor Antibody (PLA2R) Qualitative | 5700 | Serum (3 ml) | A | EIA | Daily | Third Day | ||
| 803 | P067 | Panfungal DNA Detection by PCR | 5000 | WB EDTA, Body Fluids, CSF, Sputum, Tissue in Sterile Container | A | PCR | Daily | 12th Day | ||
| 804 | P068 | Para Neoplastic Panel | 5700 | Serum | A | Immuno Blot | Daily | Third Day | ||
| 805 | P069 | Para Influenza 1, 2 & 3 Antibody IgG | 2200 | Serum (3 ml) | A | EIA | 2 | Third Day | ||
| 806 | P071 | Platelete Count, Fluorescent (PLT-F) | 300 | WB-EDTA (3 ml) | A | Fluorescent Flowcytometry | Daily | Next Day | ||
| 807 | Q001 | Quantiferon- TB Gold (Gamma Interferon) (TB Feron) or IGRA | 2150 | Blood sample to be collected in 3 TB Feron Tubes (1.0 ml in each tube) | A | ELISA | 2, 6 | Next Day | Blood to be collected in Tbferon tube (TB-NIL, TB ANTIGEN, & MITOGEN TUBE) Transported within 16 HRS of collection |
|
| 808 | R024 | Rabies Virus Antibodies Total Antibody | 5100 | Serum (3 ml) | A | EIA | 6 | 5th Day | ||
| 809 | R001 | RBC Folate | 2000 | WB-EDTA (3 ml) & Serum (2ml) | A | CLIA | Daily | Third Day | Protect sample from direct light, Treatment History Req. | |
| 810 | R002 | Red Blood Cells Count | 120 | WB-EDTA(3 ml) | A | Cell Counter & Microscopy | Daily | Same Day | ||
| 811 | R003 | Red Cell Distribution Width (RDW) | 120 | WB-EDTA(3 ml) | A | Cell Counter | Daily | Same Day | ||
| 812 | R020 | Renal Screen (Urea, Creatinine, BUN, BUN/ Creatinine Ratio) | 300 | Serum (2 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 813 | R004 | Renin Activity (PRA) | 4300 | WB-EDTA (2 ml) 807 | F | RIA | 3, 6 | Fourth Day | Overnight fasting is preffered | |
| 814 | R023 | Renin Direct | 2800 | WB-EDTA (2 ml) | F | RIA | Daily | Fourth Day | Overnight fasting is preffered | |
| 815 | R022 | Respiratory Panel PCR | 4300 | Throat / Nasal Swab | A | Real Time PCR | 3, 6 | Third Day | ||
| 816 | R005 | Reticulocyte Count | 220 | WB-EDTA (3 ml) | A | MICROSCOPY | Daily | Same Day | ||
| 817 | R006 | Rh Antibody Titre (Anti D Titre) | 780 | Serum (1 ml) | A | Gel Microtyping | Daily 3 PM | Next Day | Fresh Sample required | |
| 818 | R007 | Rheumatoid Factor, IgA Antibody | 1200 | Serum (1mL) | A | Column Agglutination Technology | Daily | 10th Day | ||
| 819 | R010 | Rheumatoid Factor, RA (Qualitative) | 280 | Serum (1 ml) | A | Agglutination | Daily | Same Day | ||
| 820 | R011 | Rheumatoid Factor, RA (Quantitative) | 350 | Serum (1 ml) | A | Biochemical | Daily | Same Day | ||
| 821 | R012 | RNP/Sm Antibodies (Sm/ RNP Antibodies) | 1500 | Serum (2 ml) | A | ELISA | 1, 4 | Third Day | ||
| 822 | R013 | ROMA index With HE4 (Epithelial Ovarian Cancer) Serum | 2800 | Serum (3 ml) | A | CMIA | Daily | Fourth Day | To Be Ordered Along With Ca- 125 To Calculate Roma Index For Diagnosis. Age (premenopausal or postmenopausal) status is compulsory | |
| 823 | R014 | Rota-Virus Antigen | 1400 | Stool (10 g) | A | ELISA | Daily | Third Day | ||
| 824 | R015 | Rubella IgG Avidity | 900 | Serum (2 ml) | A | ELISA | Daily | Same Day | ||
| 825 | R016 | Rubella RNA PCR | 4000 | 2 ml of EDTA PLASMA / CSF / AMNIOTIC FLUID / NASOPHARYN- GEAL SWAB | R/F | Nested Reverse Transcriptase PCR | 3, 6 | Third Day | ||
| 826 | R018 | Rubella Virus(German Measles) – IgG Antibodies | 500 | Serum (1 ml) | A | ELISA | Daily 3 PM | Same Day | ||
| 827 | R019 | Rubella Virus(German Measles) – IgM Antibodies | 500 | Serum (1 ml) | A | ELISA | Daily 3 PM | Same Day | ||
| 828 | S001 | Scl-70 (Scleroderma) IgG Antibodies | 1600 | Serum (2 ml) | A | ELISA | Daily | Third Day | ||
| 829 | S035 | Scrub Typhus IgM Antibody | 1200 | Serum (2 ml) | A | ELISA | Daily 3 PM | Same Day | ||
| 830 | S002 | Selenium | 3600 | 3 ml of EDTA Whole Blood/5 ml of Serum/ 10 ml of Spot Urine In Acid Wash Container/10 ml of 24 Hours Urine In Acid | R | ICPMS | Daily | 5th Day | ||
| 831 | S003 | Selenium, 24 Hr, Urine | 3800 | 24 Hour Urine 25 ml (No Preservative) | R | AAS | Daily | 5th Day | ||
| 832 | S004 | Semen Agglutination | 250 | Semen | A | Agglutination | Daily | Third Day | ||
| 833 | S005 | Semen Analysis | 200 | Semen (walk in patients) | A | MANUAL/ MICROSCOPY | Daily | Same Day | ||
| 834 | S006 | Sex Hormone Binding Globulin (SHBG) | 1800 | Serum (2 ml) | A | CLIA | Daily | Third Day | Sample from outstat ion-is not acceptable | |
| 835 | S007 | SGOT (Serum Glutamic Oxaloacetic Transaminase) (AST) | 120 | Serum (1 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 836 | S008 | SGPT (Serum Glutamic Pyruvic Transaminase) (ALT) | 120 | Serum (1 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 837 | S009 | Sickling Test | 300 | WB-EDTA (3 ml) | A | Microscopy | Daily | Third Day | ||
| 838 | S032 | Sirolimus | 4000 | Serum 2 (ml) & WB- EDTA (3 ml) | A | LCMS | Daily | 5th Day | ||
| 839 | S010 | Smear for fungal element – Fungal Staining | 300 | Any Specimen / Slides | A | Direct Microscopy | Daily | Same Day | Hard tissue sample like nail may take more time for digestion which mayresult in delayed reporting. | |
| 840 | S011 | SMITH (Sm) IgG Antibodies | 1700 | Serum (2 ml) | R/F | ELISA | 1, 4 | Third Day | ||
| 841 | S012 | Sodium (24 Hr Urine) | 120 | 24 hrs Urine (30 ml) | A | ISE | Daily | Same Day | Do not use preservative. Recorded 24 hours urine volume on TRF and Urine container | |
| 842 | S013 | Sodium (Serum) | 120 | Serum (1 ml) | A | ISE | Daily | Same Day | ||
| 843 | S014 | Sodium (Urine Random) | 120 | Urine Random (30 ml) | A | ISE | Daily | Same day | ||
| 844 | S015 | Special Stains | 600 | Paraffin Blocks / Slides | A | Staining | Daily | Fourth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 845 | S016 | SSA-Antibody (Soluble Substance) (Ro) | 1600 | Serum (2 ml) | R | ELISA | 1, 4 | Third Day | Mention ANA findings | |
| 846 | S017 | SSB-Antibody (Soluble Substance) (La) | 1600 | Serum (2ml) | R | ELISA | 1, 4 | Third Day | Mention ANA findings | |
| 847 | S018 | Stone Analysis | 700 | Stone (1 gm) | A | Biochemical | 2, 5 | Fifth Day | ||
| 848 | S019 | Stool Examination for ova & cysts | 100 | Stool (20 gm) | A | Microscopy | Daily | Same Day | ||
| 849 | S020 | Stool for Occult Blood | 120 | Stool (20 gm) | A | Card Method | Daily | Same Day | ||
| 850 | S021 | Stool Hanging Drop | 120 | Stool (20 gm) | A | Microscopy | Daily | Same Day | ||
| 851 | S022 | Stool pH & Reducing Substance | 120 | Stool (20 gm) 847 | A | Chemical Analysis | Daily | Same Day | ||
| 852 | S023 | Stool R/M | 120 | Stool (20 gm) | A | Microscopy | Daily | Same Day | ||
| 853 | S024 | Streptococcus Group B Antigen | 1300 | Serum (2 ml) | R | Latex Particle Agglutination | Daily | Third Day | ||
| 854 | S025 | Streptococcus Pneumoniae Antigen (Serum) | 1350 | Serum (2 ml) | R | Latex Particle Agglutination | Daily | Third Day | ||
| 855 | S026 | Streptococcus Pneumoniae Antigen, CSF | 1350 | CSF (2 ml) | R | Latex Particle Agglutination | Daily | Third Day | ||
| 856 | S027 | Streptococcus Pneumoniae Antigen, Urine | 1350 | 10 ml of Spot Urine | R | Latex Particle Agglutination | Daily | Third Day | ||
| 857 | S028 | Sucrose Lysis Test | 900 | 3 ml of EDTA Whole Blood And 3 ml Serum | A | Hemolysis | Daily | Fourth Day | ||
| 858 | S029 | Sudan Black B Stain | 900 | Fresh Air Dries, unstained fluids / Blood/ Bone Marrow Aspirate smear (1.0 mL) / 3-4 Smear | A | Cytochemistry special stains | Daily | Fifth Day | Clinical history required | |
| 859 | S030 | Sudan Stain, Stool | 850 | 5 gm Stool | A | Microscopy | Daily | Third Day | ||
| 860 | S031 | Syphilis Antibodies | 1250 | Serum (2 mL) | A | CMIA | 3, 6 | Fifth Day | ||
| 861 | S033 | SCA Comprehensive Panel SCA 1, 2, 3, 6, 7, 12, 17 Autosomal Dominant Ataxia | 17500 | WB EDTA | A | DNA PCR | 1, 6 | 10th Day | ||
| 862 | S034 | SCA Panel II for 1, 2, 3, 6, 7, 10, 12 | 14000 | WB EDTA | A | DNA PCR | Daily | 10th Day | ||
| 863 | S036 | Specific Gravity Urine | 100 | Urine (30ml) | A | Urine Strip | Daily | Same Day | ||
| 864 | S037 | Succinyl Acetone Urine | 4600 | Urine (30ml) | A | Gas Chromatography / Mass Spectrometry | Daily | Fifth Day | ||
| 865 | S038 | Spinal Muscular Atrophy (SMA) Microdeletion SMN1 Gene deletion Amniotic fluid/CVS | 7000 | EDTA Plasma (5 ml) | R | ARMS PCR | 2 | 10th Day | Concent form required, Mother EDTA Blood required | |
| 866 | S039 | Soluble Transferrin Receptor sTFR | 1300 | Serum (2 ml) | R | Nephelometry | daily | 5th Day | ||
| 867 | S040 | Sperm DNA Fragmentation | 4600 | Semen in sterile container | R | Gel PCR | daily | 6th day | ||
| 868 | T001 | T (12;21) or LSI TEL/ AML 1 | 5200 | Amniotic Fluid, WB Heparin, Bone Marrow Heparin in a Sterile Screw Capped Container. Ship Refrigerated. | A | FISH | Daily | Eighth Day | ||
| 869 | T002 | T3 (Trilodothyronine) | 250 | Serum (1 ml) | A | CLIA | Daily | Same Day | ||
| 870 | T003 | T4 (Thyroxine) | 250 | Serum (1 ml) | A | CLIA | Daily | Same Day | ||
| 871 | T004 | Tacrolimus Levels | 3400 | 3 ml of EDTA Whole Blood | R/F | CLIA | Daily | Third Day | Clinical history required | |
| 872 | T005 | TB Expert MTB/RIF (Gene Expert) (Nonpulmonary) | 3000 | 5 mL of Pus/ Fluid /Asitic Fluid/ Gastric Aspirate/ Tissue, CSF/ Peritoneal Fluid/ Pericardial Fluid/ Synovial/Knee Joint Fluid/Abscess Aspirate | A | PCR | Daily | Next Day | ||
| 873 | T006 | TB Expert MTB/RIF (Gene Expert) (Pulmonary) | 3000 | 4 ml Sputum / BAL Fluid/Pleural Fluid | A | PCR | Daily | Next Day | ||
| 874 | T008 | Terminal Deoxynucleotidyl Transferase (TDT) (Precursor Cell Marker) | 2600 | 3 ml of EDTA Whole Blood | A | Flowcytometry | Daily | Fourth Day | ||
| 875 | T009 | Terminal Deoxynucleotidyl Transferase (TDT) (Precursor Cell Marker) | 2600 | Bone Marrow- Heparin | A | Flowcytometry | Daily | Third Day | Clinical history required | |
| 876 | T010 | Testicular Cancer Monitor (AFP & HCG Beta) | 1600 | Serum (2 ml) | A | CLIA | Daily | Same Day | clinical history and age required | |
| 877 | T011 | Testosterone- Free | 1250 | Serum (1 ml) | R | ELISA | Daily | Same Day | ||
| 878 | T012 | Testosterone- Total | 550 | Serum (1 ml) | R | CLIA | Daily | Same Day | ||
| 879 | T044 | Thallium Blood | 4000 | 4 (ml) Blood in Heparin & EDTA/ Serum/ Urine | R | ICPMS | Daily | Third Day | ||
| 880 | T013 | Thrombin Time (TT) | 1100 | 2 ml of Platelet Poor citrated plasma Citrated plasma | R/F | Coagulation | Daily | Third Day | ||
| 881 | T014 | Thyroglobulin | 1400 | Serum (2 ml) | R/F | CLIA | Daily | Next Day | ||
| 882 | T015 | TIBC (Total Iron Binding Capacity) | 320 | Serum (1 ml) | A | Spectrophotometry | Daily | Same Day | Fasting sample required | |
| 883 | T016 | TLC (Fluid) | 120 | Fluids (any, 2 ml) | A | Microscopy | Daily | Same day | ||
| 884 | T017 | TLC (Total Leukocyte Count) (Blood) | 120 | WB-EDTA (3 ml) | A | Cell Counter & Microscopy | Daily | Same Day | ||
| 885 | T018 | TLC, DLC, ESR | 180 | WB-EDTA (3 ml) | A | Cell Counter & Microscopy | Daily | Same Day | ||
| 886 | T019 | TNF-α (Tumor Necrosis Factor-Alpha) | 4700 | Serum (2ml) | R/F | ELISA | 4 | Sixth Day | ||
| 887 | T020 | Total Count & Differential Count (TLC & DLC) | 140 | WB-EDTA (3 ml) | A | Cell Counter & Microscopy | Daily | Same Day | ||
| 888 | T021 | Toxo Plasma IgG Avidity | 900 | Serum (2 ml) | A | ELISA | Daily | Same Day | ||
| 889 | T022 | Toxoplasma DNA PCR | 2650 | WB-EDTA (3 ml) | A | Real Time PCR | Daily | Seventh Day | ||
| 890 | T023 | Toxoplasma gondii – IgG Antibodies | 500 | Serum (1 ml) | A | CLIA/ELISA | Daily | Same Day | ||
| 891 | T024 | Toxoplasma gondii – IgM Antibodies | 500 | Serum (1 ml) 885 | A | CLIA/ELISA | Daily | Same Day | ||
| 892 | T025 | Toxoplasma IgG & IgM Antibodies | 920 | Serum (1 ml) | A | ELISA | Daily | Same Day | ||
| 893 | T026 | Toxorubella PCR (Toxoplasma PCR, Rubella PCR) | 5500 | EDTA Plasma, CSF, Amniotic Fluid, Serum, Nasopharyngeal Swab (2mL) | A | PCR | 3 | Fourth Day | ||
| 894 | T027 | TPHA (Treponema Pallidum Hemagglutination) | 500 | Serum (2 ml) | A | IC | Daily | Same Day | ||
| 895 | T028 | TPMT Genotyping (Thiopurine methyltransferase) | 5500 | EDTA Whole Blood (3.0 mL) | A | PCR | Daily | Tenth Day | ||
| 896 | T029 | Transferrin | 1050 | Serum (2 ml) | A | Turbidometry | Daily | Next Day | ||
| 897 | T045 | Transferrin Saturation Index | 600 | serum (2 ml) | A | Calculated | Daily | Same Day | ||
| 898 | T030 | Triglycerides (TG) | 210 | Serum (1 ml) | A | Spectrophotometry | Daliy | Same Day | 12 hours overnight fasting is mandatory | |
| 899 | T043 | Triglycerides (TG) Urine | 210 | Urine (10 ml) | A | Spectrophotometry | Daily | Same day | ||
| 900 | T031 | Trisomy 13;21 (Amino Two Probe) | 5800 | 5 ml WB Heparin Amniotic fluid/ Chorionic villus in a sterile screw capped container. Ship refrigerated. | A | FISH | Daily | Eighth Day | ||
| 901 | T032 | Trisomy 18, X, Y (Amino three Probes) | 7800 | 5 ml WB Heparin/ Amniotic fluid/ Chorionic villus in a sterile screw capped container. Ship refrigerated. | A | FISH | Daily | Eighth Day | ||
| 902 | T033 | Trisomy 21 (Amino One Probe) | 4300 | 5 ml WB Heparin/ Amniotic fluid/ Chorionic Villus in a sterile screw capped container. Ship refrigerated. | A | FISH | Daily | Eighth Day | ||
| 903 | T034 | Troponin – I (QUALITATIVE) | 1400 | Serum (2ml) | F | Rapid Chromatography | Daily | Same Day | ||
| 904 | T035 | Troponin- T (QUALITATIVE) | 1400 | EDTA Whole Blood (2 ml) | F | Rapid Chromatography | Daily | Same Day | ||
| 905 | T050 | Troponin – I (High Sensitive) Quantitative | 1650 | Serum (2ml) | F | CLIA | Daily | 2nd Day | ||
| 906 | T051 | Troponin- T (High Sensitive) Quantitative | 1650 | EDTA Whole Blood (2 ml) Serum | F | CLIA | Daily | 2nd Day | ||
| 907 | T036 | TSH (Thyroid Stimulating Hormone) | 280 | Serum (1 ml) | A | CLIA | Daily | Same Day | ||
| 908 | T037 | TSH Receptor Antibody LATS, TSI | 4400 | Serum (2ml) 910 | A | ECLIA | 1, 4 | Fourth Day | ||
| 909 | T038 | TTG- IgA (Tissue Transglutaminase IgA Antibody) | 1100 | Serum (1 ml) | A | ELISA | Daily | Same Day | ||
| 910 | T039 | TTG- IgG (Tissue Transglutaminase IgG Antibody) | 1500 | Serum (1 ml) | A | CLIA | 2, 6 | 3rd Day | ||
| 911 | T040 | Typhi Dot (Salmonella Typhi) (IgG, IgM (Rapid) | 550 | Serum (2 ml) | A | Rapid Test/ IC | Daily | Same Day | ||
| 912 | T041 | Typhi Dot (Salmonella Typhi) IgG | 350 | Serum (2 ml) | A | IC | Daily | Same Day | ||
| 913 | T042 | Typhi Dot (Salmonella Typhi) IgM | 350 | Serum (2 ml) | A | IC | Daily | Same Day | ||
| 914 | T047 | TPHA (Treponema Pallidum Hemagglutination) With Titre | 700 | Serum (2 ml) | A | Agglutination | Daily | Next Day | ||
| 915 | T048 | TPMT Enzyme Activity (Thiopurine methyltransferase) | Discontinue | |||||||
| 916 | T049 | Torch Avidity IgG- Toxoplasma, Rubella, Cytomegalovirus | 1800 | Serum (2 ml) | A | ELISA | Daily | Third Day | ||
| 917 | U001 | U1-snRNP (68 KDa), Serum | 1700 | Serum (3ml) | A | ELISA | 1, 5 | Third Day | Mention ANA Findings If Available | |
| 918 | U002 | Urea (24 Hr Urine) | 120 | 24 hrs Urine (5 ml) | A | Spectrophotometry | Daily | Same Day | Do not use preservatives. Record 24 hours urine volume on TRF and sample container. | |
| 919 | U003 | Urea (Blood) | 120 | Serum (2 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 920 | U004 | Urea (Random Urine) | 120 | Random Urine (30 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 921 | U005 | Uric Acid | 120 | Serum (2 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 922 | U006 | Uric Acid, 24 Hr Urine | 120 | 24 hrs Urine (30 ml) | A | Spectrophotometry | Daily | Same Day | Do not use preservatives. Record 24 hours urine volume on TRF and sample container. | |
| 923 | U007 | Uric Acid (Random Urine) | 120 | Random Urine (30 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 924 | U008 | Urinary Porphobilinogen (Qualitative) | 900 | Random Urine (30 ml) | R | Biochemical | Daily | Third Day | Collect In Dark Coloured Bottle. Protect From Light. | |
| 925 | U009 | Urine Bile Salt & Bile Pigment | 140 | Urine (50 ml) 912 | A | Visual | Daily | Same Day | ||
| 926 | U010 | Urine for Chyle | 600 | Urine (30 ml) | A | Microscopy | Daily | Fourth Day | ||
| 927 | U011 | Urine for Haemoglobinuria Screening | 600 | Urine (30 ml) | A | Ammonium sulphate saturation/Staning | Daily | Third Day | ||
| 928 | U012 | Urine Ketone | 100 | Urine (30 ml) | A | Urine Strip | Daily | Same Day | ||
| 929 | U013 | Urine R/M (Urine Analysis) | 100 | Urine (50 ml) | A | Strip & Microscopy | Daily | Same Day | ||
| 930 | U014 | Urine Reducing Sugar | 100 | Urine (30 ml) | A | Chemical Analysis | Daily | Same Day | ||
| 931 | U015 | Urine Sugar | 100 | Urine (30 ml) | A | Chemical Analysis | Daily | Same Day | ||
| 932 | U016 | Urobilinogen | 120 | 10 mL aliquot of 24-hour urine without preservative, in a dark coloured container. | A | Manual Mathod | Daily | Same Day | Keep specimen refrigerated during collection and protected from light | |
| 933 | U017 | Urine for active Sediments | 100 | Urine (10 ml) | A | Manual Mathod | Daily | Same Day | ||
| 934 | U018 | UIBC | 500 | Serum (10 ml) | A | Biochemical | Daily | Same Day | ||
| 935 | V001 | Valproic Acid (Valproate, Valparin, Epilex) | 750 | Serum (2 ml) | A | CLIA | Daily 3 PM | Next Day | Do not use SST gel barrier tubes. Recommended specimen: Just before the next dose is due at steady state. | |
| 936 | V002 | Varicella zoster (VZV) (Chicken Pox/ Herpes Zoster/ Shingles) IgG Antibodies | 1600 | Serum (2 ml) | F | ELISA | Daily | Third Day | ||
| 937 | V003 | Varicella zoster (VZV) (Chicken Pox/ Herpes Zoster/ Shingles) IgM Antibodies | 1600 | Serum (2 ml) | F | ELISA | Daily | Third Day | ||
| 938 | V004 | Varicella zoster (VZV) (Chicken Pox/ Herpes Zoster/ Shingles) PCR | 5600 | Skin Lesions, Swabs, BAL, Tissue, CSF, Blood | F | PCR | 2, 6 | Fifth Day | ||
| 939 | V005 | VDRL Test (RPR) | 120 | Serum (1 ml) | A | IC | Daily | Same Day | ||
| 940 | V020 | VDRL Titre | 180 | Serum (2ml) | A | Agglutination | Daily | Next Day | ||
| 941 | V006 | VGKC Antibody-Voltage Gated Potassium Channel (LG1 and CASPR2) Autoimmune encephalitis | 10000 | Serum (3ml)/ CSF (3ml) | A | IFA | 2 | Third Day | ||
| 942 | V007 | Vitamin B1 (Thiamine) | 4300 | Serum / Plasma- EDTA (2.0 ml) | F | HPLC | 1 | Fifth Day | Specimen to be protected from light. Wrap tube in aluminium foil | |
| 943 | V008 | Vitamin B12 (Cynocobalamin) | 700 | Serum (1 ml) | R/F | CLIA | Daily | Same Day | Protect sample from direct light | |
| 944 | V009 | Vitamin B2 (Riboflavin) | 3500 | Serum / Plasma- EDTA (2 ml) | F | ELISA | 1 | Fifth Day | Specimen to be protected from light. Wrap tube in aluminium foil | |
| 945 | V010 | Vitamin B6 (Pyridoxine) | 3500 | EDTA Plasma (3 ml) | F | ELISA | 4 | 4th Day | Specimen to be protected from light. Wrap tube in aluminium foil | |
| 946 | V011 | Vitamin C (Ascorbic Acid) | 4200 | Serum / Plasma- EDTA (2 ml) | F | ELISA | 6 | Fifth Day | Specimen to be protected from light. Wrap tube in aluminium foil, Fasting Required | |
| 947 | V012 | Vitamin D (25-hydroxycho- lecalciferol) | 1300 | Serum (1 ml) | R/F | CLIA | Daily | Same Day | Labile Analyte | |
| 948 | V013 | Vitamin D3 (1, 25 Dihydroxyvitamin D3) | 2900 | Serum (3 ml) (Specimen to be protected from light, wrap tube in alluminium foil) | R/F | CLIA | 1, 5 | Fifth Day | ||
| 949 | V014 | Vitamin E (Tocopherol) | 4500 | Serum / Plasma- EDTA (2 ml), Fasting Require | F | HPLC | 2, 6 | Fifth Day | Specimen to be protected from light. Wrap tube in aluminium foil | |
| 950 | V016 | Vitamine A (Retinol) | 4500 | Serum / Plasma- EDTA (2 ml) | F | HPLC | 2, 6 | Fifth Day | Specimen to be protected from light. Wrap tube in aluminium foil | |
| 951 | V017 | VLDL | 180 | Serum (1 ml) | A | Calculated | Daily | Same Day | 12-14 hour fasting required | |
| 952 | V018 | VMA (Vanil Mandelic Acid) | 2900 | 24hrs Urine (50 ml) | A | Column Chromatography | 3, 6 | Fifth Day | Collect urine with appropriate volume of 6N HCL to maintain pH between 1 – 2. Record 24 hours urine volume on the TRF and urine container. |
|
| 953 | V019 | von Willebrand Factor (vWF Ag), PLASMA | 9000 | 2 mL plasma from 1 sodium Citrate tube. Separate plasma within 10 minutes of collection and transer into plastic container. | F | ELFA | 6 | Fifth Day | ||
| 954 | W001 | Weil – Felix Test | 1000 | Serum (1 ml) | A | Heterophile agglutination | Daily | Fifth Day | ||
| 955 | W002 | Western Blot test for HIV | 2700 | Serum (1 ml) | A | Western Blot | Daily | Third Day | Duely signed consent form must accompany the TRF. ELISA the patient should be provided. |
|
| 956 | W004 | Widal Test (Slide Test) | 120 | Serum (1 ml) | A | Slide Agglutination | Daily | Same Day | ||
| 957 | W005 | Widal Test (Tube Test) | 200 | Serum (1 ml) | A | Tube Method | Daily | Next Day | ||
| 958 | Y001 | Y Chromosomal Microdeletion | 7000 | EDTA Whole Blood/ 2.0 ml | A | PCR | Daily | Eight Day | ||
| 959 | Z001 | ZAP-70 | 7800 | EDTA Whole Blood/ Heparin Whole Blood 2.0ml/2.0ml | A | Flowcytometry | Daily | Fourth Day | ||
| 960 | Z002 | Zinc 24 Hr Urine | 1900 | 24 hour Urine (25ml) | A | AAS | Daily | Fourth Day | ||
| 961 | Z003 | Zinc Serum | 1900 | Serum (1 ml) | A | AAS | Daily | Fourth Day | ||
| 962 | Z004 | Zika Virus, PCR | 8600 | Serum (2 ml) OR Urine (10 ml) | A | PCR | Daily | Fourth Day | ||
| 963 | P288 | Accuprobe 1.1 – LFT, KFT New, Lipid Profile, Thyroid Profile I, Iron Panel Basic, Calcium | 1300 | Serum (2 ml) | A | Spectrophotome- try | Daily | Same day | ||
| 964 | P414 | Accuprobe 1.1 Plus – CBC EXTN, LFT, Kidney Panel 2, Lipid Profile, Thyroid Profile I, Glucose (F) | 1500 | Serum (2 ml), Fluride (2 ml), EDTA (3 ml), | A | Spectrophotome- try, Cell Counter Microscopy | Daily | Same day | ||
| 965 | P415 | Accuprobe 1.2 – CBC, LFT, Kidney Panel 2, Lipid Profile, Thyroid Profile I, Glucose (F), Iron Panel Bassic, HbA1c | 1750 | Serum (2 ml), Fluride (2 ml), EDTA (3 ml), | A | Spectrophotome- try, Cell Counter Microscopy | Daily | Same day | ||
| 966 | P416 | Accuprobe 1.3 – CBC, LFT, Kidney Panel 2, Lipid Profile, Thyroid Profile I, Glucose (F), Iron Panel Basic, HbA1c, Vitamin B-12, Vitamin D 25, Testosterone Total | 2300 | Serum (2 ml), Fluride (2 ml), EDTA (3 ml), | A | Spectrophotome- try, Cell Counter Microscopy | Daily | Same day | ||
| 967 | P404 | Accuprobe 15.1 – LFT, Kidney Panel 2, Lipid Profile, Thyroid Profile I, Iron Panel Basic, Vitamin B-12, Vitamin D 25 Hyd | 2100 | Serum (2 ml), EDTA (3 ml) | A | Spectrophotome- try, Cell Counter Microscopy | Daily | Same day | ||
| 968 | P405 | Accuprobe 15.2 – CBC Extn, Glucose Fasting, LFT, Kidney Panel + Calcium, Lipid Profile, Thyroid Profile I, Iron Panel Basic, HBA1C, Vitamin B-12, Vitamin D 25 Hyd | 2300 | Serum (2 ml), Fluride (2 ml), EDTA (3 ml), | A | Spectrophotome- try, Cell Counter Microscopy | Daily | Same day | ||
| 969 | P417 | Accuprobe Scan – CBC LFT, Kidney Panel 2, Lipid Profile, Thyroid Profile I, Glucose (F), Urine R/M | 1200 | Serum (2 ml), Fluride (2 ml), EDTA (3 ml), Urine (30ml) | A | Spectrophotome- try, Cell Counter Microscopy | Daily | Same day | ||
| 970 | P511 | Accuprobe Health + Cardiac Care (BSF, CBC, LFT, KFT, LIPID, TFT, IRON PANEL BASIC, VIT B12, VIT D, TESTO TOTAL, HBA1C, HSCRP, APOA1, APOB, LIPOPROTEIN, HOMOCYSTEIN) | 3500 | Serum (2 ml), Fluride F(2 ml), EDTA (3 ml), | A | Spectrophotome- try, Cell Counter Microscopy, Neph- elometry | Daily | Same day | ||
| 971 | P514 | Accuprobe Health + Arthritis Care (BSF, CBC, LFT, KFT, LIPID, TFT, Iron Panel Basic, VIT B12, VIT D, TESTO TOTAL, HBA1C, RA Quantitative, CRP Quantitative, ANTI CCP | 3500 | Serum (2 ml), Fluride F(2 ml), EDTA (3 ml), | A | Spectrophotome- try, Cell Counter Microscopy, | Daily | Same day | ||
| 972 | P101 | Acute Leukemia Compre- hensive Panel- CD3, CD4, CD8, CD10, CD13, CD14, CD11a, CD19, CD33, CD34, CD45, CD41a, CD71, CD64, Anti HLADR, Anti MPO, Cytoplastic, CD3CD117, CD79a | 13500 | WB Heparin/ EDTA | A | Flowcytometry | Daily | One Week | ||
| 973 | P102 | Acute Lymphoblastic Leukemia (ALL) Panel By Flowcytometry: | 13000 | WB EDTA/ HEPARIN | A | Flowcytometry | Daily | One Week | ||
| 974 | P103 | Acute Lymphoblastic Leukemia (ALL) Panel By Flowcytometry: | 13000 | 3 ml EDTA OR Heparin Bone Marrow | A | Flowcytometry | Daily | One Week | ||
| 975 | P104 | Acute Myeloid Leukemia(AML) Panel (Flowcytometry) | 13000 | WB EDTA/ HEPARIN | A | Flowcytometry | Daily | Third Day | ||
| 976 | P105 | Acute Myeloid Leukemia(AML) Panel (Flowcytometry) | 13000 | 3 ml EDTA OR Heparin Bone Marrow | A | Flowcytometry | 1, 4 | Fourth Day | ||
| 977 | P106 | Allergy- Allergen Panel I (Vegeterian + Non Vegitetrian+ Inhalants+ Drugs) | 5950 | Serum (2 ml) | A | ELISA | 1, 4 | Third Day | ||
| 978 | P107 | Allergy Panel II (AEC, S. IgE Total, CBC, Urine R/M) | 1100 | Serum (2 ml)+ WB- EDTA (3 ml)+ Urine | A | CLIA, Spectro- photometry, CC, mycroscopy | Daily | Same day | ||
| 979 | P497 | AMH PLUS (LH, FSH, PRL, TSH, E2, PROG, AMH) | 2800 | Serum (2 ml) | A | CLIA | Daily | Same day | ||
| 980 | P502 | AMH PLUS 2 (LH, FSH, PRL, TSH, TESTO TOTAL, E2, AMH) | 2900 | Serum (2 ml) | A | CLIA | Daily | Same day | ||
| 981 | P507 | AMH PLUS 3 (GLUCOSE F, PP, LH, FSH, PRL TESTO_T, FREE, INSULIN F, PP, DHEAS) | 2900 | Serum Fasting, Serum PP (2 ml Each), NaF Plasma (2 ml Fasting, PP), | A | CLIA, Spectophotometry | Daily | Same day | ||
| 982 | P508 | AMH PLUS 4 (GLUCOSE F, PP, LH, FSH, PRL, AMH, TESTO T, FREE, INSULIN F, PP, DHEAS) | 2803 | Serum Fasting, Serum PP (2 ml Each), NaF Plasma (2 ml Fasting, PP), | A | CLIA | Daily | Same day | ||
| 983 | P122 | ENA Profile /ANA Blot (25 Para) | 5850 | Serum (5 ml) | A | ELISA | 2, 4, 7 | Next Day | ||
| 984 | P412 | ANA BLOT CAPSULE II (17 Para) | 3200 | Serum (5 ml) | A | Immunoblot | 2, 4, 7 | Next Day | ||
| 985 | P110 | Androgen Profile: Testosterone-Total, Testosterone-Free, SHBG, DHT, FAI (Free Androgen Index), Androstenedione, Bioavailable testosterone | 4900 | Serum (5-6 ml) | R | CMIA, RIA, EIA, | 3, 6 | Fourth Day | ||
| 986 | P111 | Anemia Profile I (Ferritin, Folic Acid, Vit B12, Iron, TIBC, CBC, PS) | 2500 | Serum (2 ml), EDTA (3 ml) | F | Spectrophotome- try, CLIA, CC | Daily | Same Day | ||
| 987 | P112 | Anemia Profile II (Ferritin, Folic Acid, Vit B12, Iron, TIBC, CBC, PS, TSH) | 2600 | Serum (2 ml), WB EDTA (3 ml) | F | Spectrophotome- try, CLIA/Microsco- py, CC | Daily | Same Day | Clinical history required | |
| 988 | P113 | Anemia Study (CBC, Peripheral Blood Smear, ESR, Iron, TIBC, Iron Saturation Index, Ferretin, Folate, Vitamin- B12, Reticulocyte Count) | 3200 | Serum (2 ml), WB EDTA (3 ml) | A | Spectrophotome- try, CLIA/Microsco- py, CC | Daily | Same Day | ||
| 989 | P114 | Anti Cardiolipin Panel (IgA, IgG, IgM)- ACLA | 1650 | Serum (3mL) | A | ELISA | Daily | Next Day | ||
| 990 | P115 | Ante Natal Panel I (ABO & RH, CBC, RBS, HIV, HBsAg, Urine Routine, VDRL, HCV Rapid) | 850 | Serum (2 ml), WB EDTA (3 ml), NaF Plasma (2 ml), Urine (30 ml) | A | Spectrophotome- try, Agglutination, CC, Microscopic | Daily | Same Day | ||
| 991 | P116 | Ante Natal Panel II (ABO & RH, CBC, RBS, HIV, HBsAg, Urine R/M, VDRL, TSH) | 940 | Serum (2 ml), WB EDTA (3 ml), NaF Plasma (1 ml), Urine (30 ml) | A | CLIA, Spec- trophotometry, Agglutination, CC, Microscopic | Daily | Same Day | ||
| 992 | P117 | Ante Natal Panel III (HB, ABO & RH, RBS, VDRL, Urine R/M) | 430 | Serum (2 ml), WB EDTA (3 ml), NaF Plasma (1 ml), Urine (30 ml) | A | Spectrophotome- try, Agglutination, CC, Microscopic | Daily | Same Day | ||
| 993 | P118 | Ante Natal Panel IV (HB, ABO & RH, RBS, HIV 1&2, HBsAg, VDRL, Urine R/M) | 740 | Serum (2 ml), WB EDTA (3 ml), NaF Plasma (1 ml), Urine (30 ml) | A | Spectrophotome- try, Agglutination, CC, Microscopic | Daily | Same Day | ||
| 994 | P119 | Anti Natal Panel V (ABO & RH, CBC, RBS, HIV, HBsAg, Urine R/M, VDRL, TSH, HCV Rapid) | 1100 | Serum (2 ml), WB EDTA (3 ml), NaF Plasma (1 ml), Urine (30 ml) | A | Spectrophotome- try, Agglutination, CC, Microscopic | Daily | Same Day | ||
| 995 | P421 | Anti Natal Panel VI (ABO & RH, CBC, RBS, HIV, HBsAg, Urine R/M, VDRL, TSH, HCV Rapid, Urine Culture) | 1500 | Serum (2 ml), WB EDTA (3 ml), NaF Plasma (1 ml), Urine (30 ml) | A | Spectrophotome- try, Agglutination, CC, Microscopic | Daily | Same Day | ||
| 996 | P422 | ANC Comprehensive panel (Anti Netal Panel V + Hb Electrophoresis) | 2000 | Serum (2 ml), WB EDTA (3 ml), NaF Plasma (1 ml), Urine (5 ml) | A | Spectrophotome- try, Agglutination, CC, Microscopic HPLC | Daily | Same Day | ||
| 997 | P120 | Anti Phospholipid Antibody Profile (Anti Phospholipid Ab IgG & IgM, Anti Cardiolipin Ab IgG & IgM, Lupus Anticoagulant) | 2700 | Serum (2 ml), Plasma Citrate (1mL) | A | ELISA, CLIA, CLOTING | Daily | Same Day | ||
| 998 | P121 | Anti Thyroid Antibodies (AMA + ATG) Panel | 2100 | Serum (2 ml) | A | CLIA | Daily | Same Day | ||
| 999 | A146 | Arogyam Profile (CBC EXT., LFT, KFT New, Lipd Profile, Blood Sugar Fasting, Iron Panel, Vitamin B 12, Urine R/M, Testosterone Total, HbA1c, Thyroid Profile-I, Vitamin D-25) | 3400 | Serum (2 ml), Fluride Urine (30ml) | A | Spectrophotom- – scopic | Daily | Same Day | ||
| 1000 | P123 | Arthritis Panel I (ANA, C4, CRP, Ca, RF, ASO, Urine R/M) | 1700 | Serum (2 ml), Urine(5ml) | A | Spectrophotome- try, CC, Agglutina- tion, Microscopy, ELISA | Daily | Same day, Next Day | Clinical history required | |
| 1001 | P124 | Arthritis Panel II (CBC + ESR, RA Factor, CRP, ANA, Uric Acid, Urine Routine, Anti CCP Antibody | 2400 | Serum (2 ml), WB EDTA (3 ml), Urine (30 ml) | A | Spectrophotome- try, CC, Agglutina- tion, Microscopy, ELISA | Daily | same day | Clinical history required | |
| 1002 | P125 | Arthritis Panel (Mini) ANA, RA Factor, CRP, ASO, Uric Acid, Urine R/M | 1400 | Serum (2 ml), Urine(5ml) | A | ELISA, Agglutionation, Spectrophotometry | Daily | Same day | ||
| 1003 | P433 | Arthritis Profile Total (ANA Elisa, Anti CCP, CRP Quant, Calcium, Phosphorous, Uric Acid, ASO Titre, CBC, HLA B-27 Flow, RA Factor Quant, Vit D 25 Hyd. | 3500 | Serum (2 ml), WB EDTA (3 ml), | A | Spectrophotome- try, CC, Agglutina- tion, Microscopy, ELISA, CLIA, Flowcytometry | Daily | Next Day | ||
| 1004 | P505 | Arthritis Mega profile (CBC+ESR, LFT, KFT, LIPID, TFT, IRON PANEL BASIC, VIT B12, VIT D, RA QUALITATIVE, CRP QUALITATIVE, ASO QUALITATIVE, ANA ELISA, ANTI CCP, HBA1C, HLA B27 | 4400 | Serum (2 ml), WB EDTA (3 ml), | A | Spectrophotome- try, CC, Agglutina- tion, Microscopy, ELISA, CLIA, Flowcytometry | Daily | Next Day | ||
| 1005 | P431 | Autoimmune Cerebellarataxia Panel | 55000 (No dis- count) | Serum (5 ml) | A | IFA | 4th of Month | One Month | ||
| 1006 | P432 | Autoimmune Encephalitis Panel | 24000 | Serum (5ml)/CSF (3 ml) | A | IFA | Daily | Fifteen Days | ||
| 1007 | P126 | Autoimmune Hepatitis Panel (AMA, ANA, ASMA, LKM-1) | 5700 | Serum (4 ml) | A | ELISA, CLIA | 2, 5 | Third day | ||
| 1008 | P127 | Bad Obstetric History Profile (ANA, Anti Phospholipid IgG, IgM, Anti Cardiolipin Ab IgG & IgM, Lupus Anticoagulant, TSH, TORCH 8) | 6200 | Serum(2 ml), Plasma Citrated (1 ml) | A | ELISA, CLIA, CLOTING | Daily | Same day | Ensure Platelet Poor Plasma, | |
| 1009 | P443 | BOH TOTAL-Beta 2 Glycoprotein IgG & IgM, Cardiolipin IgG & IgM, Lupus AntiCoagulant, Torch 5 IgG & IgM | 7000 | Serum(2 ml), Plasma Citrated (1 ml) | A | ELISA, CLIA, CLOTING | Daily | Next Day | ||
| 1010 | P128 | Blood Coagulation Profile (PT, APTT, Platelets, BT/ CT) | 650 | WB EDTA (3 ml), Plasma Citrated (1 ml) | R | CC, MICROSCOPIC, CLOTING | Daily | Same Day | BT/CT Only For Walking Patient | |
| 1011 | P129 | Breast Cancer Marker Profile (CA 15.3, CEA (Carcino Embryonic Antigen)) | 1500 | Serum (2 ml) | R | CLIA | Daily | Same Day | ||
| 1012 | P130 | Breast Cancer Panel I (Er, Pr, Her 2/neu) , IHC | 5000 | 1 CM/ 1 Block | A | IHC | Daily | Sixth Day | Clinical history required | |
| 1013 | P131 | Breast Cancer Panel II (Er, Pr, Her 2/neu), EGFR IHC | 8000 | Tumour biopsy in 10 % Formal-Saline OR Formalin fixed tumour paraffin block OR 6 unstained sections / alcohol fixed cytology smears on Poly-L- Lysine coated slides. | A | IHC, Flowcytometry | Daily | Eighth Day | ||
| 1014 | P132 | Breast Cancer Panel III- Er, Pr, DNA Ploidy & S-Phase, c-erb B2 (HER-2 neu). IHC | 11000 | Tumour biopsy in 10 % Formal-Saline OR Formalin fixed tumour paraffin block OR 6 unstained sections / alcohol fixed cytology smears on Poly-L- Lysine coated slides. | A | IHC, Flowcytometry | Daily | Eighth Day | ||
| 1015 | P133 | Breast Cancer Prognosis Panel IV (ER, PR, DNA Ploidy/S Phase) IHC | 7000 | Tissue in buffered formalin/Paraffin Blocks | A | IHC, Flowcytometry | Daily | Eighth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 1016 | P134 | Breast Cancer Prognosis Panel V (ER, PR, DNA Ploidy/S Phase, Her2/neu Gene Amplification) | 18900 | Tissue in buffered formalin/Paraffin Blocks | A | IHC, Flowcytometry, Real Time PCR (Quant) | Daily | Eighth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 1017 | P135 | Breast Cancer Prognosis Panel VI (ER, PR, Her2/ neu), DNA Ploidy/S Phase) | 8500 | Tissue in buffered formalin/Paraffin Blocks | A | IHC, Flowcytometry | Daily | Eighth Day | Clinical history, Site of biopsy, Doctors phone No. | |
| 1018 | P136 | Cancer Screening For Female: CEA, CA 19.9, CA 125, CA 15.3) | 3100 | Serum (3 ml) | A | CLIA, ELISA | Daily | Same day | Clinical history required | |
| 1019 | P137 | Cancer Screening For Male: (PSA, CAE, CA 19.9) | 2100 | Serum (3 ml) | A | MEIA, CLIA, ELISA | Daily | Same day | Clinical history required | |
| 1020 | P471 | Cancer Panel For Male: (CBC, ESR, AFP, BETA HCG, PSA, CEA, CA- 19.9 | 1100 | Serum (2 ml), WB EDTA (3 ml), | A | Cell Counter & Microscopy, ECLIA | Daily | Same day | Clinical history required | |
| 1021 | P472 | Cancer Panel For Female: CBC, ESR, AFP, BETA HCG, CEA, CA19.9, CA 125, CA15.3 | 3100 | Serum (2 ml), WB EDTA (3 ml), | A | Cell Counter & Microscopy, ECLIA | DAILY | Same day | Clinical history required | |
| 1022 | P138 | Cardiac Panel -I (SGOT, CPK- MB, LDH) | 650 | Serum (2 ml) | A | Spectrophotometry | Daily | Same day | ||
| 1023 | P139 | Cardiac Panel -II (SGOT, CPK-Nac, CPK- MB, LDH) | 900 | Serum (2 ml) | A | Spectrophotometry | Daily | Same day | Same Day | |
| 1024 | P140 | Chronic Lymphoproliferative disorders (CLPD), Basic (CD45, CD14, CD5, CD19, CD3, CD79b, CD23, CD25, CD11c, CD38, FMC7, CD103) | 21000 | WB Heparin, Bone Marrow Heparin, Body Fluids Heparinised | A | Flowcytometry | Daily | Fourth Day | ||
| 1025 | P141 | Chronic Lymphoproliferative Disorders (CLPD), Comprehensive (CD45, CD14, CD5, CD19, CD3, CD4, CD8, CD79b, CD25, CD11c, CD10, CD34, KAPPA, LAMBDA, CD23, CD20, FMC7, CD103, ZAP70, CYCLIN D1) | 21000 | 6 ml (2 ml min.) whole blood each in 1 Lavender Top (EDTA) tube AND 1 Green Top (Sodium Heparin) tube OR 2 ml (1 ml min.) heparinized Bone Marrow. | A | Flowcytometry | Daily | Third Day | ||
| 1026 | P142 | CLL PANEL By Flowcytometry | 13000 | WB Heparin/Bone Marrow Heparin/ Body Fluids Heparinised | A | Flowcytometry | Daily | Third day | Clinical History | |
| 1027 | P144 | Collagen Panel (ANA, dsDNA, ANCA, C3, C4, CRP, RF, UA) | 4400 | Serum (2 ml) | A | Spectropho- tometry, CLIA, ELISA – AGGLUTINATION | Daily | NEXT Day | ||
| 1028 | P145 | Diabetic Panel- (Mini) (Lipid Profile, U.Acid, Crea, BS (Fast + PP), HbA1c, U.Microalbumin, Urine Routine, Urea) | 1350 | WB-EDTA (3 ml), Serum (2 ml), NAF- Plasma (1 ml), Urine (30 ml) | A | Spectrophotome- try, Microscopy | Daily | Same Day | ||
| 1029 | P146 | Diabetic Panel- (Maxi) (Glucose F/PP,, HbA1c, Lipid Profile, Microalbumin, Creat, Electrolytes, Insulin, C-Peptide, Urea) | 2600 | Serum (2 ml), NaF- Plasma (1 ml), Urine(30 ml), WBEDTA (5 ml) | A | Spectrophotom- etry, CC, CLIA, Microscopy | Daily | Same Day | ||
| 1030 | P147 | Diabetic Panel Screening (Glucose F/ PP, HbA1c, Urine Routine) | 600 | WB-EDTA (3 ml), NAF-Plasma (1 ml), Urine (30 ml) | A | Spectrophotome- try, Microscopy, | Daily | Same Day | ||
| 1031 | P148 | Diabetic Screening Basic (HbA1c, Blood Sugar F/ PP/R) | 480 | NaF Plasma (1 ml), Wb EDTA | A | Sepectometry | Daily | Same Day | ||
| 1032 | P149 | Dialysis Panel – I (CBC, FBS, KFT, Protein, Alkaline Phosphatase, Phosphorus, Calcium | 1100 | Serum (2 ml), NaF- Plasma (1 ml), WBEDTA (5 ml) | AA | Spectrophotom- etry, CC, Micros- copy | Daily | Same Day | ||
| 1033 | P150 | Dialysis Panel – II (Protein, Albumin, Alkaline Phosphatase, Calcium, Phosphate, Uric Acid, Creatinine, BUN, Electrolytes, GLU, CBC, SGOT, SGPT, Bil-T, Urin R/M) | 1600 | Serum (2 ml), WB EDTA (3 ml), NaF Plasma (1 ml), Urine (30 ml) | A | Spectrophotometry .CC, Microscopy | Daily | Same Day | ||
| 1034 | P151 | Drug Test 10 Panel: Marijuana, Phencyclidine(PCP) Amphetamines, Opiates, Cocaine Benzodiazepines, Barbiturates, Methadone, Methamphetamine, Propoxyphene | 4600 | Urine (5 ml) | A | Flow Chromatographic Immunoassay | Daily | Same Day | ||
| 1035 | P152 | Drug Test 11 Panel: Amphetamines Barbiturates, Benzodiazepine, Cocaine, Methadone, Methamphetamines, Ecstacy (MDMA), Opiates, Oxycontin, Phencyclidine (PCP), Marijuana (THC) | 4900 | Urine (5 ml) | A | Flow Chromatographic Immunoassay | Daily | Same Day | ||
| 1036 | P153 | Drug Test 12 Panel: Cocaine, Marijuana, Opiates, Amphetamines, Methamphetamines, Phencyclidine(PCP), Benzodiazepines, Barbiturates Methadone, Oxycodone, Ecstasy, Propoxyphene | 5400 | Urine (5 ml) | A | Flow Chromatographic Immunoassay | Daily | Same Day | ||
| 1037 | P154 | Drug Test 5 Panel: Marijuana, Phencyclidine(PCP), Amphetamines, Opiates, Cocaine | 2900 | Urine (5 ml) | A | Flow Chromatographic Immunoassay | Daily | Same Day | ||
| 1038 | P155 | Drug Test 6 Panel: Cannabinoids Amphetamine(AMP), Benzodiazepine, Opiates(Morphine), Cocaine, Barbiturate | 3300 | Urine (5 ml) | A | Flow Chromatographic Immunoassay | Daily | Same Day | ||
| 1039 | P156 | Drug Test 7 Panel: Marijuana Amphetamines, Opiates Cocaine, Methamphetamines Benzodiazepines, Barbiturates | 3800 | Urine (5 ml) | A | Flow Chromatographic Immunoassay | Daily | Same Day | ||
| 1040 | P157 | Drug Test 8 Panel: Amphetamine, Barbiturate, Benzodiazepine, Cocaine, Opiates, Phencyclidine, Marijuana, Methaqualone | 4100 | Urine (5 ml) | A | Flow Chromatographic Immunoassay | Daily | Same Day | ||
| 1041 | P158 | Drug Test 9 Panel: Marijuana, Phencyclidine(PCP), Amphetamines, Opiates, Cocaine, Benzodiazepines, Barbiturates, Methadon, Methaamphetamines | 4350 | Urine (5 ml) | A | Flow Chromatographic Immunoassay | Daily | Same Day | ||
| 1042 | P159 | Electrolytes Panel I (Na, K, Cl) | 350 | Serum (1 ml) | A | ISE | Daily | Same Day | ||
| 1043 | P160 | Electrolytes Panel II (Na, K) | 250 | Serum (1 ml) | A | ISE | Daily | Same Day | ||
| 1044 | P161 | Fever Panel Accuprobe Panel I (CBC, ESR, TYPHI IgM, Malaria Antigen, Urine R/M) | 1100 | EDTA (3mL), Serum (1mL), Urine (30 ml) | A | Cell Counter, Microscopy C.C, WG | Daily | Same day | ||
| 1045 | P162 | Fever Panel Accuprobe Panel II (CBC, ESR, TYPHI DOT IgG IgM, Malaria Antigen, Urine R/M) | 1250 | EDTA (3mL), Serum (1mL), Urine (30 ml) | A | Cell Counter, Microscopy C.C, WG | Daily | Same day | ||
| 1046 | P163 | Fever Panel I (CBC, ESR, Widal, Blood Smear for MP, Urine R/M) | 550 | WB EDTA (3 ml), Serum (2 ml) Urine (30 ml) | A | Spectrophotom- etry, Microscopy, Aggutination, CC | Daily | Same Day | ||
| 1047 | P164 | Fever Panel II (CBC, Urine, Widal, MP, CRP, Blood Culture) | 1400 | WB-EDTA (3 ml), Urine (30 ml), Serum (1 ml) Glucose broth | A | Spectrophotom- etry, Microscopy, CC, AGGLUTINA- TION | Daily | same day, Third Day & seventh Day | Blood Culture resport as per the schedule. | |
| 1048 | P165 | Fever Panel III (CBC, ESR, Widal, Blood Smear for MP, Total.Bilirubin, SGPT, Urine R/M | 650 | Serum (2 ml), WB EDTA (3 ml), Urine (30 ml) | A | Spectrophotom- etry, Microscopy, CC, AGGLUTINA- TION | Daily | Same Day | ||
| 1049 | P166 | Fever Panel IV (CBC, ESR, Urine Routine, Blood Culture, Typhi Dot IgG, IgM) | 1600 | Serum (2 ml), WB EDTA (3 ml), Urine (30 ml), Whole blood (5.0 ml) in Culture Bottle | A | CC, Microscopy, Microbiology, IC | Daily | same day, Third Day & seventh Day | ||
| 1050 | P167 | Hairy Cell Leukemia Monitoring Panel | 8800 | WB-EDTA (3ml) Heparin | A | Flowcytometry | Daily | Third day | ||
| 1051 | P168 | Health Check Profile: Complete Health Check Up (CBC, BSF, LFT, KFT, LIPID Profile, T3, T4, TSH, Urine R/M, Iron | 2400 | Serum (2 ml), Fluride (1 ml), EDTA (3 ml), Urine (30ml) | A | Spectrophotome- try, Cell Counter Microscopy | Daily | Same day | ||
| 1052 | P169 | Health Check Profile: Complete Health Check Up 1 (CBC, BSF, LFT, KFT, LIPID Profile, T3, T4, TSH, Urine R/M, Vitamin D 25-hydroxycholecalcif- erol), Vitamin B12 | 3700 | Serum (2 ml), Fluride (1 ml), EDTA (3 ml), Urine (30ml) | R | Spectrophotome- try, Cell Counter Microscopy, CLIA | Daily | Same day | ||
| 1053 | P170 | Health Check Profile: Complete Health Check Up with Hb1c (CBC, BSF, LFT, KFT, LIPID Profile, T3, T4, TSH, Urine R/M, Iron, Hba1c) | 2600 | Serum (2 ml), Fluride (1 ml), EDTA (3 ml), Urine (30ml) | A | Spectrophotome- try, Cell Counter Microscopy HPLC | Daily | Same day | ||
| 1054 | P171 | Health Check Profile: Complete Health Check Up with Vitamin D 25 OH, Hba1c (CBC, BSF, LFT, KFT, LIPID Profile, T3, T4, TSH, Urine R/M, Iron, Hba1c, Vitamin D 25-hydroxycholecalciferol) | 3600 | Serum (2 ml), Fluride (1 ml), EDTA (3 ml), Urine (30ml) | R | Spectrophotome- try, Cell Counter Microscopy, CLIA | Daily | Same day | ||
| 1055 | P172 | Health Check Profile: Comprehensive Health Checkup Female (Anemia screening (CBC, PS, FBS, PPBS), Lipid Profile, Thyroid Profile, Liver Profile, Kidney Profile, Urine Analysis, Bone Strength Calcium, Phosphorus, Alkaline Phosphatase | 2400 | Serum(3 ml) WB- EDTA (2mL), Na-F (2mL), Urine (30mL) | A | Spectrophotom- etry, Microscopy, C.C, WG | Daily | Same Day | Clinical history required | |
| 1056 | P173 | Health Check Profile: Comprehensive Health Checkup Male (Anemia Screening (CBC, PS, FBS, PPBS), Lipid Profile, Thyroid Profile, Liver Profile, Kidney Profile, Urine Analysis, PSA. | 2600 | Serum(3 ml) WB- EDTA (2mL), Na-F (2ml), Urine (30ml) | A | Spectrophotome- try, Microscopy,, C.C, WG | Daily | Same Day | Clinical history required | |
| 1057 | P174 | Health Check Profile: Executive Health Check Profile I- (CBC+ ESR, FBS, TSH, Liver Function Test, Kidney Function Test, Lipid Profile, Urine R/M) | 1900 | Serum (2 ml), WB EDTA (3 ml), NaF Plasma (1 ml), Urine (30 ml) | A | Spectrophotometry CLIA, CC, Microscopy | Daily | Same Day | ||
| 1058 | P175 | Health Check Profile: Executive Health Check Profile II – (CBC+ ESR, FBS, Liver Function Test, Kidney Function Test, Lipid Profile, Urine R/M) | 1780 | WB-EDTA (3 ml), Slides, Urine (30 ml), Serum (1 ml) | A | Spectrophotom- etry, Microscopy, C.C, WG | Daily | Same Day | ||
| 1059 | P176 | Health Check Profile: Executive Health Check Profile III – (CBC, ESR, Kidney function Test, Lipid Profile, Liver Function Test, Thyroid Function Test, Urine R/M, Blood Sugar Fasting, Calcium) | 2150 | Serum(2 ml), WB-EDTA (3ml), PLASMAF, URINE (30 Ml) | A | Spectrophotom- etry, Microscopy, C.C, WG | Daily | Same Day | ||
| 1060 | P177 | Health Check Profile: Healthy Child Profile CBC,PS, Bilirubin Total, Direct, Indirect Urea, Creatinine, Uric Acid), (SGOT, SGPT) (Calcium, Phosphorus), (HBsAg), Urine Examination) | 1500 | Serum(3 ml) WB- EDTA (2ml), (2ml), Urine (30ml) | A | Spectrophotom- etry, Microscopy, C.C, WG | Daily | Same Day | ||
| 1061 | P178 | Health Check Profile: Regular Health Check Up Comprehensive: (CBC, ESR, BSF, LFT, KFT, LIPID Profile, T3, T4, TSH, Amylase, HbA1C, CRP, Urine R/M | 3400 | WB-EDTA (3 ml), NaF Plasma (1 ml), Serum (2 ml), Urine (30 ml) | A | Spectrophotometry CLIA, CC, Microscopy, AGGLUTINATION HPLC | Daily | Same Day | ||
| 1062 | P179 | Health Check Profile: Regular Health Check Up Profile (CBC, ESR, BSF, LFT, KFT, LIPID Profile, Calcium, Phosphorus, T3, T4, TSH, Amylase, GGT, HbA1C, hsCRP, Urine R/M | 3680 | WB-EDTA (3 ml), NaF Plasma (1 ml), Serum (2 ml), Urine (30 ml) | A | Spectrophotometry CLIA, CC, Microscopy, Agglutination | Daily | Next day | ||
| 1063 | P180 | Health Check Profile: Regular Health Check Up Basic (CBC, ESR, BSF, LFT, KFT, Lipid Profile, Calcium, T3, T4, TSH, Amylase, GGT | 2520 | WB-EDTA (3 ml), NaF Plasma (1 ml), Serum (1 ml), Urine (30 ml) | A | CC, Aggulutination, Microscopy, Spectrophotometry | Daily | Same Day | ||
| 1064 | P181 | Health Check Profile: Regular Health Check Up Screening: (CBC, ESR, UR, ABO & RH, RBS, CHOL-T) | 590 | WB-EDTA (3 ml), NaF Plasma, Serum (2 ml), Urine (30 ml) | A | CC, WG, Microscopy, Aggulutination, Spectrophotometry | Daily | Same Day | ||
| 1065 | P182 | Health Check Profile: Senior Citizen Package Female (Lipid Profile, Diabetic Screening(Sugar Fasting, Sugar Postprandial), Bone Strength (Calcium, Phosphorus, Alkaline Phosphatase), Liver Screening (SGOT, SGPT, Bilirubin-Total), Kidney Screening (Urea, Creatinine), Urine Analysis, Anemia Screening (Complete blood count, Peripheral Blood Smear), Arthritis – joint pain (RA factor), T3, T4, TSH | 2700 | Serum(3 ml) WB- EDTA (2ml), Na-F (2mL), Urine (30ml) | A | Spectrophotom- etry, Microscopy, C.C, WG | Daily | Same Day | ||
| 1066 | P183 | Health Check Profile: Senior Citizen Package Male (Lipid Profile, Diabetic Screening (Sugar Fasting, Sugar Postprandial), Bone Strength (Calcium, Phosphorus, Alkaline Phosphatase), Liver Screening (SGOT, SGPT, Bilirubin-Total), Kidney Screening (Urea, Creatinine), Urine Analysis, Anemia Screening (Complete blood count, Peripheral Blood Smear), Arthritis – Joint pain (RA Factor), PSA | 2700 | Serum(3 ml) WB- EDTA (2ml), Na-F (2ml), Urine (30ml) | A | Spectrophotom- etry, Microscopy, C.C, WG | Daily | Same Day | ||
| 1067 | P184 | HemoCheck (LDH, Ferritin, Creatinine, Reticcount, Coombs test direct, Hb electrophoresis) | 1950 | Serum(2 ml), WB-EDTA (3ml) HPLC | A | Spectro, CLIA, HPLC, Miicrscopic, Agglutination | Daily | Next day | ||
| 1068 | P185 | Hemophilia Panel (APTT, Factor VIII and IX) | 3400 | WB-EDTA (3ml), Plasma Citrate (2ml) | R | Clotting | Daily | Third day | Ensure Platelet Poor Plasma | |
| 1069 | P186 | Hepatitis Panel –I (HAV IgM, HBs Ag, HBc IgM, HBc T, HBeT, HBs T, HCV T, HBeAg, HEV IgM) | 4500 | Serum (2 ml) | A | CLIA, ELISA | Daily | Third day | ||
| 1070 | P187 | Hepatitis Panel–II (HCV RNA PCR Qualitative & Anti HCV Antibodies) | 4580 | Serum (2 ml), WB EDTA (2ml) | A | Real TimePCR, ELISA | Daily | Third day | ||
| 1071 | P188 | Hirustism Panel (LH, FSH, PRL, DHEAS, Testosterone T) | 1750 | Serum (2ml) | A | CLIA/ELISA | Daily | Same Day | ||
| 1072 | P189 | HIV I Panel I (HIV, Western Blot, CD4/D8) | 4000 | WB-EDTA, Serum- -(3ml) | A | Flowcytometry, Immunoblot | 1, 3, 5 | Third day | ||
| 1073 | P190 | HIV Monitoring (CD4/CD8, Viral Load) | 5300 | 4 ml (2 ml min.) (EDTA) tube. Ship refrigerated. | A | PCR, Flowcytometry | Daily | Fifth Day | ||
| 1074 | P191 | HLA DNA TYPING Class I & II, PCR A, B, C, DR & DQ Typing | 28000 | EDTA 2 ML, HEP 2 ml | A | PCR | Daily | Seventh Day | ||
| 1075 | P192 | Hypertension Profile (Kidney Profile, Lipid Profile, Blood Sugar Fasting, TSH, HbA1C, CBC) | 1150 | Serum, PlasmaF (1ml) | A | Spectro, HPLC | Daily | Same Day | ||
| 1076 | P193 | IMD Panel Quantitative Blood: Amino Acid, Fatty Acid, Organic Acid | 5200 | 1 drop of heel / finger prick blood each on 5 spots of filter paper | R | Tandem Mass Spectrometry | 4, 6 | Third Day | ||
| 1077 | P195 | Immunoglobin Panel (IgG, IgM, IgA) | 1400 | Serum (2 ml) | A | Nephelometry | Daily | Same Day | ||
| 1078 | P437 | Infections Profile- (HIV I & II Quant, HBs Ag CLIA, HCV CLIA, VDRL) | 1400 | Serum (3 ml) | A | CLIA, IC | Daily | Same Day | ||
| 1079 | P196 | Infertility – Female Profile –I (LH, FSH, PRL) | 990 | Serum (2 ml) | A | CLIA | Daily | Same Day | ||
| 1080 | P197 | Infertility – Female Profile– II (LH, FSH, PRL, E2, TSH) | 1350 | Serum (2 ml) | A | CLIA | Daily | Same Day | ||
| 1081 | P198 | Infertility– Female Profile –III (AFP, ASAB, bHCG, DHEAS, E2, FSH, LH, PROG, PRL) | 4100 | Serum (2 ml) | A | CLIA /ELISA | 2, 4 | Next day | ||
| 1082 | P199 | Infertility– Female Profile-IV (LH, FSH, PRL, Testosteron T) | 1280 | Serum (2 ml) | A | CLIA | Daily | Same Day | ||
| 1083 | P200 | Infertility Female Profile-V (FSH, LH, PRL, TSH) | 1100 | Serum (2 ml) | A | CLIA | Daily | Same Day | ||
| 1084 | P201 | Infertility– Female Profile-VI (LH, FSH, PRL, E2, Insulin Random, T3T4TSH, Testosterone Total) | 2500 | Serum (2 ml), | A | CLIA – | Daily | Same Day | ||
| 1085 | P202 | Infertility- Male Profile- IV (LH, FSH, PRL, Testosteron T) | 1280 | Serum (2 ml) | A | CLIA | Daily | Same Day | ||
| 1086 | P203 | Iron Panel With Ferritin (Iron, TIBC, Ferritin, Iron saturation Index) | 950 | Serum (2 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 1087 | P204 | KFT NEW (Kidney Profile-1) (Urea, Creatinine, Uric Acid, Na, K, Cl) | 580 | Serum (2 ml) | A | Spectrophotome- try, ISE, – | Daily | Same Day | ||
| 1088 | P449 | Kidney Panel-2 (Urea, Creatinine, Uric Acid, Na, K, CL, Calcium, Phosphorous) | 650 | Serum (2 ml) | A | Spectrophotometry ISE | Daily | Same Day | ||
| 1089 | P205 | Kidney Profile Mini (Urea, Creatinine, Uric Acid, Calcium) | 350 | Serum (2 ml) | A | Sepectometry | Daily | Same Day | ||
| 1090 | P206 | Large Granular Lymphocyte Panel (CD45, CD14, CD3, CD16+56) | 4300 | WB Heparin/Bone Marrow Heparin/ Body Fluids Heparinised | A | Flowcytometry | Daily | Third day | Fasting sample required | |
| 1091 | P207 | Leukemia Custom (Limited) Panel (10 Marker) | 7000 | WB Heparin/Bone Marrow Heparin/ Body Fluids Heparinised | A | Flowcytometry | Daily | Third day | Clinical History | |
| 1092 | P208 | Leukemia Differentiation Pane- CD45, CD34, CD10, CD19, CD5, CD7, HLA-DR, CD13, CD33, CD117, MPO, CYTO CD3, CYTO CD79a, TDT. If required (Optional: any four Marker) CD20, CYTO CD22, CD1a, CD2, CD4, CD8, CD14, CD64, CD11b, CD11c | 8800 | WB Heparin/Bone Marrow Heparin/ Body Fluids Heparinised | A | Flowcytometry | Daily | Third day | Clinical History | |
| 1093 | P209 | Lipid Profile | 530 | Serum (2 ml) | A | Spectrophotometry | Daily | Same Day | Minimum 12 hrs Fasting Required | |
| 1094 | P418 | Lipid Profile Extended- [Lipid Profile, APO A1 / APO B Ratio, Lipoprotein-a (Lp-a)] | 1500 | Serum (2 ml) | A | Nephelometry Spectrophotometry | Daily | Same Day | ||
| 1095 | P210 | Liver Panel (Bilirubin (Total, Direct, Indirect), (AST/SGOT), (ALT/SGPT), GGT, Total Protein, Globulin, Albumin, A/G ratio) | 650 | Serum (2 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 1096 | P211 | Liver panel Mini (Bilirubin T/D/ID, SGOT, SGPT, ALP) | 470 | Serum (2 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 1097 | P213 | Lupa Care- (Anti Phospholipid Ab IgG & IgM, Anti Cardiolipin Ab IgG & IgM, Lupus Anticoagulant) | 3500 | Plasma Citrated (2 ml), Serum (2ml) | R | DRVVT, ELISA | Same | Next day | ||
| 1098 | P214 | Lymphoma Diagnostic Panel I | 15500 | WB-Na Heparin (3 ml), Body Fluid and Serum | A | Flowcytometry | Daily | Third day | Clinical History Required | |
| 1099 | P215 | Lymphoma Diagnostic Panel II | 13500 | WB Heparin/Bone Marrow Heparin/ Body Fluids & EDTA | A | Flowcytometry | Daily | Third day | Clinical History | |
| 1100 | P216 | Maternal screen: Double Marker (Papp-A, Beta -HCG Free) First trimester test (10 to 13.6 weeks) | 2250 | Serum (3 ml) | A | CLIA | Daily 2 Pm | Same Day | Provide maternal Date of birth, LMP or gestational age in weeks and days, number of fetuses (single/twins) Diabetic status and body weight. Valid between 10-13.6 weeks gestation. Latest USA Report is required |
|
| 1101 | P217 | Maternal screen: Quadruple Test (AFP, hCG, uE3, Inhibin A) 2nd trimester test (15 to 21.6 weeks) | 3450 | Serum (3 ml) | A | CLIA | Daily 2 Pm | Same Day | Provide maternal Date of birth, LMP or gestational age in weeks and days, number of fetuses (single/twins) Diabetic status and body weight. Valid between 15-21.6 weeks gestation. Latest USA Report is required |
|
| 1102 | P218 | Maternal screen: Triple Marker Panel (b-HCG, AFP, E3) 2nd trimester test (15 to 21.6 weeks) | 2000 | Serum (3 ml) | A | CLIA | Daily 2 Pm | Same Day | Provide maternal Date of birth, LMP or gestational age in weeks and days, number of fetuses (single/twins) Diabetic status and body weight. Valid between 15-21.6 weeks gestation. Latest USA Report is required |
|
| 1103 | P219 | Menarche- I (LH, FSH, PRL, T3, T4, TSH, E2, Testosterone- Free, Testoterone Total) | 2500 | Serum (2mL) | A | CLIA, ELISA | Daily | Same Day | ||
| 1104 | P220 | Menarche- II (LH, FSH, PRL, TSH, T3, T4, E2, Progesterone) | 1810 | Serum (2mL) | A | CLIA | Daily | Same Day | ||
| 1105 | P221 | Menarche- III (LH, FSH, PRL, TSH, T3, T4, E2, Testosterone Total, Progesterone) | 2200 | Serum (2mL) | A | CLIA | Daily | Same Day | ||
| 1106 | P222 | Metabolic Screen Comprehensive: (Reducing Substances, Ferric Chloride Test, DNPH Test, Nitrosonaphthol test, Nitroprusside Test, Silver Nitroprusside test, Amino Acids Qualitative) | 2600 | 10 ml aliquot of first morning urine in a sterile screw capped container. | A | RI | 2, 4 | Fourth Day | No preservative required.For infants on breast milk, feed the child and then collect urine. Provide a brief clinical and drug history ove the last 3 days prior to specimen collection. |
|
| 1107 | P223 | Metabolic Screen: (FBS, HbA1c, Lipid profile, LFT, Calcium, Uric Acid, BUN, S.Creatinine, BUN/ Creatinine Ratio , IRON, TIBC, Transferrin saturation, T3, T4, TSH, Vitamin D-25) | 3870 | Serum (2 ml), Fluride (1 ml), EDTA (3 ml), Urine (30mL) | A | Spectrophotome- try, Cell Counter Microscopy | Daily | RI | ||
| 1108 | P224 | Multiple Sclerosis Panel: IgG Synthesis Index & Rate, Oligoclonal Bands | 7100 | 4 ml Cerebrospinal fluid & 2 ml Serum | A | BCG, Nephelome- try, Immunoturbidi- metry, Agarose Gel Electrophoresis | Daily | Third Day | The collection date and time must be the same for both specimens. | |
| 1109 | P438 | Myositis Profile 11 Antigen | 9500 | Serun (3 ml) | A | Immunoblot | Daily | Fifth Day | ||
| 1110 | P225 | Neonatal Screening-I (8 Parameters) | 3200 | Edta / Serum | A | Dry Blood Spot | 5 | Fifth Day | ||
| 1111 | P226 | Neonatal Screening- (5 Parameters) | 2000 | Edta / Serum | A | Dry Blood Spot | 3, 6 | Fifth Day | ||
| 1112 | P227 | Neonatal Screening- III (3 Parameters) | 1400 | DRY BLOOD SPOT | A | ELISA | 3, 6 | Fifth Day | ||
| 1113 | P228 | Nirogyam Accuprobe Profile I (CBC+ESR, LFT, KFT, Lipd Profile, Blood Sugar Fasting, Iron Panel, Microalbumin, Urine R/M, Calcium Total, HbA1c, Thyroid Profile-I, Vitamin D-25) | 2500 | Serum (2 ml), Fluride (1 ml), EDTA (3 ml), Urine (30ml) | A | Spectrophotome- try, Cell Counter Microscopy HPLC | Daily | Same day | ||
| 1114 | P229 | Nirogyam Accuprobe Profile II (CBC+ESR, LFT, KFT, Lipd Profile, Blood Sugar Fasting, Iron Panel, Vitamin B 12, Urine R/M, Calcium Total, HbA1c, Thyroid Profile-I, Vitamin D-25) | 2500 | Serum (2 ml), Fluride (1 ml), EDTA (3 ml), Urine (30ml) | A | Spectrophotome- try, Cell Counter Microscopy HPLC | Daily | Same day | ||
| 1115 | P266 | Nirogyam Accuprobe Profile III (CBC+ESR, LFT, KFT, Lipd Profile, Blood Sugar Fasting, Iron Panel, Vitamin B 12, Urine R/M, Calcium Total, HbA1c, Thyroid Profile-I, Vitamin D-25, Microalbumin) | 2800 | Serum (2 ml), Fluride (1 ml), EDTA (3 ml), Urine (30ml) | A | Spectrophotome- try, Cell Counter Microscopy HPLC | Daily | Same day | ||
| 1116 | P339 | Nirogyam Accuprobe Profile IV (CBC+ESR, LFT, KFT, Lipd Profile, Blood Sugar Fasting, Iron Panel, Vitamin B 12, Urine R/M, Calcium Total, HbA1c, Thyroid Profile-I, Vitamin D-25, Microalbumin, ASO Titre, CRP Qualitative, RA Qualitative) | 3300 | Serum (2 ml), Fluride (1 ml), EDTA (3 ml), Urine (30ml) | A | Spectrophotome- try, Cell Counter Microscopy HPLC | Daily | Same day | ||
| 1117 | P230 | NK Cell Panel (CD3, CD16+56) | 4300 | EDTA (3 ml) | A | Flowcytometry | Daily | 4th Day | Clinical history required | |
| 1118 | P231 | Obesity Panel-I (T3, T4, TSH Lipid Profile, Electrolytes, Calcium, Creatinine, Phosphorus, Uric Acid) | 1600 | Serum 2ml, | A | CLIA, Spectrophotometry | Daily | Same Day | ||
| 1119 | P232 | Obesity Panel-II (APLA, ACLA Screen, LA, Male & Female Karyotyping) | 10000 | Serum 2ml, Citrated Plasma (1 ml), WB -Heparin (3 ml) | A | CLIA, CLOTING, Spectrophotometry | Daily | 3 Weeks | ||
| 1120 | P233 | Osteomon Profile (Beta Crosslaps & Total P1NP) | 3200 | Serum (2.0 ml) | A | ECLIA | 2, 6 | Third Day | ||
| 1121 | P234 | Ovarian Cancer Marker (Beta- HCG Total, CA- 125, AFP, CA 19.9) | 2500 | Serum (2 ml) | A | CLIA | Daily | Next Day | ||
| 1122 | P235 | PNH (Paroxysmal nocturnal hemoglobinuria) Comprehensive Panel (CD33, CD 14, Flaer, CD 55, CD 58, CD 59) | 5900 | 3-4 ml, Na Heparin, 3 ml Whole Blood EDTA | A | Flowcytometry | Daily | 6th Day | Clinical History | |
| 1123 | N | Pneumonia Panel Viral I (Influenza A, Influenza B, RSV-RNA, Enterovirus RNA | 8000 | Throat / Nasal Swab | A | PCR | Daily | 6th Day | ||
| 1124 | P236 | Polycystic Ovarian Syndrome (PCOS/PCOD) (LH, FSH, PRL, DHEAs, SO4, Testosterone, Insulin F | 1900 | Serum (2 ml) | A | CLIA | Daily | Same Day | Fasting Sample | |
| 1125 | P237 | Pre Operative Panel –I (PT, APTT, Platelet Count) | 580 | EDTA, Citrated Plasma (1 ml) | R | CC, Clotting | Daily | Same Day | ||
| 1126 | P238 | Pre-Operative Panel –II (CBC, ABO & RH, FBS, HIV, HbsAg, BUN, VDRL) | 1200 | Serum (2 ml), NaF-Plasma (2 ml), WB-EDTA (3 ml) | A | CC, Aggulutination, Rapid, Spectrophotometry | Daily | Same Day | ||
| 1127 | P239 | Pre-Operative Panel -III (CBC, Blood Grouping, Creatinine, FBS, HIV 1& 2, HBsAg, Anti HCVAb) | 1480 | Serum (2 ml), NaF-Plasma (2 ml), WB-EDTA (3 ml) | A | Spectrophotometr, CC, Agglutination, Microscopy, Rapid | Daily | Same Day | ||
| 1128 | P240 | Pre-Operative Panel -IV (CBC+ESR, Blood Grouping, BUN, FBS, HIV 1 & 2, HBsAg, VDRL, PT, APTT, Urine Routine) | 1510 | WB-EDTA (3 ml), NaF Plasma (1 ml), Citrated Plasma (1 ml), Serum (2 ml), Urine (30 ml) | A | Spectropho- tometry, CLIA, CLOTING, CC, Microscopy, RAP- ID IC | Daily | Same Day | ||
| 1129 | P241 | Pre-Operative Panel -V (CBC+ESR, Blood Grouping, BUN, FBS, HIV 1 & 2, HBsAg, VDRL, PT, APTT, Urine Routine, HCV Rapid) | 1900 | WB-EDTA (3 ml), NaF Plasma (1 ml), Citrated Plasma (1 ml), Serum (2 ml), Urine (30 ml) | A | Spectrophotometry CLIA, CLOTING, CC, Microscopy, RAPID IC | Daily | Same Day | ||
| 1130 | P242 | Rheumatoid Panel (CBC, ESR, Protein Electro, CRP, UricAcid, ANA, ASO, RF, Urine R/M) | 2100 | Serum (1 ml), WB- EDTA (3 ml), Urine (30 ml) | A | CC, WG, Ag- gulutination, electrophoresis, Spectropho- tometry, ELISA, Microscopic | Daily | Next day | ||
| 1131 | P439 | Routine Investigation Panel (ABO & RH, CBC+ESR, RBS, HIV, HBsAg, Urine R/M, VDRL, TSH, HCV Rapid, SGPT, Creatinine, Urea) | 1500 | Serum (2 ml), Fluride (1 ml), EDTA (3 ml), Urine (30mL) | A | Spectrophotome- try, Agglutination, CC, Microscopic | Daily | Same Day | ||
| 1132 | P243 | SAAG(Serum Albumin, Ascitic Albumin Gradient) | 250 | Serum (2 ml), fluid (2 ml) | A | Spectrophotometry | Daily | Same Day | ||
| 1133 | P244 | Systemic Lupus Erythematosus Panel (SLE) (CBC, ESR, Creatinin, RA, ASO, ANA, dsDNA) | 2200 | WB-EDTA (3 ml), Serum (1 ml) | A | CLIA, Spectro- photometry, CC, ELISA | Daily | Next Day | ||
| 1134 | P367 | STD Detection Package (HIV, HBsAg, HCV All Rapid, VDRL) | 1000 | Serum (3ml) | A | Rapid/IC | Daily | Same Day | ||
| 1135 | P441 | STD Profile Extended (HIV I & II Ab CLIA, HBsAg CLIA, HCV CLIA, VDRL) | 1500 | Serum (3 ml) | A | CLIA / IC | Daily | Same Day | ||
| 1136 | P245 | Thallasemia Profile (CBC, PS, ESR, Total Iron, TIBC, Ferritin, Hb Electrophoresis) | 1900 | WB-EDTA (3 ml), Serum (1 ml) | A | CC, Electrophoresis, Spectrophotometry | Daily | Next day | ||
| 1137 | P246 | Thrombophilia Panel (Anti Throm-III, Protein C, Protein S) | 10000 | Plasma Citrate (2 ml) | R | CLIA | Daily | Third day | ||
| 1138 | P247 | Thyroid Profile – I (T3, T4, TSH) | 600 | Serum (2 ml) | A | CLIA | Daily | Same Day | ||
| 1139 | P248 | Thyroid Profile – II (T3, T4, TSH, PRL) | 820 | Serum (2 ml) | A | CLIA | Daily | Same Day | ||
| 1140 | P249 | Thyroid Profile – III (T3, T4, TSH, FT3, FT4) | 880 | Serum (2 ml) | A | CLIA | Daily | Same Day | ||
| 1141 | P250 | Thyroid Profile – IV (T3, T4, TSH, LH, FSH, PRL) | 1200 | Serum (2 ml) | A | CLIA | Daily | Same Day | ||
| 1142 | P251 | Thyroid Profile – V (FT3, FT4, TSH) | 680 | Serum (2 ml) | A | CLIA | Daily | Same Day | ||
| 1143 | P252 | Torch Avidity IgG- Toxoplasma, Rubella, Cytomegalovirus | 1800 | Serum (3 ml) | A | ELISA | Daily | Same Day | ||
| 1144 | P253 | TORCH Panel – 4 IgG | 960 | Serum (2 ml) | A | ELISA | Daily | Same Day | ||
| 1145 | P254 | TORCH Panel – 4 IgM | 960 | Serum (2 ml) | A | ELISA | Daily | Same Day | ||
| 1146 | P255 | TORCH Panel – 5 IgG | 1130 | Serum (2 ml) | A | ELISA | Daily | Same Day | ||
| 1147 | P256 | TORCH Panel – 5 IgM | 1130 | Serum (2 ml) | A | ELISA | Daily | Same Day | ||
| 1148 | P257 | TORCH Panel – 8 (IgG & IgM) | 1800 | Serum (2 ml) | A | ELISA | Daily | Same Day | ||
| 1149 | P258 | TORCH Panel -10 (IgG & IgM) | 2130 | Serum (2 ml) | A | ELISA | Daily | Same Day | ||
| 1150 | P259 | Triple Infection (HIV, HbsAg, AntiHCV) | 990 | Serum (2 ml) | A | Rapid/IC | Daily | Same Day | ||
| 1151 | P261 | Tuberculosis Panel III (Qualitative TB DNA PCR, ADA) | 2300 | Serum (1 ml), Any Fluid | A | Real Time PCR, Spectro | 1, 3, 5 | Next day | ||
| 1152 | P262 | IHC Final Diagnostics Panel | 8500 | Tissue in buffered formalin/Paraffin Blocks | A | IHC | Daily | 10 Day | Clinical History | |
| 1153 | P263 | Osteoporosis Panel (Vitamin D, Vitamin B-12, Calcium) | 1850 | Serum (2 ml) | R | CLIA, Spect | Daily | Same Day | ||
| 1154 | P264 | Ovarian Reserve Panel (AMH, FSH, E2 | 2350 | serum (2 ml) | A | CLIA | Daily | Same Day | ||
| 1155 | P265 | Vitamin Duo (Vitamin D 25 OH + Vitanin B12) | 1500 | Serum (2 ml) | R | CLIA | Daily | Same Day | Sample not to be exposed with light | |
| 1156 | P421 | Vasculitis Panel- ANA (ELISA), C-ANCA (PR3), P-ANCA (MPO), ds DNA(ELISA) | 3000 | Serum (3 ml) | R | ELISA | Daily | Third day | ||
| 1157 | P434 | Multiple Myeloma Screening Panel – Immunoglobulin Panel (IgG, IgM, IgA), Immunofixation Electrophoresis, Kappa / Lambda Free Light Chain Ratio, Protein / Serum Electrophoresis | 11500 | Serum (3 ml) | R | Spectrophotometry /Electrophorisis | Daily | Fourth Day | ||
| 1158 | P325 | Ovarian Reserve Panel II – LH, FSH, Prolactin, E2, TSH, AMH | 2800 | Serum (3 ml) | A | CLIA | Daily | Same Day | ||
| 1159 | P450 | Ovarian Reserve Panel III – LH, FSH, Prolactin, E2, TSH, Testosterone Total & Free, Progestrone, AMH | 3400 | Serum (3 ml) | A | CLIA, ELISA | Daily | Same Day | ||
| 1160 | P435 | PCOD GOLD- LH, FSH, Prolactin, Insulin (F), Testosterone Total, DHEA- SO4, AMH | 3500 | Serum (3 ml) | A | CLIA | Daily | Same Day | Fasting Sample Required | |
| 1161 | P436 | PCOD Platinum – LH, FSH, Prolactin, E2, TSH, Insulin (F), Testosterone Total, Progestrone, DHEA- SO4, AMH | 4000 | Serum (3 ml) | A | CLIA | Daily | Same Day | Fasting Sample Required | |
| 1162 | P444 | Neuronal Antibody Profile 1 (6 Antigens) | 8300 | Serum (3 ml) | A | 1 | Fourth Day | |||
| 1163 | P445 | Neuronal Antibody Profile 2 (9 Antigens) | 11000 | Serum (3 ml) | A | 6 | Fourth Day | |||
| 1164 | P446 | Neuronal Antibody Profile 3 (12 Antigens) | 13500 | Serum (3 ml) | A | 6 | Fourth Day | |||
| 1165 | P517 | Accuprobe Immunity Profile – CBC, CRP Quantitative, Kidney panel, Liver Panel, CPK NAC, Ferritin, LDH, Serim IgE, Vit D-25 Hy | 2000 | WB-EDTA (3 ml), Serum (1 ml) | A | Cell Counter, Biochemistry, CLIA | Daily | Same Day | ||
| 1166 | P518 | Accuprobe Health Plus Immunity Profile – CBC, Immunoglobulin Panel IgG, IgA, IgM, Lipid Profile, Liver Panel, Kidney Panel, Thyroid Panel, Glucose (F), Iron Panel Basic, Vit B-12, Vit D-25 Hy, Urine Routine, HBA1C, | 3000 | WB-EDTA (3 ml), Serum (1 ml), Floride 2 ml, Urine(30 ml) | A | Cell Counter, Biochemistry, CLIA | Daily | Same Day | ||
| 1167 | P519 | Immunity Check Plus – CBC, CRP Quantitative, Kidney Panel, Liver Panel, Vit D-25 Hy, Covid-19 IgG Ab, Iron Panel Basic | 2500 | WB-EDTA (3 ml), Serum (1 ml) | A | Cell Counter, Biochemistry, CLIA | Daily | Same Day | ||
| 1168 | P520 | Fever Profile C-19 – CBC, CRP Quantitative, Malaria Ag, Typhi Dot IgG, IgM, Urine R/M, Covid-19 Total Ab | 1500 | Serum, EDTA (3ml) Urine (30ml) | A | Cell Counter, Biochemistry, CLIA | Daily | Same Day | ||
| 1169 | P521 | Covid-19 Combo – Covid-19 IgG Ab, Covid-19 Total Ab | 1800 | Serum | A | CLIA | Daily | Same Day | ||
| 1170 | P522 | Immunity Check – CBC, Iron Panel Basic, Kidney Panel, Liver Panel, CRP Quantitative, Vit-D 25 HY | 2000 | WB-EDTA (3 ml), Serum (1 ml) | A | Cell Counter, Biochemistry, CLIA | Daily | Same Day | ||
| 1171 | P524 | Covid Severity Profile – CBC+ESR, D-Dimer, Interlukin 6, LDH, SGPT, CRP Quantitative, Ferritin | 3200 | WB-EDTA (3 ml), Serum (1 ml), Citrate 2 ml | R | Cell Counter, Biochemistry, CLIA | Daily | Same Day | Separate serum / plasma within 2 hours of collection in a plastic vial immediately with cold chain maintained |
|
| 1172 | P525 | Fever Plus Profile – CBC, Dengu IgG, IgM, Malaria Ag, Typhi Dot IgG IgM, Chikungunya IgM, Leptospirosis IgM | 2200 | WB-EDTA (3 ml), Serum (1 ml) | A | Cell Counter, Rapid Test/ IC | Daily | Same Day | ||
| 1173 | P453 | Accuprobe Silver Panel – CBC+ESR, Iron Panel, Lipid Profile, Thyroid Profile-I, Glucose Fasting Kidney Panel, Liver Panel | 1500 | WB-EDTA (3 ml), Serum (1 ml), Floride 2 ml, Urine(30 ml) | A | Cell Counter, Biochemistry, CLIA | Daily | Same Day | ||
| 1174 | P527 | Accuprobe Silver Basic – CBC, Lipid Profile, Thyroid Profile-I, Glucose Fasting Kidney Panel, Liver Panel | 1500 | WB-EDTA (3 ml), Serum (1 ml), Floride 2 ml, Urine(30 ml) | A | Cell Counter, Biochemistry, CLIA | Daily | Same Day | ||
| 1175 | P452 | Accuprobe Golden Panel – CBC+ESR, HbA1c,Lipid Profile, Thyroid Profile-I Urine R/M, Glucose Fasting, Kidney Panel, Liver Panel | 1850 | WB-EDTA (3 ml), Serum (1 ml), Floride 2 ml, Urine(30 ml) | A | Cell Counter, Biochemistry, CLIA | Daily | Same Day | ||
| 1176 | P454 | Accuprobe Platinum Panel- CBC+ESR, Iron Panel Lipid Profile, Thyroid Profile-I, Vit B-12, Glucose Fasting, Kidney Panel, Liver Panel, Urine R/M, Vit D-25 OH | 2500 | WB-EDTA (3 ml), Serum (1 ml), Floride 2 ml, Urine(30 ml) | A | Cell Counter, Biochemistry, CLIA | Daily | Same Day | ||
| 1177 | P543 | Accuprobe Platinum Plus- CBC+ESR, Iron Panel Liver Panel, Thyroid Profile-I, Vit B-12, Glucose Fasting, Kidney Panel, Rheumatoid Factor (Quantitative), Urine R/M, Vit D-25 OH, HbA1c Lipid Profile | 3000 | WB-EDTA (3 ml), Serum (1 ml), Floride 2 ml, Urine(30 ml) | A | Cell Counter, Biochemistry, CLIA | Daily | Same Day | ||
| 1178 | P550 | Routine Investigation II- ABO Group & RH Type HBsAG (Rapid), HIV I & II Serology (Rapid), Liver Panel, Urine R/M, CBC Hepatitis C Virus, Kidney Panel – 1, TSH, VDRL Test Glucose Random | 1800 | WB-EDTA (3 ml), Serum (1 ml), Floride 2 ml, Urine(30 ml) | A | Cell Counter, Biochemistry, CLIA | Daily | Same Day |
